Age_Median,Sex,Histologic Type ICD-O-3,Histology_Unified,T_Unified,N_Unified,Radiation_Binary,Chemotherapy_Binary,Time from diagnosis to treatment in days recode,COD to site recode,Survival months
77,Male,8041,Small cell carcinoma,p2,Pathologic,1,1,67,Myeloma,14
67,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,0,104,Alive,37
57,Female,8502,Adenocarcinoma,T1,N0,0,0,0,Alive,36
57,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,26,Alive,9
47,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,46
90,Female,8500,Adenocarcinoma,T2,N0,0,0,Unable to calculate,Alive,2
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,34,Alive,59
87,Female,8430,Mucoepidermoid carcinoma,TX,N0,0,1,0,Lung and Bronchus,6
90,Male,8000,unspecified neoplasms,T3,N0,1,0,28,Septicemia,11
52,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,97
67,Male,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,109
62,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,80
82,Female,8982,Myoepithelial carcinoma,T1,N0,0,0,0,Alive,35
72,Male,8070,Squamous cell carcinoma,T2,N1,1,0,46,Salivary Gland,62
77,Male,8046,"epithelial neoplasms, NOS",c2,Clinical,1,1,60,Intrahepatic Bile Duct,15
62,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,19,Alive,59
77,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,15
87,Female,8123,Transitional cell carcinoma,88,88,1,0,0,Alive,36
72,Male,8070,Squamous cell carcinoma,T4a,NX,0,0,0,Miscellaneous Malignant Cancer,21
77,Female,8940,Mixed tumor,T1,N1,1,0,41,Cerebrovascular Diseases,57
52,Male,8070,Squamous cell carcinoma,T1,N2b,0,0,65,Alive,20
72,Male,8010,Carcinoma NOS,p3,Pathologic,1,1,19,Alive,63
47,Male,8140,Adenocarcinoma,T2,N0,1,0,55,Thyroid,18
67,Female,8525,ductal and lobular neoplasms,T4a,N0,0,0,61,Alive,53
87,Male,8500,Adenocarcinoma,T1,N0,0,0,22,Salivary Gland,20
77,Male,8070,Squamous cell carcinoma,cX,Clinical,0,0,92,Other Cause of Death,39
77,Female,8070,Squamous cell carcinoma,TX,NX,1,0,21,Alive,17
90,Male,8430,Mucoepidermoid carcinoma,c2,Clinical,1,0,0,Salivary Gland,13
87,Male,8070,Squamous cell carcinoma,T4a,N2b,1,1,23,Other Cause of Death,7
72,Male,8323,Adenocarcinoma,88,88,0,0,97,Alive,15
52,Male,8290,Oncocytic carcinoma,T1,N2b,1,0,0,Alive,89
77,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,46,Alive,128
42,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,103
47,Male,8140,Adenocarcinoma,T4b,N0,0,0,0,Miscellaneous Malignant Cancer,63
87,Male,8071,Squamous cell carcinoma,T4a,N0,1,0,23,Diseases of Heart,57
47,Female,8550,Acinar cell carcinoma,T2,N0,0,0,23,Alive,85
87,Male,8070,Squamous cell carcinoma,T3,N3,1,0,34,Salivary Gland,1
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,23,Alive,122
72,Female,8147,Adenocarcinoma,T2,N0,0,0,0,Alive,59
57,Female,8070,Squamous cell carcinoma,T2,N2b,1,0,29,Corpus Uteri,56
87,Male,8200,Adenoid cystic carcinoma,TX,N0,0,0,50,Salivary Gland,44
77,Female,8010,Carcinoma NOS,T3,N2a,0,1,41,Alive,10
42,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,153
67,Male,8140,Adenocarcinoma,T1,N0,0,0,0,Alive,148
77,Female,8941,Carcinoma ex pleomorphic adenoma,T3,N0,1,0,0,Alive,149
67,Male,8550,Acinar cell carcinoma,T3,N0,1,0,41,Alive,4
57,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,25,Salivary Gland,74
77,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,23,Alive,31
72,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Hypertension without Heart Disease,37
82,Male,8140,Adenocarcinoma,T3,N2b,1,0,27,Alive,16
82,Male,8430,Mucoepidermoid carcinoma,T4a,N2b,1,1,56,Septicemia,3
72,Male,8010,Carcinoma NOS,T2,N2b,1,0,41,Salivary Gland,10
72,Female,8010,Carcinoma NOS,p1,Clinical,0,0,0,Alive,69
82,Male,8430,Mucoepidermoid carcinoma,TX,N0,0,0,162,Lung and Bronchus,30
57,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,56,Alive,105
67,Female,8500,Adenocarcinoma,T2,N0,0,0,Unable to calculate,Salivary Gland,42
87,Female,8147,Adenocarcinoma,T2,N0,0,0,0,Chronic Obstructive Pulmonary Disease and Allied Cond,28
67,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,147
77,Male,8200,Adenoid cystic carcinoma,T4a,N0,1,0,0,Alive,30
62,Female,8010,Carcinoma NOS,T3,N0,1,0,30,Alive,130
90,Female,8071,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Diseases of Heart,0
82,Male,8070,Squamous cell carcinoma,T1,N0,1,0,0,Non-Melanoma Skin,62
90,Male,8500,Adenocarcinoma,T3,N1,0,0,Unable to calculate,Salivary Gland,2
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,119
62,Female,8550,Acinar cell carcinoma,T4a,N0,1,0,93,Alzheimers (ICD-9 and 10 only),104
72,Female,8140,Adenocarcinoma,T2,N2b,1,0,20,Salivary Gland,72
47,Female,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,0,Alive,61
90,Male,8070,Squamous cell carcinoma,T3,N0,1,0,70,Salivary Gland,7
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,41,Alive,129
82,Female,8140,Adenocarcinoma,TX,N1,0,0,0,Chronic Obstructive Pulmonary Disease and Allied Cond,2
87,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,34,Diseases of Heart,115
87,Male,8000,unspecified neoplasms,T4a,N1,0,0,Unable to calculate,Other Infectious and Parasitic Diseases including HIV,1
87,Female,8071,Squamous cell carcinoma,T3,N0,0,0,48,Miscellaneous Malignant Cancer,1
42,Female,8430,Mucoepidermoid carcinoma,T3,N0,1,0,0,Alive,101
72,Male,8070,Squamous cell carcinoma,T2,N0,1,0,20,Miscellaneous Malignant Cancer,19
77,Male,8070,Squamous cell carcinoma,T1,NX,0,0,181,Non-Hodgkin Lymphoma,6
32,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,60,Alive,78
82,Male,8200,Adenoid cystic carcinoma,T1,N0,0,0,0,Alive,52
82,Male,8140,Adenocarcinoma,T4a,N2b,0,0,47,Miscellaneous Malignant Cancer,86
77,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,Unable to calculate,Alive,39
62,Male,8500,Adenocarcinoma,p2,Pathologic,1,0,0,Alive,69
87,Male,8430,Mucoepidermoid carcinoma,T2,N1,1,0,10,Other Cause of Death,45
37,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,96
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,76
90,Male,8070,Squamous cell carcinoma,c4A,Clinical,1,0,Unable to calculate,Chronic Lymphocytic Leukemia,5
72,Female,8430,Mucoepidermoid carcinoma,p4A,Pathologic,1,0,0,Miscellaneous Malignant Cancer,14
57,Female,8562,Epithelial-myoepithelial carcinoma,T3,N0,1,1,51,Alive,5
27,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,0,56,Alive,139
77,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,Unable to calculate,Miscellaneous Malignant Cancer,8
72,Female,8410,Adenocarcinoma,T2,N0,1,0,22,Alive,46
72,Female,8550,Acinar cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,2
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,152,Breast,27
72,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,17,Alzheimers (ICD-9 and 10 only),91
87,Male,8070,Squamous cell carcinoma,T2,N0,0,0,0,Diseases of Heart,42
62,Female,8550,Acinar cell carcinoma,T1,N0,1,0,84,Alive,37
82,Female,8480,Mucinous adenocarcinoma,T1,N0,1,1,39,Lung and Bronchus,26
82,Female,8070,Squamous cell carcinoma,c4B,Clinical,1,0,21,Non-Melanoma Skin,2
87,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Non-Melanoma Skin,3
87,Male,8070,Squamous cell carcinoma,T2,N0,1,0,55,Alive,54
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,84
77,Female,8550,Acinar cell carcinoma,TX,N0,1,0,0,Alive,144
62,Female,8200,Adenoid cystic carcinoma,p3,Pathologic,1,0,34,Alive,70
72,Male,8070,Squamous cell carcinoma,c1,Pathologic,1,0,52,Alive,62
72,Female,8430,Mucoepidermoid carcinoma,p2,Pathologic,1,0,28,Alive,68
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,47,Alive,9
77,Male,8500,Adenocarcinoma,p4A,Pathologic,1,0,21,Alive,63
62,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,52
77,Male,8070,Squamous cell carcinoma,T4a,N0,0,0,106,Non-Melanoma Skin,29
82,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,21,Thyroid,57
82,Male,8070,Squamous cell carcinoma,T3,N0,1,0,30,Alive,4
67,Female,8070,Squamous cell carcinoma,TX,N3,0,0,0,Alive,139
57,Female,8430,Mucoepidermoid carcinoma,T1,NX,0,0,0,Alive,131
82,Female,8430,Mucoepidermoid carcinoma,p2,Clinical,0,0,0,Alive,65
77,Male,8041,Small cell carcinoma,TX,N3b,1,1,42,Alive,53
62,Male,8430,Mucoepidermoid carcinoma,p3,Pathologic,0,0,17,Alive,70
82,Female,8502,Adenocarcinoma,T1,N0,0,0,0,Cerebrovascular Diseases,15
82,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,1
52,Female,8082,squamous cell neoplasms,TX,N2b,1,1,0,Alive,14
67,Female,8982,Myoepithelial carcinoma,T4a,N0,1,0,55,Alive,58
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,59
90,Male,8001,unspecified neoplasms,T4a,N2a,0,0,Unable to calculate,Salivary Gland,2
90,Male,8070,Squamous cell carcinoma,T2,N2b,0,0,Unable to calculate,Miscellaneous Malignant Cancer,6
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,27
62,Male,8982,Myoepithelial carcinoma,p3,Pathologic,1,0,0,Alive,64
67,Male,8982,Myoepithelial carcinoma,T1,N0,0,0,0,Alive,9
90,Male,8083,Squamous cell carcinoma,T2,N2c,1,0,49,Alive,0
67,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,114
47,Female,8550,Acinar cell carcinoma,p2,Pathologic,1,0,0,Salivary Gland,22
87,Male,8140,Adenocarcinoma,T3,N0,1,0,10,Alive,7
77,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,1
62,Male,8140,Adenocarcinoma,T2,N1,1,1,63,Salivary Gland,17
62,Male,8070,Squamous cell carcinoma,TX,N1,1,0,28,Non-Melanoma Skin,67
67,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Other Cause of Death,140
62,Male,8083,Squamous cell carcinoma,T4a,N2b,1,1,22,Prostate,13
57,Female,8200,Adenoid cystic carcinoma,T1,N0,0,0,0,Alive,29
57,Female,8980,complex mixed and stromal neoplasms,T3,N0,0,1,Unable to calculate,Salivary Gland,16
62,Female,8140,Adenocarcinoma,T2,N1,1,0,0,Alive,154
72,Female,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,154
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,147
42,Male,8010,Carcinoma NOS,T4b,N0,1,1,37,Alive,153
72,Female,8500,Adenocarcinoma,T4a,N3b,1,1,47,Alive,28
37,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,179,Alive,154
27,Female,8082,squamous cell neoplasms,T2,N0,1,0,15,Alive,150
62,Male,8147,Adenocarcinoma,T3,N0,1,0,17,Alive,155
22,Female,8430,Mucoepidermoid carcinoma,T4a,N1,1,0,20,Alive,150
27,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,32
62,Male,8140,Adenocarcinoma,T3,N0,1,1,0,Alive,148
87,Female,8070,Squamous cell carcinoma,T1,N0,1,0,20,"Nephritis, Nephrotic Syndrome and Nephrosis",87
87,Male,8071,Squamous cell carcinoma,T4a,N0,1,0,21,Miscellaneous Malignant Cancer,35
82,Female,8982,Myoepithelial carcinoma,T2,N0,1,0,0,Acute Myeloid Leukemia,19
62,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,148
57,Male,8550,Acinar cell carcinoma,T1,N0,0,0,65,Alive,153
72,Male,8200,Adenoid cystic carcinoma,T2,N0,0,0,0,Salivary Gland,47
42,Male,8550,Acinar cell carcinoma,T4a,N0,0,0,35,Alive,153
77,Male,8070,Squamous cell carcinoma,T1,N0,1,0,0,Alive,151
22,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,73,Alive,149
42,Female,8550,Acinar cell carcinoma,T2,N0,0,0,34,Alive,155
52,Male,8070,Squamous cell carcinoma,T3,N0,1,1,35,Alive,154
37,Male,8500,Adenocarcinoma,T4a,N2b,1,1,0,Salivary Gland,113
82,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,151
62,Male,8010,Carcinoma NOS,T3,N0,1,0,0,Alive,154
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,151
42,Male,8140,Adenocarcinoma,T2,N2b,1,1,19,Other Infectious and Parasitic Diseases including HIV,72
67,Male,8430,Mucoepidermoid carcinoma,T1,NX,0,0,0,Alive,146
77,Male,8070,Squamous cell carcinoma,T4a,N1,1,1,60,Miscellaneous Malignant Cancer,36
57,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,34
57,Female,8140,Adenocarcinoma,T2,N0,1,0,0,Salivary Gland,27
62,Male,8083,Squamous cell carcinoma,T4a,N0,1,1,118,Diseases of Heart,87
77,Female,8070,Squamous cell carcinoma,T3,N1,1,0,38,Other Cause of Death,78
67,Male,8010,Carcinoma NOS,TX,N0,0,0,38,Intrahepatic Bile Duct,41
82,Male,8070,Squamous cell carcinoma,T3,N0,0,0,28,Non-Melanoma Skin,46
27,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,144
72,Male,8200,Adenoid cystic carcinoma,T4a,N0,1,0,42,Diseases of Heart,107
52,Male,8982,Myoepithelial carcinoma,TX,N0,0,0,56,Alive,131
90,Female,8000,unspecified neoplasms,TX,N0,0,0,Unable to calculate,Bones and Joints,2
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,142
17,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,149
87,Male,8010,Carcinoma NOS,T2,N2b,1,0,46,State DC not available or state DC available but no COD,41
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,30,Alive,144
82,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,124
52,Female,8550,Acinar cell carcinoma,T3,N0,0,0,38,Alive,141
67,Male,8010,Carcinoma NOS,T2,N0,1,0,35,Salivary Gland,13
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,124,Alive,146
62,Male,8200,Adenoid cystic carcinoma,T4b,N2b,1,0,119,Gum and Other Mouth,12
77,Male,8070,Squamous cell carcinoma,T2,N2b,1,1,23,Alzheimers (ICD-9 and 10 only),95
82,Male,8502,Adenocarcinoma,T1,N0,1,0,0,Alive,2
67,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Miscellaneous Malignant Cancer,109
72,Male,8072,Squamous cell carcinoma,T3,N0,1,0,32,Alive,141
62,Male,8010,Carcinoma NOS,TX,N2NOS,1,1,0,Nasopharynx,13
42,Female,8440,Adenocarcinoma,T1,N0,0,0,3,Alive,142
12,Female,8430,Mucoepidermoid carcinoma,T2,N2b,1,0,0,Alive,141
77,Female,8200,Adenoid cystic carcinoma,T3,N0,0,0,0,Alive,127
87,Male,8430,Mucoepidermoid carcinoma,T2,N1,1,0,14,Miscellaneous Malignant Cancer,29
52,Female,8200,Adenoid cystic carcinoma,T1,N0,0,0,0,Alive,137
72,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,112,Other Cause of Death,32
52,Male,8200,Adenoid cystic carcinoma,T4b,N2b,1,0,44,Salivary Gland,133
67,Male,8070,Squamous cell carcinoma,T4b,N0,1,1,30,Alive,135
77,Male,8070,Squamous cell carcinoma,T2,N0,1,0,31,Lung and Bronchus,35
77,Female,8147,Adenocarcinoma,T4b,N0,0,0,0,State DC not available or state DC available but no COD,34
57,Male,8941,Carcinoma ex pleomorphic adenoma,T4a,N3,1,1,37,Alive,142
42,Male,8140,Adenocarcinoma,T1,N0,1,0,0,Alive,141
72,Male,8071,Squamous cell carcinoma,T3,N1,1,0,34,Salivary Gland,64
47,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,31
90,Male,8071,Squamous cell carcinoma,T4a,N0,1,0,16,Cerebrovascular Diseases,58
77,Male,8070,Squamous cell carcinoma,T1,N2b,1,0,0,"Other Diseases of Arteries, Arterioles, Capillaries",37
82,Female,8000,unspecified neoplasms,T2,N0,0,0,Unable to calculate,Cerebrovascular Diseases,104
52,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,140
67,Female,8071,Squamous cell carcinoma,T2,N0,1,0,20,Alive,138
52,Male,8147,Adenocarcinoma,T2,N0,1,0,0,"Peritoneum, Omentum and Mesentery",77
72,Male,8070,Squamous cell carcinoma,TX,N2b,0,1,0,Diseases of Heart,6
72,Male,8071,Squamous cell carcinoma,T3,N0,0,0,Unable to calculate,Cerebrovascular Diseases,0
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,136
62,Male,8430,Mucoepidermoid carcinoma,T4a,N2b,1,1,39,Alive,102
57,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,136
42,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,138
57,Female,8140,Adenocarcinoma,T4a,N1,1,0,0,Salivary Gland,7
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,20
72,Female,8500,Adenocarcinoma,T4a,N2b,1,1,0,Salivary Gland,32
57,Female,8010,Carcinoma NOS,T2,N0,1,0,56,"In situ, benign or unknown behavior neoplasm",62
77,Male,8200,Adenoid cystic carcinoma,T3,N1,1,0,0,Salivary Gland,93
77,Male,8070,Squamous cell carcinoma,T3,N2b,1,1,32,Suicide and Self-Inflicted Injury,66
67,Male,8140,Adenocarcinoma,T3,N0,1,0,0,Lung and Bronchus,12
82,Male,8010,Carcinoma NOS,T1,N0,1,0,0,Other Cause of Death,9
42,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,134
22,Female,8550,Acinar cell carcinoma,T3,N0,0,0,58,Alive,134
62,Male,8070,Squamous cell carcinoma,T1,N0,1,0,0,Alive,145
62,Female,8022,Undifferentiated carcinoma,T4b,N2b,1,1,Unable to calculate,Salivary Gland,27
22,Male,8550,Acinar cell carcinoma,T3,N0,0,0,0,Alive,134
77,Female,8550,Acinar cell carcinoma,T2,N0,1,0,60,Alive,134
72,Female,8500,Adenocarcinoma,T2,N0,0,0,0,Alive,17
82,Male,8071,Squamous cell carcinoma,T4a,N0,1,0,28,Miscellaneous Malignant Cancer,8
62,Male,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,36,Alive,132
57,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,132
37,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,131
67,Female,8550,Acinar cell carcinoma,T1,N0,1,0,0,Other Cause of Death,116
47,Female,8430,Mucoepidermoid carcinoma,TX,NX,0,0,Unable to calculate,Alive,0
57,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,131
87,Female,8070,Squamous cell carcinoma,T3,N0,0,0,Unable to calculate,Salivary Gland,2
42,Female,8200,Adenoid cystic carcinoma,TX,N0,1,1,25,Alive,131
62,Male,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Alive,38
47,Male,8430,Mucoepidermoid carcinoma,T4NOS,N2a,1,0,35,Salivary Gland,3
82,Male,8070,Squamous cell carcinoma,T4a,N0,1,0,0,Pancreas,41
37,Male,8140,Adenocarcinoma,T1,N0,1,0,31,Alive,129
52,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,Unable to calculate,Alive,130
77,Male,8000,unspecified neoplasms,T2,N0,0,0,Unable to calculate,Diseases of Heart,56
77,Male,8200,Adenoid cystic carcinoma,T2,N2b,1,0,0,Salivary Gland,27
37,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,129
32,Male,8430,Mucoepidermoid carcinoma,T3,N1,0,0,0,Alive,128
42,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,22,Alive,128
52,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,81
82,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,109
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,127
67,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,123
32,Female,8502,Adenocarcinoma,T1,N0,0,0,0,Alive,130
82,Male,8070,Squamous cell carcinoma,T1,N0,0,0,0,Other Cause of Death,21
12,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,126
47,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,0,73,Alive,118
77,Male,8200,Adenoid cystic carcinoma,T1,N0,0,0,38,Alive,122
67,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Breast,75
72,Female,8550,Acinar cell carcinoma,T2,N0,0,0,19,Alive,126
82,Male,8430,Mucoepidermoid carcinoma,T4a,N2b,1,0,24,Salivary Gland,39
87,Female,8070,Squamous cell carcinoma,T4a,N0,1,1,28,Salivary Gland,18
90,Male,8010,Carcinoma NOS,T4a,N3b,1,1,0,Alive,45
37,Male,8083,Squamous cell carcinoma,TX,N0,0,0,0,Salivary Gland,48
82,Male,8140,Adenocarcinoma,T1,N0,0,0,66,Diseases of Heart,99
82,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,73,Salivary Gland,46
62,Female,8982,Myoepithelial carcinoma,T3,N0,0,0,0,Alive,122
90,Male,8140,Adenocarcinoma,T4a,N0,1,0,44,Alive,17
82,Male,8140,Adenocarcinoma,T1,N0,1,0,50,Alzheimers (ICD-9 and 10 only),117
62,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,58,Alive,123
22,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,123
87,Male,8430,Mucoepidermoid carcinoma,T4a,N1,1,0,38,Miscellaneous Malignant Cancer,26
72,Male,8500,Adenocarcinoma,T2,N0,1,0,26,Diseases of Heart,105
32,Male,8550,Acinar cell carcinoma,T2,N0,0,0,55,Alive,126
72,Male,8070,Squamous cell carcinoma,T3,N2b,1,0,27,Alive,124
42,Female,8941,Carcinoma ex pleomorphic adenoma,T4a,N0,1,0,98,Alive,142
22,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,121
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,122
52,Male,8010,Carcinoma NOS,T3,N2b,1,1,52,Salivary Gland,10
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,123
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,120
72,Male,8032,Undifferentiated carcinoma,T4a,N0,1,1,30,Salivary Gland,14
77,Female,8200,Adenoid cystic carcinoma,T4b,N1,1,0,0,Miscellaneous Malignant Cancer,19
27,Male,8200,Adenoid cystic carcinoma,T2,N1,1,0,0,Alive,123
32,Female,8502,Adenocarcinoma,T2,N0,0,0,37,Alive,122
62,Male,8147,Adenocarcinoma,T3,N1,1,1,19,Alive,121
77,Male,8070,Squamous cell carcinoma,T2,N0,1,0,33,Diseases of Heart,18
27,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,120
62,Female,8450,"cystic, mucinous and serous neoplasms",T1,N0,0,0,0,Alive,118
77,Female,8140,Adenocarcinoma,T2,N2b,0,0,Unable to calculate,Miscellaneous Malignant Cancer,38
52,Male,8941,Carcinoma ex pleomorphic adenoma,T1,N0,0,0,0,Alive,118
77,Male,8140,Adenocarcinoma,T4a,N0,1,0,0,Salivary Gland,10
87,Male,8070,Squamous cell carcinoma,T1,N0,1,0,10,Accidents and Adverse Effects,35
82,Male,8010,Carcinoma NOS,T3,N2b,1,0,37,State DC not available or state DC available but no COD,70
90,Male,8000,unspecified neoplasms,T3,N0,1,0,54,Chronic Obstructive Pulmonary Disease and Allied Cond,63
62,Female,8500,Adenocarcinoma,T3,N2b,1,0,101,Esophagus,11
67,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,118
87,Male,8982,Myoepithelial carcinoma,TX,NX,0,0,Unable to calculate,Alive,13
67,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,117,Alive,45
22,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,118
72,Male,8072,Squamous cell carcinoma,T3,N0,1,0,21,Salivary Gland,66
82,Male,8046,"epithelial neoplasms, NOS",T1,N2b,1,0,0,Salivary Gland,26
42,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,0,0,Salivary Gland,37
57,Male,8430,Mucoepidermoid carcinoma,T3,N1,0,1,0,Salivary Gland,33
90,Female,8070,Squamous cell carcinoma,T2,N1,0,0,Unable to calculate,Alive,51
72,Male,8070,Squamous cell carcinoma,T1,N0,0,0,29,Alive,126
57,Male,8500,Adenocarcinoma,T4a,N2b,1,0,18,Salivary Gland,71
87,Male,8247,Neuroendocrine carcinoma,T3,N0,1,0,32,Chronic Obstructive Pulmonary Disease and Allied Cond,11
77,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,Unable to calculate,Alive,104
52,Female,8430,Mucoepidermoid carcinoma,T1,N2b,0,0,0,Alive,118
47,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,116
77,Female,8071,Squamous cell carcinoma,T4a,N2b,0,0,31,Gum and Other Mouth,18
77,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,116
7,Female,8430,Mucoepidermoid carcinoma,T3,N0,1,0,5,Alive,116
87,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,25
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Ovary,40
42,Male,8550,Acinar cell carcinoma,T1,N0,0,0,34,Alive,117
57,Male,8000,unspecified neoplasms,T3,N0,0,0,Unable to calculate,Alive,114
77,Male,8010,Carcinoma NOS,T1,N0,1,0,17,Salivary Gland,31
87,Female,8070,Squamous cell carcinoma,T1,N2b,1,0,56,Alive,114
72,Male,8070,Squamous cell carcinoma,T1,N2b,1,1,0,Alive,115
67,Male,8560,Adenosquamous carcinoma,T2,N2b,1,0,0,Diabetes Mellitus,74
42,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,114
57,Male,8140,Adenocarcinoma,c1,Pathologic,0,0,8,Alive,62
90,Male,8041,Small cell carcinoma,TX,N1,0,0,Unable to calculate,Miscellaneous Malignant Cancer,1
67,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,29,Diseases of Heart,67
37,Male,8502,Adenocarcinoma,T1,N0,0,0,15,Alive,113
57,Female,8550,Acinar cell carcinoma,T4a,N0,1,0,0,Alive,38
47,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,17,Alive,112
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,113
82,Female,8200,Adenoid cystic carcinoma,T4a,N1,1,0,46,Salivary Gland,83
77,Female,8147,Adenocarcinoma,T1,N0,1,0,0,Alive,111
82,Female,8982,Myoepithelial carcinoma,T3,N0,1,0,0,Salivary Gland,77
90,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Other Cause of Death,8
82,Male,8430,Mucoepidermoid carcinoma,T2,N2b,0,0,0,Salivary Gland,9
62,Female,8010,Carcinoma NOS,T4a,N2b,1,1,Unable to calculate,Alive,28
62,Male,8140,Adenocarcinoma,T1,N0,0,0,0,Alive,115
77,Male,8200,Adenoid cystic carcinoma,T4b,N0,0,0,Unable to calculate,Salivary Gland,6
72,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,111
87,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Diseases of Heart,82
82,Male,8290,Oncocytic carcinoma,T1,N0,0,0,0,Alive,35
77,Male,8140,Adenocarcinoma,T1,N0,0,1,21,Salivary Gland,4
47,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,2
72,Female,8310,Adenocarcinoma,T2,N0,0,0,0,Brain and Other Nervous System,113
77,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,Unable to calculate,"In situ, benign or unknown behavior neoplasm",90
52,Male,8010,Carcinoma NOS,T3,N2c,0,0,Unable to calculate,Pneumonia and Influenza,2
22,Female,8550,Acinar cell carcinoma,T4a,N0,1,0,13,Alive,109
57,Male,8430,Mucoepidermoid carcinoma,TX,N2b,0,0,0,Alive,108
77,Female,8070,Squamous cell carcinoma,T2,N1,1,0,0,Diseases of Heart,52
42,Male,8500,Adenocarcinoma,T3,N2b,1,1,0,Alive,107
87,Male,8070,Squamous cell carcinoma,T1,N0,1,0,50,Alive,108
87,Male,8010,Carcinoma NOS,T1,N1,1,0,26,Alive,18
42,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,0
82,Female,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Diseases of Heart,62
62,Female,8550,Acinar cell carcinoma,T4a,N2b,1,0,75,Alive,107
90,Female,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
72,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,106
67,Male,8033,Undifferentiated carcinoma,T3,N0,0,0,63,Other Cause of Death,2
72,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,0,Alive,34
62,Female,8310,Adenocarcinoma,T1,N0,0,0,53,Alive,102
67,Female,8550,Acinar cell carcinoma,T4b,N0,1,0,14,Alive,103
57,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,103
67,Male,8550,Acinar cell carcinoma,T3,N0,1,1,7,Salivary Gland,64
77,Male,8140,Adenocarcinoma,T1,N2b,1,0,25,Alive,102
52,Male,8550,Acinar cell carcinoma,T3,N0,1,0,0,Alive,101
57,Male,8200,Adenoid cystic carcinoma,T2,N2b,0,1,0,Salivary Gland,18
62,Male,8010,Carcinoma NOS,T4a,N2b,1,1,26,Miscellaneous Malignant Cancer,17
90,Male,8500,Adenocarcinoma,T1,N2b,1,0,42,Alive,57
47,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,102
82,Male,8140,Adenocarcinoma,T4a,N1,1,0,47,Alive,17
87,Female,8070,Squamous cell carcinoma,T1,N0,1,0,17,Non-Melanoma Skin,47
37,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,4
57,Male,8070,Squamous cell carcinoma,T4a,N2b,1,0,69,Alive,101
52,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,100
57,Male,8010,Carcinoma NOS,T1,N2b,1,1,35,Alive,99
87,Female,8071,Squamous cell carcinoma,TX,N1,1,0,17,Alive,101
77,Female,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,State DC not available or state DC available but no COD,99
37,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,99
77,Female,8500,Adenocarcinoma,T2,N2b,1,0,30,Alive,99
72,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,99
82,Male,8500,Adenocarcinoma,T3,N2b,1,0,25,State DC not available or state DC available but no COD,67
52,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,0,0,0,Alive,94
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,32,Alive,40
82,Male,8070,Squamous cell carcinoma,T4a,N0,1,0,50,Oropharynx,20
62,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,97
77,Male,8500,Adenocarcinoma,T3,N2b,0,0,0,Diseases of Heart,28
77,Male,8070,Squamous cell carcinoma,T3,N2b,1,1,Unable to calculate,Other Cause of Death,10
37,Male,8982,Myoepithelial carcinoma,T4a,N0,1,1,0,Alive,97
62,Male,8010,Carcinoma NOS,T1,N1,1,1,0,Alive,98
47,Male,8430,Mucoepidermoid carcinoma,TX,N0,0,0,0,Alive,118
77,Male,8070,Squamous cell carcinoma,T2,N0,0,0,0,Salivary Gland,8
52,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,96
72,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Non-Melanoma Skin,18
62,Female,8500,Adenocarcinoma,T3,N0,1,1,0,Salivary Gland,41
72,Male,8550,Acinar cell carcinoma,T3,N0,0,0,0,Alive,95
62,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,96
52,Male,8200,Adenoid cystic carcinoma,T1,N0,0,0,0,Alive,94
87,Male,8070,Squamous cell carcinoma,T3,N2b,1,1,0,Salivary Gland,23
67,Male,8502,Adenocarcinoma,T2,N0,0,0,0,Alive,4
67,Female,8550,Acinar cell carcinoma,T2,N0,0,0,25,Alive,94
67,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,93
77,Female,8147,Adenocarcinoma,TX,NX,0,0,Unable to calculate,Alive,8
52,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,93
67,Female,8200,Adenoid cystic carcinoma,T1,N0,0,0,62,Alive,94
57,Male,8200,Adenoid cystic carcinoma,T2,N0,0,0,0,Alive,92
57,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,0,0,Miscellaneous Malignant Cancer,55
72,Female,8550,Acinar cell carcinoma,p2,Clinical,1,0,0,Colon excluding Rectum,10
72,Male,8147,Adenocarcinoma,T2,N0,0,0,0,Alive,91
87,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Diseases of Heart,74
22,Female,8550,Acinar cell carcinoma,T2,N0,1,0,29,Alive,90
67,Female,8200,Adenoid cystic carcinoma,T4a,N0,0,0,0,Salivary Gland,36
77,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,90
52,Female,8500,Adenocarcinoma,T1,N0,1,0,28,Alive,89
32,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,48,Alive,89
77,Male,8500,Adenocarcinoma,T4b,N3b,1,0,23,Salivary Gland,55
67,Male,8147,Adenocarcinoma,T2,N0,1,0,0,Alive,88
62,Male,8041,Small cell carcinoma,T3,N2b,1,1,33,Alive,88
67,Male,8941,Carcinoma ex pleomorphic adenoma,TX,N0,0,0,0,Alive,99
42,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,88
77,Female,8070,Squamous cell carcinoma,T3,N1,0,0,42,Alive,83
72,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,88
87,Male,8010,Carcinoma NOS,TX,N0,0,0,Unable to calculate,Salivary Gland,9
32,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,87
82,Female,8070,Squamous cell carcinoma,c3,Clinical,0,0,Unable to calculate,Other Cause of Death,6
62,Female,8550,Acinar cell carcinoma,T2,N0,1,0,20,Alive,87
82,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,60,Alive,84
52,Female,8140,Adenocarcinoma,T1,N0,1,0,0,Alive,88
62,Male,8940,Mixed tumor,T3,N2b,1,0,35,Alive,86
37,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,84
82,Male,8000,unspecified neoplasms,T2,N0,1,0,48,Salivary Gland,9
57,Male,8140,Adenocarcinoma,T1,N1,1,0,47,Alive,84
42,Male,8550,Acinar cell carcinoma,T1,N0,0,0,33,Alive,85
72,Male,8073,Squamous cell carcinoma,TX,N0,0,0,Unable to calculate,Salivary Gland,17
62,Male,8140,Adenocarcinoma,TX,NX,1,1,Unable to calculate,Salivary Gland,41
47,Male,8022,Undifferentiated carcinoma,T3,N0,1,0,21,Alive,85
42,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,84
67,Female,8010,Carcinoma NOS,T3,N0,1,0,6,Salivary Gland,56
47,Male,8550,Acinar cell carcinoma,T2,N0,0,0,28,Alive,84
22,Female,8430,Mucoepidermoid carcinoma,T4a,N2b,0,0,0,Alive,103
67,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,55
67,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,65,Alive,85
77,Female,8310,Adenocarcinoma,T2,N2a,1,0,51,Tongue,5
82,Female,8500,Adenocarcinoma,p3,Clinical,1,0,7,Alive,81
32,Female,8550,Acinar cell carcinoma,T2,N0,1,0,42,Alive,84
72,Female,8010,Carcinoma NOS,p2,Pathologic,1,1,31,Alive,81
62,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,84
22,Female,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,0,Alive,82
72,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,55,Alive,84
72,Male,8562,Epithelial-myoepithelial carcinoma,p2,Pathologic,1,0,0,Alive,83
22,Female,8147,Adenocarcinoma,c2,Pathologic,0,0,0,Alive,81
87,Male,8941,Carcinoma ex pleomorphic adenoma,c2,Clinical,0,0,Unable to calculate,Miscellaneous Malignant Cancer,8
57,Female,8200,Adenoid cystic carcinoma,p2,Pathologic,1,0,0,Alive,76
42,Female,8200,Adenoid cystic carcinoma,p3,Pathologic,1,0,98,Alive,80
37,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,81
52,Male,8550,Acinar cell carcinoma,p2,Pathologic,0,0,0,Alive,79
77,Male,8070,Squamous cell carcinoma,c4A,Clinical,1,0,43,Miscellaneous Malignant Cancer,1
52,Female,8941,Carcinoma ex pleomorphic adenoma,p2,Clinical,0,0,0,Alive,78
42,Male,8941,Carcinoma ex pleomorphic adenoma,p2,Clinical,1,0,0,Alive,78
67,Male,8000,unspecified neoplasms,TX,NX,0,1,Unable to calculate,Brain and Other Nervous System,82
77,Female,8200,Adenoid cystic carcinoma,p2,Pathologic,1,0,54,Alive,78
52,Male,8500,Adenocarcinoma,p3,Clinical,1,0,43,Lung and Bronchus,75
62,Female,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,0,Alive,79
42,Male,8200,Adenoid cystic carcinoma,p2,Pathologic,0,0,49,Alive,77
62,Male,8140,Adenocarcinoma,TX,N0,0,0,0,Alive,93
67,Female,8550,Acinar cell carcinoma,p2,Pathologic,0,0,13,Alive,80
72,Male,8562,Epithelial-myoepithelial carcinoma,p4A,Pathologic,1,0,0,Alive,79
77,Female,8430,Mucoepidermoid carcinoma,T3,N0,1,0,0,Salivary Gland,9
82,Male,8982,Myoepithelial carcinoma,p1,Pathologic,1,0,0,Alive,76
72,Male,8562,Epithelial-myoepithelial carcinoma,c1,Pathologic,0,0,0,Alive,79
67,Female,8502,Adenocarcinoma,p1,Clinical,0,0,0,Alive,76
77,Female,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,5
52,Female,8550,Acinar cell carcinoma,p2,Pathologic,1,0,15,Alive,78
52,Male,8247,Neuroendocrine carcinoma,c3,Clinical,0,1,15,Non-Melanoma Skin,9
47,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,72
37,Male,8140,Adenocarcinoma,p3,Pathologic,0,1,0,Salivary Gland,33
87,Female,8200,Adenoid cystic carcinoma,p1,Clinical,0,0,0,Cerebrovascular Diseases,36
47,Male,8147,Adenocarcinoma,p2,Clinical,1,0,0,Alive,66
72,Male,8010,Carcinoma NOS,p2,Clinical,1,0,0,Alive,72
72,Female,8200,Adenoid cystic carcinoma,p2,Pathologic,1,0,0,Alive,73
27,Male,8010,Carcinoma NOS,p1,Pathologic,0,0,0,Alive,77
90,Female,8010,Carcinoma NOS,c2,Clinical,1,0,38,Chronic Obstructive Pulmonary Disease and Allied Cond,4
62,Male,8033,Undifferentiated carcinoma,p2,Pathologic,1,0,20,Alive,75
67,Male,8070,Squamous cell carcinoma,p4A,Pathologic,1,1,36,Diseases of Heart,21
87,Female,8550,Acinar cell carcinoma,c4B,Clinical,1,0,56,State DC not available or state DC available but no COD,5
90,Female,8071,Squamous cell carcinoma,p3,Pathologic,1,0,32,Miscellaneous Malignant Cancer,16
52,Female,8550,Acinar cell carcinoma,p2,Pathologic,1,0,38,Alive,78
67,Female,8550,Acinar cell carcinoma,p1,Clinical,0,0,0,Alive,75
57,Male,8140,Adenocarcinoma,p2,Pathologic,1,0,12,Alive,75
57,Female,8550,Acinar cell carcinoma,p1,Pathologic,1,0,18,Alive,74
82,Male,8010,Carcinoma NOS,p3,Pathologic,1,0,28,Salivary Gland,23
67,Male,8070,Squamous cell carcinoma,p2,Pathologic,1,1,50,Salivary Gland,8
87,Female,8070,Squamous cell carcinoma,T4a,N0,0,0,0,Miscellaneous Malignant Cancer,2
62,Male,8070,Squamous cell carcinoma,p3,Pathologic,1,1,0,Alive,64
72,Female,8001,unspecified neoplasms,88,88,0,0,Unable to calculate,Miscellaneous Malignant Cancer,4
57,Male,8430,Mucoepidermoid carcinoma,p2,Clinical,1,0,0,Alive,70
62,Male,8140,Adenocarcinoma,c2,Clinical,1,1,5,Salivary Gland,37
72,Female,8000,unspecified neoplasms,T4b,N0,0,0,Unable to calculate,Salivary Gland,0
62,Female,8550,Acinar cell carcinoma,p2,Pathologic,0,0,40,Alive,70
72,Male,8070,Squamous cell carcinoma,p2,Pathologic,0,0,0,Alive,69
67,Female,8010,Carcinoma NOS,p2,Clinical,0,0,0,Alive,75
42,Male,8550,Acinar cell carcinoma,T2,N1,0,0,469,Alive,66
90,Female,8123,Transitional cell carcinoma,88,88,0,0,Unable to calculate,Cerebrovascular Diseases,7
67,Male,8070,Squamous cell carcinoma,p4B,Pathologic,1,0,30,Alive,71
37,Female,8550,Acinar cell carcinoma,p1,Pathologic,0,0,0,Alive,68
52,Female,8140,Adenocarcinoma,p2,Pathologic,1,1,20,Alive,66
87,Male,8071,Squamous cell carcinoma,c1,Clinical,1,0,59,Salivary Gland,19
52,Female,8430,Mucoepidermoid carcinoma,p2,Clinical,0,0,0,Alive,35
27,Female,8200,Adenoid cystic carcinoma,p2,Clinical,1,0,233,Alive,68
67,Male,8941,Carcinoma ex pleomorphic adenoma,p4A,Pathologic,1,1,70,Alive,66
32,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,68
62,Male,8500,Adenocarcinoma,p3,Pathologic,1,0,50,Salivary Gland,30
62,Male,8200,Adenoid cystic carcinoma,p4A,Pathologic,1,0,0,Diseases of Heart,8
72,Male,8010,Carcinoma NOS,c2,Clinical,0,0,Unable to calculate,Alive,67
67,Female,8982,Myoepithelial carcinoma,p4B,Clinical,1,1,43,Alive,33
67,Male,8140,Adenocarcinoma,p1,Clinical,0,0,27,Alive,66
57,Female,8941,Carcinoma ex pleomorphic adenoma,p2,Clinical,0,0,0,Alive,67
62,Female,8430,Mucoepidermoid carcinoma,p2,Clinical,0,0,0,Alive,67
32,Male,8430,Mucoepidermoid carcinoma,p2,Clinical,0,0,0,Alive,83
67,Female,8082,squamous cell neoplasms,p2,Pathologic,1,0,34,Alive,68
32,Female,8502,Adenocarcinoma,p1,Pathologic,0,0,48,Alive,67
47,Male,8010,Carcinoma NOS,p2,Pathologic,1,0,0,Alive,63
77,Male,8010,Carcinoma NOS,p4A,Pathologic,1,0,111,Lung and Bronchus,9
62,Female,8550,Acinar cell carcinoma,p1,Pathologic,0,0,35,Alive,65
32,Male,8430,Mucoepidermoid carcinoma,p3,Pathologic,1,1,14,Salivary Gland,34
67,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,12
67,Male,8140,Adenocarcinoma,p3,Pathologic,1,0,89,Alive,22
90,Female,8000,unspecified neoplasms,cX,Clinical,0,0,Unable to calculate,Salivary Gland,4
82,Female,8941,Carcinoma ex pleomorphic adenoma,p2,Clinical,1,0,0,Alive,69
67,Male,8941,Carcinoma ex pleomorphic adenoma,p1,Pathologic,0,0,0,Alive,63
52,Male,8200,Adenoid cystic carcinoma,p2,Pathologic,1,0,16,Alive,62
67,Male,8010,Carcinoma NOS,c1,Clinical,0,0,Unable to calculate,Alive,64
67,Male,8082,squamous cell neoplasms,p3,Pathologic,1,0,43,Salivary Gland,45
72,Male,8071,Squamous cell carcinoma,p2,Pathologic,1,0,20,Alive,60
67,Male,8070,Squamous cell carcinoma,cX,Clinical,0,0,Unable to calculate,State DC not available or state DC available but no COD,21
47,Male,8941,Carcinoma ex pleomorphic adenoma,p4A,Pathologic,1,1,48,Non-Melanoma Skin,11
72,Female,8550,Acinar cell carcinoma,p3,Pathologic,1,0,0,Alive,61
67,Female,8070,Squamous cell carcinoma,p3,Pathologic,0,0,29,Alive,60
62,Male,8070,Squamous cell carcinoma,p1,Pathologic,1,1,0,Lung and Bronchus,32
47,Male,8502,Adenocarcinoma,p3,Pathologic,1,0,0,Alive,61
52,Female,8200,Adenoid cystic carcinoma,p4A,Pathologic,1,0,0,Alive,60
67,Male,8200,Adenoid cystic carcinoma,p2,Pathologic,1,0,0,Alive,60
77,Male,8500,Adenocarcinoma,p2,Pathologic,1,0,56,Alive,60
67,Male,8246,Neuroendocrine carcinoma,p4A,Pathologic,1,0,53,Salivary Gland,8
57,Male,8090,Basal cell carcinoma,c0,Clinical,1,1,43,Alive,64
82,Male,8430,Mucoepidermoid carcinoma,p2,Pathologic,0,0,16,Alive,71
67,Female,8410,Adenocarcinoma,p1,Pathologic,1,0,0,Alive,70
47,Male,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,0,"Nephritis, Nephrotic Syndrome and Nephrosis",8
57,Male,8200,Adenoid cystic carcinoma,T4a,N0,1,1,41,Alive,5
32,Male,8010,Carcinoma NOS,p2,Pathologic,0,0,0,Alive,65
52,Male,8070,Squamous cell carcinoma,p4B,Pathologic,0,0,23,Alive,4
82,Male,8071,Squamous cell carcinoma,p4A,Pathologic,1,0,28,Alive,66
57,Female,8200,Adenoid cystic carcinoma,p2,Pathologic,1,0,0,Alive,60
52,Female,8147,Adenocarcinoma,TX,N0,0,0,Unable to calculate,Alive,51
67,Female,8200,Adenoid cystic carcinoma,T3,N1,1,0,111,Alive,57
87,Female,8010,Carcinoma NOS,c3,Clinical,0,0,Unable to calculate,Miscellaneous Malignant Cancer,2
82,Male,8500,Adenocarcinoma,T3,N0,1,0,0,Alive,52
87,Male,8010,Carcinoma NOS,T2,N1,1,0,27,Non-Melanoma Skin,26
77,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N2b,1,1,43,Alive,50
72,Male,8082,squamous cell neoplasms,T1,N0,1,0,38,Alive,54
47,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,28,Alive,54
77,Male,8562,Epithelial-myoepithelial carcinoma,TX,NX,0,0,Unable to calculate,Alive,55
72,Male,8070,Squamous cell carcinoma,T4a,N1,1,0,0,Alive,53
57,Female,8082,squamous cell neoplasms,T3,N2b,1,0,0,Alive,59
77,Male,8070,Squamous cell carcinoma,T1,N2a,0,0,27,Rectum and Rectosigmoid Junction,47
77,Male,8941,Carcinoma ex pleomorphic adenoma,TX,NX,0,0,Unable to calculate,Alive,45
72,Female,8430,Mucoepidermoid carcinoma,TX,N0,1,0,68,Alive,48
62,Female,8941,Carcinoma ex pleomorphic adenoma,T4a,N2b,1,0,38,Alive,49
62,Male,8010,Carcinoma NOS,TX,N2b,0,0,Unable to calculate,Miscellaneous Malignant Cancer,2
82,Male,8200,Adenoid cystic carcinoma,T2,N2b,1,1,34,Salivary Gland,13
72,Male,8140,Adenocarcinoma,T1,N0,0,0,32,Alive,19
52,Male,8200,Adenoid cystic carcinoma,T3,N2b,1,0,37,Miscellaneous Malignant Cancer,47
72,Female,8550,Acinar cell carcinoma,T1,N0,0,0,37,Alive,56
62,Male,8500,Adenocarcinoma,T1,N0,1,0,26,Alive,59
52,Male,8500,Adenocarcinoma,T2,N0,1,0,24,Alive,57
90,Male,8500,Adenocarcinoma,T1,N0,0,0,38,Alive,54
57,Male,8550,Acinar cell carcinoma,T1,N1,0,0,46,Alive,44
90,Male,8890,Leiomyosarcoma,TX,N0,0,0,0,Alive,51
52,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,56
32,Female,8010,Carcinoma NOS,T4a,N2b,1,1,6,Alive,52
87,Female,8550,Acinar cell carcinoma,T2,N1,0,0,0,Alive,52
82,Male,8070,Squamous cell carcinoma,T3,N3b,1,0,40,Alive,52
57,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,64,Alive,55
47,Male,8200,Adenoid cystic carcinoma,T4a,N0,0,0,15,State DC not available or state DC available but no COD,22
82,Female,8941,Carcinoma ex pleomorphic adenoma,T3,N0,0,0,0,Alive,54
62,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,51
72,Male,8010,Carcinoma NOS,T1,N0,0,0,Unable to calculate,Alive,59
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,51
37,Female,8147,Adenocarcinoma,T3,N0,1,0,0,Alive,40
87,Female,8140,Adenocarcinoma,T4b,N3b,1,0,43,Salivary Gland,15
87,Female,8502,Adenocarcinoma,TX,NX,0,0,0,Alive,42
77,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,41
47,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,27,Alive,42
67,Female,8982,Myoepithelial carcinoma,T1,N0,0,0,0,Alive,44
77,Male,8070,Squamous cell carcinoma,T2,N2b,0,0,70,Diabetes Mellitus,12
77,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,11
62,Male,8200,Adenoid cystic carcinoma,T2,N0,1,1,47,Miscellaneous Malignant Cancer,14
82,Female,8070,Squamous cell carcinoma,T2,N2c,0,0,Unable to calculate,Colon excluding Rectum,6
27,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,0,0,0,Alive,53
77,Male,8502,Adenocarcinoma,T1,N0,0,0,0,Alive,54
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,42
42,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,33,Alive,50
32,Male,8010,Carcinoma NOS,T2,N0,0,0,59,Alive,7
37,Male,8550,Acinar cell carcinoma,T3,N0,0,0,0,Alive,37
52,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,49
57,Male,8500,Adenocarcinoma,T4a,N2c,1,0,56,Salivary Gland,9
72,Female,8502,Adenocarcinoma,T2,N0,0,0,41,Alive,51
90,Male,8982,Myoepithelial carcinoma,TX,NX,0,0,Unable to calculate,Alive,0
27,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,41,Alive,43
72,Male,8562,Epithelial-myoepithelial carcinoma,T3,N2b,1,0,51,Alive,38
77,Male,8290,Oncocytic carcinoma,TX,N0,1,0,26,Salivary Gland,2
57,Male,8140,Adenocarcinoma,T4a,N1,1,1,46,Miscellaneous Malignant Cancer,10
77,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,53,Alive,41
37,Female,8502,Adenocarcinoma,T2,N0,0,0,49,Alive,35
62,Female,8550,Acinar cell carcinoma,T1,N0,0,0,Unable to calculate,Alive,45
67,Male,8246,Neuroendocrine carcinoma,T2,N2b,1,0,27,Lung and Bronchus,5
67,Male,8147,Adenocarcinoma,TX,NX,0,0,Unable to calculate,Alive,32
82,Female,8010,Carcinoma NOS,T2,N2b,1,1,0,Alive,36
77,Male,8500,Adenocarcinoma,TX,N0,0,0,40,Alive,39
82,Male,8071,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Other Cause of Death,7
62,Male,8200,Adenoid cystic carcinoma,T2,N0,0,0,Unable to calculate,Alive,59
62,Male,8941,Carcinoma ex pleomorphic adenoma,T4a,N2b,1,1,20,Alive,46
47,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,47
62,Female,8140,Adenocarcinoma,T4a,N3b,1,1,16,Other Infectious and Parasitic Diseases including HIV,3
77,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
82,Male,8500,Adenocarcinoma,T3,N3b,0,1,81,Alive,43
52,Male,8200,Adenoid cystic carcinoma,T3,N0,0,0,0,Alive,40
72,Female,8550,Acinar cell carcinoma,T2,N0,0,0,42,Alive,12
52,Female,8140,Adenocarcinoma,T1,N0,0,0,0,Alive,36
67,Male,8550,Acinar cell carcinoma,T3,N2b,1,0,48,Salivary Gland,9
52,Male,8200,Adenoid cystic carcinoma,T3,N0,0,0,16,Alive,44
62,Male,8550,Acinar cell carcinoma,T1,N0,0,0,39,Alive,49
77,Female,8000,unspecified neoplasms,T3,N0,0,0,Unable to calculate,Alive,46
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,41
67,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,47
52,Male,8500,Adenocarcinoma,TX,N2b,0,1,7,Salivary Gland,3
67,Male,8200,Adenoid cystic carcinoma,T3,N1,0,0,Unable to calculate,Alive,42
57,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,85,Alive,41
67,Male,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Alive,0
47,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,39
90,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Chronic Lymphocytic Leukemia,3
37,Female,8430,Mucoepidermoid carcinoma,T2,N2b,1,0,0,Alive,40
72,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,0,0,Salivary Gland,9
57,Male,8982,Myoepithelial carcinoma,T1,N0,0,0,0,Alive,37
42,Male,8200,Adenoid cystic carcinoma,TX,NX,0,0,Unable to calculate,Alive,0
82,Female,8010,Carcinoma NOS,T4a,N1,0,0,Unable to calculate,Salivary Gland,5
57,Male,8290,Oncocytic carcinoma,T2,N0,0,0,39,Alive,36
77,Male,8430,Mucoepidermoid carcinoma,T3,N2b,1,0,30,Alive,13
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,41
42,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,36
62,Female,8430,Mucoepidermoid carcinoma,TX,NX,0,0,Unable to calculate,Alive,0
57,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,35
32,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,35
57,Male,8010,Carcinoma NOS,T2,N3b,1,1,44,Salivary Gland,23
62,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,33
67,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Miscellaneous Malignant Cancer,7
67,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,33
82,Male,8010,Carcinoma NOS,T1,N2b,1,0,12,Salivary Gland,20
67,Male,8070,Squamous cell carcinoma,T2,N0,1,0,36,Alive,35
42,Male,8200,Adenoid cystic carcinoma,T4a,N0,1,0,0,Alive,31
82,Female,8070,Squamous cell carcinoma,T3,N2b,1,1,32,Oropharynx,19
57,Male,8070,Squamous cell carcinoma,T0,N1,0,0,67,Alive,16
47,Male,8502,Adenocarcinoma,T1,N0,0,0,18,Alive,32
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,33,Alive,5
77,Male,8010,Carcinoma NOS,T1,N0,1,0,34,Alive,35
7,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,30
72,Female,8550,Acinar cell carcinoma,T2,N0,0,0,86,Alive,3
52,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,202,Alive,37
72,Male,8070,Squamous cell carcinoma,T2,N3b,1,1,34,Alive,50
47,Male,8200,Adenoid cystic carcinoma,T1,N0,0,0,56,Alive,37
67,Male,8010,Carcinoma NOS,T3,N3b,1,1,36,Alive,35
47,Female,8941,Carcinoma ex pleomorphic adenoma,T1,N0,0,0,0,Alive,34
67,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,30
57,Male,8550,Acinar cell carcinoma,T2,N0,0,0,47,Alive,35
87,Male,8033,Undifferentiated carcinoma,88,88,1,0,14,Accidents and Adverse Effects,41
47,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,44
72,Female,8550,Acinar cell carcinoma,T3,N0,1,0,0,Alive,41
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,41
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,50,Alive,45
82,Male,8200,Adenoid cystic carcinoma,T3,N3b,1,0,0,Alive,37
37,Female,8982,Myoepithelial carcinoma,T3,N0,0,0,0,Alive,32
72,Male,8070,Squamous cell carcinoma,T1,N1,0,0,28,Alive,124
57,Female,8070,Squamous cell carcinoma,T2,N0,1,0,0,Alive,34
62,Male,8140,Adenocarcinoma,T3,N2b,1,1,0,Salivary Gland,13
37,Female,8430,Mucoepidermoid carcinoma,TX,N0,0,0,0,Alive,27
42,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,29
37,Male,9043,synovial-like neoplasms,T3,N0,1,0,59,Alive,26
42,Male,8500,Adenocarcinoma,T3,N1,1,1,0,Alive,27
87,Male,8071,Squamous cell carcinoma,T2,N0,1,0,12,Salivary Gland,6
57,Male,8200,Adenoid cystic carcinoma,T3,N0,1,0,94,Intrahepatic Bile Duct,17
47,Female,8502,Adenocarcinoma,T2,N0,0,0,0,Alive,39
52,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,15,Alive,29
82,Male,8070,Squamous cell carcinoma,TX,N2a,0,0,Unable to calculate,Alive,28
42,Female,8550,Acinar cell carcinoma,T3,N0,1,0,0,Alive,28
62,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,33
27,Male,8502,Adenocarcinoma,T1,N0,1,0,40,Alive,39
72,Male,8147,Adenocarcinoma,T2,N0,0,0,0,Alive,29
17,Male,8502,Adenocarcinoma,T3,N0,0,0,30,Alive,29
67,Male,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
62,Male,8200,Adenoid cystic carcinoma,T2,N0,0,0,Unable to calculate,Alive,36
17,Female,8550,Acinar cell carcinoma,T1,N0,0,0,30,Alive,28
77,Male,8502,Adenocarcinoma,T2,N0,0,0,45,Alive,26
47,Female,8982,Myoepithelial carcinoma,T2,N0,1,0,9,Alive,25
57,Female,8140,Adenocarcinoma,T3,N0,0,1,99,Salivary Gland,19
90,Female,8071,Squamous cell carcinoma,T4b,N0,1,0,59,Salivary Gland,10
57,Male,8550,Acinar cell carcinoma,T1,N0,0,0,30,Alive,39
72,Female,8550,Acinar cell carcinoma,T2,N0,0,0,81,Alive,25
87,Female,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,0
62,Male,8982,Myoepithelial carcinoma,T3,N0,0,0,0,Alive,36
72,Male,8140,Adenocarcinoma,TX,NX,0,0,Unable to calculate,Alive,24
37,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Alive,28
47,Female,8200,Adenoid cystic carcinoma,T2,N3b,1,1,0,Alive,24
27,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,34
82,Male,8010,Carcinoma NOS,T4a,N1,1,0,51,Alive,20
42,Male,8200,Adenoid cystic carcinoma,T4b,N0,1,1,136,Alive,31
72,Male,8500,Adenocarcinoma,T4a,N3b,1,0,48,Alive,27
82,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,44
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,19
77,Male,8430,Mucoepidermoid carcinoma,TX,N2c,1,0,13,Salivary Gland,1
82,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,1
47,Male,8500,Adenocarcinoma,T2,N3b,1,1,0,Alive,26
72,Male,8147,Adenocarcinoma,T4a,N0,1,0,0,Alive,23
37,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,23,Alive,24
57,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,22
52,Female,8200,Adenoid cystic carcinoma,T2,N0,1,1,0,Alive,24
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,40,Alive,22
72,Male,8500,Adenocarcinoma,T4b,N0,1,0,0,Alive,24
57,Male,8200,Adenoid cystic carcinoma,T3,N1,1,1,39,Salivary Gland,2
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,48,Alive,24
77,Male,8200,Adenoid cystic carcinoma,T3,N2b,1,0,36,Miscellaneous Malignant Cancer,11
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,13,Alive,26
67,Female,8500,Adenocarcinoma,T1,N1,1,0,16,Alive,23
62,Male,8200,Adenoid cystic carcinoma,T1,N0,0,1,0,Salivary Gland,29
47,Male,8500,Adenocarcinoma,T4a,N3b,1,1,0,Alive,22
22,Female,8430,Mucoepidermoid carcinoma,TX,NX,0,0,Unable to calculate,Alive,5
7,Female,8550,Acinar cell carcinoma,T2,N0,0,0,29,Alive,22
42,Female,8500,Adenocarcinoma,T4a,N3b,1,0,237,Alive,27
47,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,25,Alive,21
47,Female,8562,Epithelial-myoepithelial carcinoma,TX,NX,0,0,Unable to calculate,Alive,19
72,Male,8200,Adenoid cystic carcinoma,T3,N0,1,1,20,Alive,21
67,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,8,Alive,20
62,Male,8083,Squamous cell carcinoma,T4a,N0,1,1,7,Miscellaneous Malignant Cancer,15
12,Female,8430,Mucoepidermoid carcinoma,T2,N1,1,0,21,Alive,19
67,Male,8290,Oncocytic carcinoma,T2,N1,1,0,0,Alive,20
57,Female,8200,Adenoid cystic carcinoma,T3,N3b,1,0,69,Alive,20
62,Male,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Alive,20
47,Male,8550,Acinar cell carcinoma,T1,N0,0,0,48,Alive,18
67,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,17
52,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,30,Alive,17
67,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,39,Alive,17
32,Female,8430,Mucoepidermoid carcinoma,TX,N0,0,0,0,Alive,16
57,Male,8071,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,14
62,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,18
72,Female,8500,Adenocarcinoma,T2,N3b,1,0,63,Alive,18
57,Male,8502,Adenocarcinoma,T1,N0,0,0,49,Alive,16
67,Female,8200,Adenoid cystic carcinoma,TX,N3b,0,0,Unable to calculate,Alive,1
62,Female,8550,Acinar cell carcinoma,T2,N2a,1,0,26,Alive,15
52,Male,8500,Adenocarcinoma,T3,N2b,1,1,31,Alive,13
42,Female,8430,Mucoepidermoid carcinoma,T3,N0,0,0,32,Alive,19
72,Male,8500,Adenocarcinoma,T4a,N0,1,0,32,Alive,13
57,Male,8500,Adenocarcinoma,T3,N3b,1,1,86,Salivary Gland,10
37,Female,8502,Adenocarcinoma,T3,N0,0,0,0,Alive,16
72,Male,8070,Squamous cell carcinoma,T1,N0,0,0,0,Alive,15
72,Male,8500,Adenocarcinoma,T4b,N2b,1,1,41,Alive,14
62,Male,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,18
87,Male,8070,Squamous cell carcinoma,TX,NX,0,1,54,Salivary Gland,7
87,Female,8000,unspecified neoplasms,T2,N0,0,0,Unable to calculate,Salivary Gland,8
67,Male,8200,Adenoid cystic carcinoma,T2,N0,0,0,57,Alive,18
52,Female,8502,Adenocarcinoma,T2,N0,0,0,19,Alive,18
87,Male,8071,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,3
57,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,14
77,Female,8140,Adenocarcinoma,T2,N0,1,0,26,Alive,19
62,Male,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,15
62,Male,8070,Squamous cell carcinoma,T1,N3b,0,0,67,Alive,15
42,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,0
72,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,13
67,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,26,Alive,13
47,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,45,Alive,17
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,18
72,Female,8200,Adenoid cystic carcinoma,T4a,N2b,1,0,96,Soft Tissue including Heart,7
67,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,8
17,Female,8550,Acinar cell carcinoma,T2,N0,0,0,15,Alive,13
57,Male,8200,Adenoid cystic carcinoma,T2,N3b,1,0,48,Salivary Gland,8
57,Male,8550,Acinar cell carcinoma,T3,N0,0,0,33,Alive,12
37,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,12
37,Female,8200,Adenoid cystic carcinoma,T2,N2a,1,0,28,Alive,15
57,Female,8147,Adenocarcinoma,T4a,N0,1,0,33,Alive,13
77,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,50,Alive,16
82,Female,8500,Adenocarcinoma,T4a,N2b,0,0,53,Salivary Gland,9
52,Male,8982,Myoepithelial carcinoma,T2,N3b,1,1,27,Alive,14
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,16
47,Female,8982,Myoepithelial carcinoma,T2,N0,0,0,0,Alive,10
62,Female,8550,Acinar cell carcinoma,T1,N0,0,0,39,Alive,16
57,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,10
77,Male,8070,Squamous cell carcinoma,T2,N1,1,0,0,Alive,10
87,Male,8000,unspecified neoplasms,T2,N0,1,0,139,Alive,15
62,Male,8500,Adenocarcinoma,T4a,N3b,1,1,0,Alive,11
47,Male,8430,Mucoepidermoid carcinoma,p2,Pathologic,1,0,Unable to calculate,Alive,79
27,Female,8200,Adenoid cystic carcinoma,T4a,N2c,1,1,37,Miscellaneous Malignant Cancer,6
72,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,15
67,Male,8982,Myoepithelial carcinoma,T3,N0,0,0,0,Salivary Gland,6
82,Male,8200,Adenoid cystic carcinoma,T3,N0,1,0,59,Alive,6
67,Male,8070,Squamous cell carcinoma,T3,N0,1,0,15,Alive,12
87,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Cerebrovascular Diseases,7
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,9
37,Female,8982,Myoepithelial carcinoma,T1,N0,0,0,0,Alive,5
67,Female,8982,Myoepithelial carcinoma,T4b,N3b,1,0,77,Alive,10
57,Female,8500,Adenocarcinoma,T3,N0,1,1,0,Alive,8
47,Male,8010,Carcinoma NOS,T1,N0,0,0,24,Alive,3
62,Male,8500,Adenocarcinoma,T4a,N3b,1,1,19,Alive,6
12,Female,8010,Carcinoma NOS,T1,N0,0,0,0,Alive,4
62,Male,8071,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,0
27,Male,8550,Acinar cell carcinoma,T4a,N0,1,0,56,Alive,4
37,Female,8550,Acinar cell carcinoma,T2,N0,1,0,145,Alive,6
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,83,Alive,3
82,Male,8071,Squamous cell carcinoma,T3,N3b,1,0,74,Alive,9
67,Male,8147,Adenocarcinoma,T2,N0,0,0,0,Alive,4
72,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,10
57,Female,8070,Squamous cell carcinoma,T2,N2b,1,0,43,Alive,10
62,Male,8500,Adenocarcinoma,T3,N2b,1,0,91,Alive,2
42,Male,8071,Squamous cell carcinoma,T2,N1,1,0,32,Alive,0
42,Male,8502,Adenocarcinoma,T3,N0,0,0,144,Alive,2
67,Female,8550,Acinar cell carcinoma,T4a,N2b,1,0,56,Alive,10
82,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,0,0,21,Alive,11
62,Female,8550,Acinar cell carcinoma,T1,N0,0,0,56,Alive,1
62,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,33,Alive,10
47,Male,8430,Mucoepidermoid carcinoma,T2,N1,0,0,26,Alive,11
82,Female,8070,Squamous cell carcinoma,T2,N2b,1,0,34,Alive,10
82,Male,8010,Carcinoma NOS,T3,N0,1,1,34,Alive,9
67,Female,8082,squamous cell neoplasms,TX,NX,0,0,Unable to calculate,Alive,8
37,Male,8200,Adenoid cystic carcinoma,T2,NX,0,0,15,Alive,0
67,Female,8200,Adenoid cystic carcinoma,T2,N1,1,0,28,Alive,8
77,Male,8982,Myoepithelial carcinoma,T3,N0,0,0,0,Alive,8
87,Female,8070,Squamous cell carcinoma,T1,N0,0,0,40,Alive,2
77,Male,8562,Epithelial-myoepithelial carcinoma,T3,N0,1,0,53,Alive,7
7,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,7
82,Male,8140,Adenocarcinoma,T1,N0,0,0,0,Alive,7
57,Female,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,32,Alive,7
72,Male,8500,Adenocarcinoma,T2,N3b,1,0,55,Alive,8
57,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,8
62,Female,8140,Adenocarcinoma,T2,N0,1,0,58,Alive,7
42,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,54,Alive,7
77,Male,8070,Squamous cell carcinoma,T2,N2b,1,0,33,Alive,5
62,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,49,Alive,4
47,Male,8550,Acinar cell carcinoma,T2,N0,0,0,26,Alive,4
67,Female,8550,Acinar cell carcinoma,T2,N0,0,0,36,Alive,4
82,Female,8430,Mucoepidermoid carcinoma,T1,N3b,0,0,0,Alive,4
27,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,3
62,Female,8140,Adenocarcinoma,T2,N2b,1,0,11,Alive,0
67,Male,8010,Carcinoma NOS,T1,N0,0,0,101,Alive,5
82,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,12,Alive,6
27,Male,8550,Acinar cell carcinoma,T2,N0,0,0,25,Alive,0
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,7
90,Female,8500,Adenocarcinoma,T2,N2b,0,0,48,Alive,4
47,Male,8500,Adenocarcinoma,T4a,N2b,1,1,46,Alive,0
87,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Non-Melanoma Skin,2
52,Male,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,3
72,Female,8430,Mucoepidermoid carcinoma,TX,NX,0,0,Unable to calculate,Alive,0
82,Female,8010,Carcinoma NOS,T3,N2b,1,0,0,Alive,2
90,Female,8000,unspecified neoplasms,T2,N0,1,0,54,Alive,10
47,Female,8010,Carcinoma NOS,T2,N0,1,0,0,Alive,8
52,Female,8982,Myoepithelial carcinoma,T2,N0,0,0,10,Alive,113
87,Male,8480,Mucinous adenocarcinoma,T4a,N0,1,0,62,Salivary Gland,2
90,Male,8140,Adenocarcinoma,T2,N0,0,0,Unable to calculate,Salivary Gland,15
77,Female,8140,Adenocarcinoma,T1,N0,1,0,0,Other Cause of Death,78
52,Female,8010,Carcinoma NOS,T1,N0,0,0,0,Alive,118
90,Male,8070,Squamous cell carcinoma,c4B,Clinical,1,0,34,Suicide and Self-Inflicted Injury,37
42,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,144
67,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,52
82,Male,8982,Myoepithelial carcinoma,T3,N0,1,0,0,Alive,22
67,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,0,42,Alive,110
87,Female,8550,Acinar cell carcinoma,p4A,Pathologic,0,0,29,Non-Hodgkin Lymphoma,30
82,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,126
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,143
87,Female,8070,Squamous cell carcinoma,T3,N0,1,0,31,"Nose, Nasal Cavity and Middle Ear",19
72,Female,8070,Squamous cell carcinoma,T1,N2b,1,0,0,Alive,94
87,Male,8140,Adenocarcinoma,T2,N2b,0,1,46,Salivary Gland,19
37,Male,8140,Adenocarcinoma,T4a,N2b,1,1,0,Alive,112
90,Male,8070,Squamous cell carcinoma,T1,N0,0,0,Unable to calculate,Other Cause of Death,57
67,Female,8982,Myoepithelial carcinoma,T1,N0,1,0,0,Alive,2
72,Female,8010,Carcinoma NOS,TX,N1,0,1,0,Alive,36
90,Female,8070,Squamous cell carcinoma,T3,N2a,0,0,138,Alive,1
82,Female,8070,Squamous cell carcinoma,T1,N0,0,0,0,Miscellaneous Malignant Cancer,20
90,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Diseases of Heart,20
32,Female,8200,Adenoid cystic carcinoma,T4b,N0,1,1,27,Miscellaneous Malignant Cancer,97
87,Female,8082,squamous cell neoplasms,T4a,N1,0,0,Unable to calculate,Alzheimers (ICD-9 and 10 only),9
82,Female,8200,Adenoid cystic carcinoma,T3,N2a,0,0,0,Alive,58
87,Male,8070,Squamous cell carcinoma,T4a,N2b,1,1,19,Septicemia,91
62,Male,8430,Mucoepidermoid carcinoma,p4A,Pathologic,1,0,88,Alive,73
32,Male,8430,Mucoepidermoid carcinoma,T4a,N1,0,0,0,Alive,126
77,Female,8941,Carcinoma ex pleomorphic adenoma,T4a,N0,0,1,21,Soft Tissue including Heart,5
67,Female,8071,Squamous cell carcinoma,T4a,N1,1,1,0,Alive,106
47,Female,8010,Carcinoma NOS,TX,N1,0,0,Unable to calculate,Lung and Bronchus,0
90,Male,8500,Adenocarcinoma,T3,N2b,0,0,22,Diseases of Heart,35
77,Male,8070,Squamous cell carcinoma,T0,N1,1,0,27,Alive,130
67,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,120,Alive,94
67,Female,8525,ductal and lobular neoplasms,T1,N0,0,0,26,Alive,123
62,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,19,Alive,26
82,Male,8070,Squamous cell carcinoma,T4a,N2b,0,0,0,Non-Melanoma Skin,4
87,Male,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Diseases of Heart,0
77,Male,8200,Adenoid cystic carcinoma,T4b,N1,1,0,67,Miscellaneous Malignant Cancer,6
87,Male,8070,Squamous cell carcinoma,TX,N0,1,0,25,Colon excluding Rectum,21
90,Female,8074,Squamous cell carcinoma,c2,Clinical,0,0,Unable to calculate,Other Cause of Death,38
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,1,Alive,143
87,Male,8070,Squamous cell carcinoma,T3,N0,1,0,31,Diseases of Heart,72
82,Female,8020,Undifferentiated carcinoma,T4a,N2b,1,0,42,Salivary Gland,6
82,Female,8071,Squamous cell carcinoma,T3,N1,1,0,35,Alive,86
72,Female,8140,Adenocarcinoma,T3,N0,1,0,0,Salivary Gland,9
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,123
72,Female,8982,Myoepithelial carcinoma,T1,N0,0,0,0,Alive,39
77,Male,8010,Carcinoma NOS,T3,N0,1,0,65,Alive,39
87,Male,8070,Squamous cell carcinoma,T4a,NX,0,0,Unable to calculate,Alive,5
62,Female,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,0,Alive,97
67,Female,8430,Mucoepidermoid carcinoma,TX,NX,0,0,Unable to calculate,Alive,17
82,Female,8071,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Salivary Gland,0
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Breast,113
82,Male,8140,Adenocarcinoma,T3,N0,1,0,59,Miscellaneous Malignant Cancer,29
87,Female,8071,Squamous cell carcinoma,T1,N0,0,0,Unable to calculate,Alive,5
82,Male,8140,Adenocarcinoma,T2,N2b,1,0,25,Prostate,29
72,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,105
90,Male,8071,Squamous cell carcinoma,T2,N2b,1,0,50,Alive,54
57,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,107
77,Female,8010,Carcinoma NOS,T3,N2b,1,0,0,Other Cause of Death,101
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,29,Alive,53
77,Male,8140,Adenocarcinoma,T4a,N2c,1,1,127,"Symptoms, Signs and Ill-Defined Conditions",23
82,Female,8000,unspecified neoplasms,T2,N1,0,0,Unable to calculate,Chronic Obstructive Pulmonary Disease and Allied Cond,0
87,Male,8010,Carcinoma NOS,c2,Pathologic,1,0,49,Other Cause of Death,64
82,Female,8290,Oncocytic carcinoma,p2,Pathologic,0,0,0,Alive,62
87,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,27,Salivary Gland,13
72,Male,8010,Carcinoma NOS,p2,Pathologic,1,1,33,Alive,64
77,Male,8140,Adenocarcinoma,TX,NX,1,1,44,Salivary Gland,9
22,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Acute Lymphocytic Leukemia,27
90,Male,8010,Carcinoma NOS,T2,N0,0,0,Unable to calculate,Salivary Gland,1
72,Male,8071,Squamous cell carcinoma,T4a,N2c,1,1,70,Miscellaneous Malignant Cancer,6
82,Male,8033,Undifferentiated carcinoma,T3,N2b,1,0,53,Miscellaneous Malignant Cancer,59
72,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,20
82,Female,8430,Mucoepidermoid carcinoma,c1,Pathologic,0,0,51,Diseases of Heart,81
82,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Urinary Bladder,3
72,Female,8140,Adenocarcinoma,p2,Pathologic,0,0,0,Alive,72
77,Male,8940,Mixed tumor,T3,N2b,1,1,31,Stomach,18
90,Male,8070,Squamous cell carcinoma,T3,N0,1,0,57,Non-Melanoma Skin,3
87,Female,8200,Adenoid cystic carcinoma,T1,N0,0,0,62,Other Cause of Death,21
82,Male,8550,Acinar cell carcinoma,T4b,N0,1,0,0,Alive,104
82,Male,8070,Squamous cell carcinoma,TX,N1,0,0,Unable to calculate,Diseases of Heart,3
90,Female,8071,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Diseases of Heart,49
77,Male,8010,Carcinoma NOS,T1,N0,0,0,0,Alive,50
72,Female,8070,Squamous cell carcinoma,p2,Clinical,1,0,0,Alive,69
62,Male,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Miscellaneous Malignant Cancer,128
62,Male,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,151
62,Male,8500,Adenocarcinoma,T1,N0,0,0,0,Alive,57
77,Male,8010,Carcinoma NOS,T3,N2b,1,0,46,Salivary Gland,24
62,Female,8430,Mucoepidermoid carcinoma,T3,N0,1,0,44,Alive,123
82,Male,8071,Squamous cell carcinoma,p4A,Clinical,1,0,0,Diseases of Heart,29
82,Male,8070,Squamous cell carcinoma,T2,N2a,0,0,50,Alive,22
82,Male,8450,"cystic, mucinous and serous neoplasms",T1,N0,0,0,117,Diseases of Heart,45
42,Male,8430,Mucoepidermoid carcinoma,T1,N1,0,0,Unable to calculate,Alive,110
72,Female,8200,Adenoid cystic carcinoma,T1,N0,0,0,45,Alive,137
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,115
82,Female,8500,Adenocarcinoma,T3,N2a,1,0,61,Diabetes Mellitus,29
52,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,1,23,Miscellaneous Malignant Cancer,13
52,Female,8430,Mucoepidermoid carcinoma,T2,N1,1,0,0,Alive,130
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,97,Alive,43
42,Male,8550,Acinar cell carcinoma,T3,N1,0,0,0,Alive,136
82,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Diseases of Heart,64
77,Male,8012,"epithelial neoplasms, NOS",T2,N2b,1,0,11,Salivary Gland,6
72,Male,8070,Squamous cell carcinoma,T2,N0,1,0,19,Prostate,66
67,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,0
82,Male,8200,Adenoid cystic carcinoma,p1,Pathologic,0,0,32,Alive,70
67,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,75
72,Male,8070,Squamous cell carcinoma,T0,N1,1,0,0,Alive,57
72,Female,8147,Adenocarcinoma,T2,N0,1,0,1,Alive,18
77,Male,8500,Adenocarcinoma,T1,N0,1,0,0,Alive,119
72,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,25,Diseases of Heart,78
72,Male,8247,Neuroendocrine carcinoma,T2,N0,1,1,14,Non-Melanoma Skin,28
72,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Diseases of Heart,12
77,Male,8430,Mucoepidermoid carcinoma,T4a,N1,0,0,Unable to calculate,Other Cause of Death,0
57,Female,8070,Squamous cell carcinoma,T2,N0,1,0,0,Alive,30
72,Male,8430,Mucoepidermoid carcinoma,p2,Clinical,0,0,0,Lung and Bronchus,11
57,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Lung and Bronchus,49
77,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,30
62,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,22,Alive,50
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,131
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,23
57,Female,8033,Undifferentiated carcinoma,88,88,1,1,24,Alive,59
90,Female,8071,Squamous cell carcinoma,T4a,N2b,0,0,0,Lip,15
77,Male,8010,Carcinoma NOS,T3,N2b,1,1,26,Salivary Gland,41
67,Male,8070,Squamous cell carcinoma,p2,Pathologic,0,0,41,Alive,64
72,Male,8523,ductal and lobular neoplasms,T1,N0,1,0,0,Pneumonia and Influenza,98
57,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,15,Alive,115
67,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,25,State DC not available or state DC available but no COD,19
82,Female,8500,Adenocarcinoma,p1,Pathologic,1,0,54,Alive,69
90,Male,8070,Squamous cell carcinoma,T1,N2b,1,0,49,Prostate,6
82,Female,8500,Adenocarcinoma,T2,N0,0,0,0,Alive,26
62,Female,8010,Carcinoma NOS,T2,N0,0,0,0,Breast,15
67,Female,8941,Carcinoma ex pleomorphic adenoma,T4b,N0,0,0,24,State DC not available or state DC available but no COD,87
67,Male,8550,Acinar cell carcinoma,p2,Clinical,1,0,0,Alive,77
72,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,15
77,Male,8200,Adenoid cystic carcinoma,p1,Pathologic,1,0,47,Alive,64
72,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Lung and Bronchus,0
87,Male,8940,Mixed tumor,T3,N0,1,0,27,Diseases of Heart,10
72,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,45,Alive,26
87,Female,8147,Adenocarcinoma,T3,N0,1,0,33,Accidents and Adverse Effects,19
87,Male,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,48,Alive,13
77,Female,8982,Myoepithelial carcinoma,T2,N0,0,0,0,Alive,47
77,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,0,Alive,13
72,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Colon excluding Rectum,76
82,Male,8200,Adenoid cystic carcinoma,TX,NX,0,0,Unable to calculate,Other Cause of Death,99
47,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,75
47,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,0,Alive,71
77,Male,8147,Adenocarcinoma,T2,N0,0,0,27,Alive,20
72,Female,8000,unspecified neoplasms,T1,N0,1,0,64,Melanoma of the Skin,65
22,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,45
72,Male,8500,Adenocarcinoma,T3,N3b,1,1,23,Prostate,9
90,Male,8550,Acinar cell carcinoma,T3,N0,1,0,44,Salivary Gland,15
62,Female,8550,Acinar cell carcinoma,T2,N0,1,0,28,Alive,148
62,Male,8550,Acinar cell carcinoma,T4a,N0,1,0,Unable to calculate,Alive,150
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,35,Alive,50
47,Female,8941,Carcinoma ex pleomorphic adenoma,T3,N0,1,0,0,Accidents and Adverse Effects,107
67,Male,8550,Acinar cell carcinoma,T3,N2b,1,1,0,Salivary Gland,94
82,Male,8070,Squamous cell carcinoma,TX,N1,1,0,35,Lung and Bronchus,114
82,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,32,Alive,151
82,Male,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Nasopharynx,45
82,Female,8430,Mucoepidermoid carcinoma,T2,N1,1,0,39,Lung and Bronchus,19
87,Female,8140,Adenocarcinoma,T1,N0,0,0,Unable to calculate,Diseases of Heart,103
77,Female,8550,Acinar cell carcinoma,T1,N0,1,0,Unable to calculate,Alive,152
57,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,63,Alive,154
77,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,146
82,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Miscellaneous Malignant Cancer,6
52,Female,8200,Adenoid cystic carcinoma,T1,N0,0,0,29,Alive,151
67,Female,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,0,Lung and Bronchus,50
52,Male,8550,Acinar cell carcinoma,T2,N0,0,0,36,Miscellaneous Malignant Cancer,43
72,Male,8041,Small cell carcinoma,TX,N0,0,0,Unable to calculate,"Trachea, Mediastinum and Other Respiratory Organs",0
72,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,145
32,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,144
77,Female,8440,Adenocarcinoma,T1,N0,0,0,69,Alive,145
82,Female,8430,Mucoepidermoid carcinoma,TX,NX,0,0,Unable to calculate,Alive,121
87,Female,8140,Adenocarcinoma,T2,N0,1,0,49,Other Cause of Death,79
57,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,122
62,Male,8140,Adenocarcinoma,T2,N0,1,0,17,Alive,144
72,Female,8010,Carcinoma NOS,T2,N3,0,0,0,Alive,85
47,Female,8200,Adenoid cystic carcinoma,T3,N0,0,0,0,Alive,155
17,Male,8200,Adenoid cystic carcinoma,T4b,N0,1,0,6,Alive,153
82,Male,8010,Carcinoma NOS,TX,NX,1,0,20,Miscellaneous Malignant Cancer,3
67,Male,8550,Acinar cell carcinoma,p1,Pathologic,1,0,0,Alive,81
62,Female,8430,Mucoepidermoid carcinoma,TX,N1,0,0,0,Alive,17
27,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,151
22,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,105
37,Female,8430,Mucoepidermoid carcinoma,TX,N0,0,0,0,Alive,22
82,Female,8200,Adenoid cystic carcinoma,T3,N0,0,0,0,Salivary Gland,80
77,Male,8070,Squamous cell carcinoma,T1,N0,1,0,57,Miscellaneous Malignant Cancer,13
12,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,153
37,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,70,Alive,151
72,Female,8200,Adenoid cystic carcinoma,T1,N0,0,0,63,Alive,149
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,141
47,Male,8022,Undifferentiated carcinoma,T1,N0,0,0,19,Alive,149
77,Female,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Other Cause of Death,27
72,Male,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,139
67,Male,8982,Myoepithelial carcinoma,T2,N0,1,0,0,Alive,141
47,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,1,0,0,Alive,135
57,Male,8000,unspecified neoplasms,TX,N0,0,0,Unable to calculate,Alive,106
87,Female,8000,unspecified neoplasms,T2,N0,0,0,Unable to calculate,Urinary Bladder,1
67,Female,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,136
62,Male,8147,Adenocarcinoma,TX,N0,1,0,42,Alive,53
57,Male,8070,Squamous cell carcinoma,T4a,N0,1,1,0,Alive,139
72,Male,8562,Epithelial-myoepithelial carcinoma,p1,Pathologic,0,0,0,Alive,66
82,Male,8070,Squamous cell carcinoma,T3,N2b,1,0,0,Other Cause of Death,20
77,Male,8430,Mucoepidermoid carcinoma,T3,N3,1,1,0,Alive,137
67,Female,8290,Oncocytic carcinoma,T2,N0,0,0,0,Alive,140
82,Male,8200,Adenoid cystic carcinoma,T4a,N0,1,0,59,Septicemia,5
72,Male,8574,Adenocarcinoma with neuroendocrine differentiation,TX,NX,0,0,Unable to calculate,Lung and Bronchus,6
82,Male,8070,Squamous cell carcinoma,T3,N1,1,0,43,Non-Melanoma Skin,63
67,Male,8070,Squamous cell carcinoma,T3,N0,1,0,0,Non-Melanoma Skin,36
77,Female,8140,Adenocarcinoma,T1,N0,1,0,0,Alive,134
87,Female,8070,Squamous cell carcinoma,T3,N2b,1,0,55,Other Cause of Death,34
72,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,21,Alive,142
42,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,135
52,Male,8550,Acinar cell carcinoma,T3,N2b,1,0,26,Diseases of Heart,11
42,Female,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,13
72,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,54,Alive,135
57,Male,8500,Adenocarcinoma,T4a,N2b,1,1,27,"In situ, benign or unknown behavior neoplasm",23
77,Female,8200,Adenoid cystic carcinoma,T4NOS,N1,1,0,0,State DC not available or state DC available but no COD,127
82,Male,8500,Adenocarcinoma,T4NOS,N1,0,0,0,Salivary Gland,53
27,Male,8502,Adenocarcinoma,T2,N0,0,0,0,Alive,141
67,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,139
42,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,139
67,Male,8430,Mucoepidermoid carcinoma,T1,N2b,1,1,0,Salivary Gland,31
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,139
57,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,0,Suicide and Self-Inflicted Injury,125
62,Female,8140,Adenocarcinoma,T2,N0,1,0,22,Alive,135
67,Female,8525,ductal and lobular neoplasms,T1,N0,1,0,36,Alive,137
52,Female,8010,Carcinoma NOS,T2,N0,0,0,0,Chronic Obstructive Pulmonary Disease and Allied Cond,68
82,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Diseases of Heart,13
57,Male,8070,Squamous cell carcinoma,T3,N2b,1,1,0,Alive,132
67,Male,8500,Adenocarcinoma,T3,N2b,1,0,42,Alive,137
62,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,134
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,134
57,Male,8022,Undifferentiated carcinoma,T2,N2b,1,1,0,Alive,134
72,Male,8070,Squamous cell carcinoma,T2,N0,1,0,34,Lung and Bronchus,39
77,Male,8071,Squamous cell carcinoma,TX,N1,0,0,Unable to calculate,Other Cause of Death,128
67,Male,8010,Carcinoma NOS,TX,N0,0,0,Unable to calculate,Alive,135
62,Female,8147,Adenocarcinoma,T2,N0,0,0,0,Alive,134
57,Male,8982,Myoepithelial carcinoma,T2,N0,0,0,0,Alive,127
72,Female,8041,Small cell carcinoma,T2,N1,1,1,26,Acute Myeloid Leukemia,16
57,Female,8430,Mucoepidermoid carcinoma,p3,Pathologic,1,0,0,Alive,62
37,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,141
87,Male,8070,Squamous cell carcinoma,TX,NX,0,0,22,Miscellaneous Malignant Cancer,3
82,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Diseases of Heart,88
82,Female,8010,Carcinoma NOS,T4a,N0,1,0,59,Other Cause of Death,2
87,Male,8070,Squamous cell carcinoma,T2,N1,0,0,17,Diseases of Heart,98
62,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,0,0,Alive,138
67,Female,8071,Squamous cell carcinoma,T2,N3b,1,1,47,Alive,18
17,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,128
67,Female,8010,Carcinoma NOS,c3,Clinical,0,0,0,Homicide and Legal Intervention,46
82,Male,8200,Adenoid cystic carcinoma,p4A,Pathologic,1,0,44,Salivary Gland,11
57,Female,8430,Mucoepidermoid carcinoma,p2,Clinical,1,0,0,Alive,63
52,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,0,14,Alive,131
82,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Diseases of Heart,46
87,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Other Cause of Death,60
52,Female,8550,Acinar cell carcinoma,T1,N0,0,0,74,Alive,125
87,Male,8246,Neuroendocrine carcinoma,TX,NX,0,1,11,Miscellaneous Malignant Cancer,14
87,Female,8070,Squamous cell carcinoma,T3,N0,0,0,21,Hypertension without Heart Disease,5
17,Male,8550,Acinar cell carcinoma,T2,N0,0,0,49,Alive,130
77,Male,8430,Mucoepidermoid carcinoma,T4a,N2b,1,0,0,"Symptoms, Signs and Ill-Defined Conditions",91
72,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Salivary Gland,61
82,Female,8941,Carcinoma ex pleomorphic adenoma,T3,N0,0,0,0,Other Cause of Death,103
57,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,131
77,Male,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Diseases of Heart,50
62,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,126
57,Female,8240,Neuroendocrine tumor,TX,NX,0,0,28,Alive,129
90,Female,8982,Myoepithelial carcinoma,T2,N0,0,0,0,Lung and Bronchus,46
87,Male,8147,Adenocarcinoma,T2,N0,0,0,0,Diseases of Heart,81
87,Female,8562,Epithelial-myoepithelial carcinoma,T3,N0,1,0,0,Aortic Aneurysm and Dissection,75
62,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,125
47,Female,8982,Myoepithelial carcinoma,T1,N0,0,0,0,Diseases of Heart,105
57,Female,8440,Adenocarcinoma,T1,N1,1,0,63,Alive,125
82,Male,8010,Carcinoma NOS,T4b,N2b,0,1,5,Salivary Gland,0
47,Female,8562,Epithelial-myoepithelial carcinoma,T3,N0,1,0,39,Alive,131
62,Male,8430,Mucoepidermoid carcinoma,T2,N2b,1,0,14,"In situ, benign or unknown behavior neoplasm",21
57,Female,8940,Mixed tumor,T4b,N1,1,0,0,Alive,121
87,Male,8070,Squamous cell carcinoma,TX,N0,0,0,Unable to calculate,Lung and Bronchus,2
47,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,28
87,Female,8071,Squamous cell carcinoma,T2,N0,0,0,22,Alive,122
57,Male,8430,Mucoepidermoid carcinoma,T2,N2b,1,1,27,Miscellaneous Malignant Cancer,66
82,Male,8010,Carcinoma NOS,TX,N0,0,0,Unable to calculate,Alive,12
67,Male,8012,"epithelial neoplasms, NOS",T3,N0,1,0,0,Alive,125
67,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,123
12,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,125
82,Female,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,56,Lung and Bronchus,7
87,Male,8010,Carcinoma NOS,T1,N2b,1,0,35,Alive,7
77,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,45,Other Cause of Death,74
77,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,84,"Nephritis, Nephrotic Syndrome and Nephrosis",40
47,Female,8020,Undifferentiated carcinoma,p2,Pathologic,0,0,0,Alive,76
72,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,0,8,State DC not available or state DC available but no COD,19
82,Male,8980,complex mixed and stromal neoplasms,T4a,N1,1,0,26,Non-Melanoma Skin,17
62,Male,8140,Adenocarcinoma,TX,N1,1,1,34,Alive,126
47,Male,8071,Squamous cell carcinoma,T2,N1,1,0,0,Alive,128
82,Male,8071,Squamous cell carcinoma,T4a,N0,1,0,22,Miscellaneous Malignant Cancer,12
77,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,38,Alive,3
17,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,125
7,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,122
90,Male,8070,Squamous cell carcinoma,T3,N0,0,0,0,Diseases of Heart,22
90,Female,8070,Squamous cell carcinoma,T2,N2b,0,0,Unable to calculate,Salivary Gland,8
52,Male,8525,ductal and lobular neoplasms,T1,N0,0,0,Unable to calculate,Alive,127
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,114
32,Female,8430,Mucoepidermoid carcinoma,T3,N0,1,0,0,Alive,113
57,Male,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,114
77,Male,8430,Mucoepidermoid carcinoma,T3,N2b,1,0,17,Diseases of Heart,6
72,Female,8941,Carcinoma ex pleomorphic adenoma,T1,N0,1,0,0,Alive,117
90,Male,8560,Adenosquamous carcinoma,T2,N1,0,0,34,Other Cause of Death,5
87,Male,8140,Adenocarcinoma,T1,N0,0,0,24,Diseases of Heart,16
67,Male,8070,Squamous cell carcinoma,T4b,N2b,1,1,7,Accidents and Adverse Effects,22
42,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,89
47,Female,8550,Acinar cell carcinoma,TX,NX,0,0,8,Alive,117
52,Female,8010,Carcinoma NOS,T1,N0,0,0,0,Alive,116
27,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,118
72,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,118
52,Male,8010,Carcinoma NOS,TX,N0,0,0,0,Alive,0
67,Male,8070,Squamous cell carcinoma,T3,N0,0,1,28,Colon excluding Rectum,34
47,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,112
72,Male,8010,Carcinoma NOS,T1,N0,0,0,43,Alive,116
62,Male,8500,Adenocarcinoma,T4b,N1,1,1,17,Alive,116
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,110
90,Female,8560,Adenosquamous carcinoma,TX,N0,0,0,57,Salivary Gland,2
47,Male,8550,Acinar cell carcinoma,TX,N0,0,0,0,Alive,35
47,Male,8940,Mixed tumor,T4a,N0,0,0,21,Alive,119
62,Female,8200,Adenoid cystic carcinoma,T2,N0,0,0,0,Alive,63
77,Male,8070,Squamous cell carcinoma,T4a,N2b,0,0,0,Miscellaneous Malignant Cancer,8
42,Male,8070,Squamous cell carcinoma,T3,N3,1,1,0,Alive,112
72,Female,8941,Carcinoma ex pleomorphic adenoma,T3,N0,0,0,0,Alive,114
82,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,0,14,Alive,118
57,Female,8010,Carcinoma NOS,T1,N0,0,0,0,Alive,108
62,Male,8070,Squamous cell carcinoma,T1,N2b,1,0,0,Alive,108
12,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,116
72,Female,8071,Squamous cell carcinoma,T3,N0,0,1,19,Miscellaneous Malignant Cancer,35
72,Female,8941,Carcinoma ex pleomorphic adenoma,TX,NX,0,0,Unable to calculate,Salivary Gland,15
67,Female,8982,Myoepithelial carcinoma,T4b,NX,1,1,0,Alive,113
72,Female,8550,Acinar cell carcinoma,T3,N2b,1,0,6,Miscellaneous Malignant Cancer,78
7,Female,8147,Adenocarcinoma,T3,N0,1,0,15,Alive,100
42,Male,8200,Adenoid cystic carcinoma,T3,N0,1,0,48,Alive,31
82,Male,8010,Carcinoma NOS,T3,N1,1,0,40,Diseases of Heart,82
42,Female,8430,Mucoepidermoid carcinoma,T3,N1,0,0,0,Alive,109
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,38,Alive,110
72,Male,8071,Squamous cell carcinoma,T2,N0,0,0,26,Other Infectious and Parasitic Diseases including HIV,33
42,Male,8010,Carcinoma NOS,T3,N0,1,0,0,Salivary Gland,3
82,Male,8070,Squamous cell carcinoma,T3,N1,0,0,0,Miscellaneous Malignant Cancer,14
67,Male,8550,Acinar cell carcinoma,T2,N0,1,0,Unable to calculate,Diseases of Heart,54
52,Female,8550,Acinar cell carcinoma,T2,N1,1,0,0,Alive,36
52,Female,8140,Adenocarcinoma,T1,N0,1,0,0,Alive,105
72,Female,8200,Adenoid cystic carcinoma,T1,N0,0,0,Unable to calculate,Alive,103
82,Female,8010,Carcinoma NOS,T2,N0,1,0,0,Liver,54
62,Female,8200,Adenoid cystic carcinoma,p3,Clinical,1,0,0,Alive,65
87,Male,8140,Adenocarcinoma,T4a,N2b,1,0,120,Salivary Gland,5
77,Male,8071,Squamous cell carcinoma,T2,N0,1,0,28,Other Cause of Death,85
72,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,106
87,Male,8140,Adenocarcinoma,T4a,N0,0,0,Unable to calculate,"In situ, benign or unknown behavior neoplasm",8
57,Female,8562,Epithelial-myoepithelial carcinoma,p4A,Pathologic,1,0,22,Alive,69
82,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,98
37,Male,8010,Carcinoma NOS,T3,N2b,1,1,19,Salivary Gland,31
32,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,100
42,Male,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,101
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,99
90,Male,8070,Squamous cell carcinoma,T1,N2b,1,0,52,Tongue,88
52,Female,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,106
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,113,Alive,104
82,Male,8010,Carcinoma NOS,T2,N1,1,0,0,Alive,101
62,Female,8010,Carcinoma NOS,TX,N1,0,0,Unable to calculate,Alive,106
77,Male,8070,Squamous cell carcinoma,T3,N1,1,0,74,Alive,101
27,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,97
90,Female,8140,Adenocarcinoma,T3,N0,1,0,0,Other Cause of Death,51
62,Male,8980,complex mixed and stromal neoplasms,T3,N2b,0,0,17,Soft Tissue including Heart,1
77,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,1,0,0,Alive,100
82,Female,8940,Mixed tumor,T3,N2b,1,1,36,Alive,104
82,Male,8574,Adenocarcinoma with neuroendocrine differentiation,T1,N0,1,0,0,Salivary Gland,12
27,Female,8550,Acinar cell carcinoma,T1,N0,0,0,17,Alive,105
57,Male,8290,Oncocytic carcinoma,T2,N0,0,0,0,Alive,97
87,Male,8074,Squamous cell carcinoma,T2,N0,1,0,0,Diseases of Heart,20
67,Male,8010,Carcinoma NOS,T4b,N0,0,0,37,Alive,107
27,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,103
90,Male,8940,Mixed tumor,T4a,N0,0,0,0,Diabetes Mellitus,3
67,Female,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,66
47,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,106
82,Male,8070,Squamous cell carcinoma,TX,N0,1,1,21,Miscellaneous Malignant Cancer,7
62,Male,8290,Oncocytic carcinoma,T2,N2b,1,0,0,Salivary Gland,68
67,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,135
67,Female,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Alive,90
72,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,0,0,116,Other Cause of Death,71
47,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,85
52,Male,8140,Adenocarcinoma,T4NOS,N1,1,1,14,Alive,6
90,Female,8550,Acinar cell carcinoma,T1,N0,0,0,Unable to calculate,Diseases of Heart,12
62,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,13
52,Male,8550,Acinar cell carcinoma,T3,N0,1,0,0,Alive,92
67,Male,8140,Adenocarcinoma,T1,N0,0,0,0,Prostate,73
47,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,85
72,Female,8230,Adenocarcinoma,T2,N0,1,0,38,Salivary Gland,41
52,Female,8430,Mucoepidermoid carcinoma,TX,NX,0,0,Unable to calculate,Alive,3
72,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,26
52,Male,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,92
52,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,61,Alive,92
62,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,58,Alive,84
62,Female,8550,Acinar cell carcinoma,T3,N2b,1,1,13,Salivary Gland,24
77,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,95
82,Female,8200,Adenoid cystic carcinoma,p1,Clinical,0,0,46,Alive,74
90,Male,8070,Squamous cell carcinoma,T2,N0,1,0,41,Salivary Gland,1
57,Female,8430,Mucoepidermoid carcinoma,TX,NX,0,0,0,Alive,92
67,Female,8430,Mucoepidermoid carcinoma,T4a,N2b,1,0,33,Non-Melanoma Skin,20
42,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,15,Alive,85
87,Male,8071,Squamous cell carcinoma,T3,N0,1,0,21,Diseases of Heart,5
52,Male,8200,Adenoid cystic carcinoma,T2,N0,0,1,32,Acute Myeloid Leukemia,50
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Other Cause of Death,52
62,Female,8982,Myoepithelial carcinoma,T3,N0,1,0,0,Alive,93
77,Male,8982,Myoepithelial carcinoma,T3,N0,0,0,0,Alive,13
57,Female,8982,Myoepithelial carcinoma,T2,N0,0,0,0,Other Cause of Death,67
52,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,79
7,Male,8010,Carcinoma NOS,T1,N0,0,0,59,Alive,35
77,Female,8072,Squamous cell carcinoma,TX,N2c,0,1,0,Esophagus,15
32,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,84
57,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,109,Alive,85
17,Male,8200,Adenoid cystic carcinoma,T4a,N0,1,0,208,Salivary Gland,62
72,Male,8074,Squamous cell carcinoma,T3,N2b,1,0,0,Salivary Gland,8
62,Male,8255,adenomas and adenocarcinomas,T4a,N1,1,1,36,Alive,84
42,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,9
57,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,0,0,Alive,86
72,Male,8070,Squamous cell carcinoma,T3,N2b,0,0,Unable to calculate,Salivary Gland,0
47,Male,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,84
47,Male,8550,Acinar cell carcinoma,T2,N2b,1,1,0,Alive,95
42,Female,8550,Acinar cell carcinoma,T2,N1,0,0,30,Alive,91
52,Female,8200,Adenoid cystic carcinoma,T3,N1,1,1,63,Ovary,16
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,20
47,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,95
37,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,94
90,Male,8140,Adenocarcinoma,T2,N0,1,0,24,Salivary Gland,28
72,Male,8500,Adenocarcinoma,p1,Pathologic,1,0,0,Alive,78
77,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,31,Alive,80
37,Male,8550,Acinar cell carcinoma,p4B,Pathologic,1,0,0,Alive,72
72,Male,8430,Mucoepidermoid carcinoma,p2,Pathologic,1,0,133,Alive,76
67,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,79
67,Male,8070,Squamous cell carcinoma,TX,N2c,1,1,49,Alive,52
67,Male,8500,Adenocarcinoma,p2,Pathologic,1,1,48,Salivary Gland,34
22,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,83
77,Male,8430,Mucoepidermoid carcinoma,p3,Pathologic,1,0,21,Salivary Gland,16
72,Female,8098,Basal cell carcinoma,p2,Clinical,0,0,0,Alive,80
42,Male,8550,Acinar cell carcinoma,p1,Pathologic,0,0,0,Alive,77
57,Female,8200,Adenoid cystic carcinoma,p4A,Pathologic,1,0,0,Alive,83
87,Female,8290,Oncocytic carcinoma,p2,Pathologic,0,0,0,Alive,74
27,Female,8200,Adenoid cystic carcinoma,p4A,Pathologic,1,0,0,Alive,81
67,Female,8147,Adenocarcinoma,p2,Pathologic,1,0,0,Miscellaneous Malignant Cancer,67
72,Male,8046,"epithelial neoplasms, NOS",c4B,Clinical,1,1,44,Alive,78
67,Male,8430,Mucoepidermoid carcinoma,p2,Pathologic,1,0,127,Alive,77
77,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,0,Alive,83
82,Female,8082,squamous cell neoplasms,p2,Pathologic,0,0,0,Alive,80
72,Male,8070,Squamous cell carcinoma,T2,N3a,0,0,35,Other Cause of Death,19
32,Female,8200,Adenoid cystic carcinoma,p2,Pathologic,1,0,47,Alive,78
72,Male,8071,Squamous cell carcinoma,p4B,Pathologic,1,1,0,Miscellaneous Malignant Cancer,21
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,9
77,Male,8072,Squamous cell carcinoma,c4A,Clinical,1,1,24,Salivary Gland,33
57,Male,8200,Adenoid cystic carcinoma,p2,Pathologic,1,0,0,Miscellaneous Malignant Cancer,26
52,Male,8310,Adenocarcinoma,p3,Pathologic,1,0,40,Alive,72
77,Male,8430,Mucoepidermoid carcinoma,p4A,Clinical,0,0,0,Alive,74
67,Male,8500,Adenocarcinoma,p3,Pathologic,1,1,15,Salivary Gland,48
67,Male,8070,Squamous cell carcinoma,p3,Pathologic,1,0,26,Other Cause of Death,13
72,Male,8941,Carcinoma ex pleomorphic adenoma,p2,Pathologic,1,0,75,Atherosclerosis,8
22,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,79
37,Male,8010,Carcinoma NOS,p3,Pathologic,1,1,44,Salivary Gland,59
77,Male,8070,Squamous cell carcinoma,p3,Pathologic,1,1,41,Alive,79
47,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,51,Alive,81
62,Male,8502,Adenocarcinoma,p3,Pathologic,1,0,13,Alive,77
87,Male,8071,Squamous cell carcinoma,c3,Clinical,0,1,43,Salivary Gland,7
37,Female,8550,Acinar cell carcinoma,p1,Pathologic,0,0,22,Alive,2
17,Female,8550,Acinar cell carcinoma,p3,Pathologic,0,0,0,Alive,75
87,Female,8070,Squamous cell carcinoma,p3,Pathologic,1,0,60,Alive,79
67,Female,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,0,Alive,78
37,Female,8430,Mucoepidermoid carcinoma,p2,Pathologic,0,0,0,Alive,7
67,Female,8071,Squamous cell carcinoma,c1,Pathologic,1,0,0,Alive,73
72,Female,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,0,Alive,74
62,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Kidney and Renal Pelvis,11
52,Male,8500,Adenocarcinoma,p4A,Pathologic,1,1,24,Miscellaneous Malignant Cancer,30
67,Female,8147,Adenocarcinoma,p1,Pathologic,1,0,0,Salivary Gland,33
37,Male,8010,Carcinoma NOS,p2,Pathologic,0,0,20,Alive,2
87,Male,8010,Carcinoma NOS,p3,Pathologic,1,0,27,Diseases of Heart,31
52,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,61
87,Female,8070,Squamous cell carcinoma,p1,Pathologic,1,0,46,Alive,74
37,Female,8430,Mucoepidermoid carcinoma,cX,Clinical,0,0,Unable to calculate,Alive,0
82,Male,8071,Squamous cell carcinoma,TX,NX,0,0,0,Alive,91
67,Male,8041,Small cell carcinoma,cX,Pathologic,1,1,0,Alive,70
57,Female,8562,Epithelial-myoepithelial carcinoma,p2,Pathologic,1,0,35,Alive,60
87,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Diseases of Heart,17
47,Female,8550,Acinar cell carcinoma,p2,Pathologic,1,0,20,Alive,64
62,Male,8147,Adenocarcinoma,p3,Pathologic,1,0,29,Alive,63
27,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,0,Alive,66
77,Female,8071,Squamous cell carcinoma,c4A,Clinical,1,0,22,Diseases of Heart,44
47,Female,8430,Mucoepidermoid carcinoma,cX,Pathologic,1,0,0,Alive,70
17,Female,8550,Acinar cell carcinoma,p2,Pathologic,0,0,0,Alive,56
17,Female,8550,Acinar cell carcinoma,p1,Pathologic,0,0,0,Alive,69
27,Female,8550,Acinar cell carcinoma,p2,Clinical,0,0,0,Alive,68
72,Male,8071,Squamous cell carcinoma,p2,Pathologic,1,0,34,Alive,64
77,Female,8140,Adenocarcinoma,p4B,Pathologic,1,1,54,Salivary Gland,29
57,Male,8525,ductal and lobular neoplasms,cX,Clinical,0,0,0,Alive,63
77,Male,8246,Neuroendocrine carcinoma,p1,Pathologic,1,1,19,Salivary Gland,3
82,Female,8147,Adenocarcinoma,cX,Clinical,1,0,0,Alive,64
67,Female,8200,Adenoid cystic carcinoma,p2,Pathologic,1,0,25,Alive,69
17,Female,8550,Acinar cell carcinoma,p1,Clinical,0,0,0,Alive,63
47,Female,8550,Acinar cell carcinoma,p1,Pathologic,0,0,24,Alive,64
72,Male,8071,Squamous cell carcinoma,p2,Pathologic,1,0,23,Alive,65
72,Male,8401,Adenocarcinoma,cX,Clinical,1,0,63,Salivary Gland,10
42,Female,8200,Adenoid cystic carcinoma,p2,Pathologic,1,0,0,Alive,69
62,Female,8940,Mixed tumor,p1,Pathologic,0,0,63,Alive,70
12,Female,8200,Adenoid cystic carcinoma,p3,Pathologic,1,0,47,Alive,21
67,Male,8071,Squamous cell carcinoma,p3,Pathologic,1,0,19,Alive,65
82,Male,8430,Mucoepidermoid carcinoma,p3,Pathologic,1,0,20,Salivary Gland,9
52,Male,8071,Squamous cell carcinoma,T4a,N1,1,0,38,Alive,47
87,Male,8070,Squamous cell carcinoma,T2,N0,1,0,0,Alive,1
77,Male,8500,Adenocarcinoma,p3,Pathologic,1,0,33,Alive,66
57,Male,8070,Squamous cell carcinoma,p3,Pathologic,1,0,0,Alive,60
77,Male,8071,Squamous cell carcinoma,TX,N0,0,0,39,Prostate,15
72,Female,8430,Mucoepidermoid carcinoma,p4A,Pathologic,1,0,0,Salivary Gland,9
67,Male,8140,Adenocarcinoma,p4A,Pathologic,1,0,0,Alive,68
77,Male,8140,Adenocarcinoma,p2,Pathologic,1,0,44,Pneumonia and Influenza,33
27,Female,8500,Adenocarcinoma,p1,Clinical,1,0,0,Alive,66
72,Male,8070,Squamous cell carcinoma,p3,Pathologic,1,0,0,Diseases of Heart,13
82,Female,8430,Mucoepidermoid carcinoma,T3,N0,0,0,42,Breast,5
77,Male,8070,Squamous cell carcinoma,T4a,N2b,1,1,60,Alive,7
12,Male,8550,Acinar cell carcinoma,p1,Pathologic,0,0,0,Alive,64
32,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,2,Salivary Gland,13
72,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,34
62,Male,8071,Squamous cell carcinoma,T2,N2c,1,1,0,Chronic Obstructive Pulmonary Disease and Allied Cond,52
57,Female,8200,Adenoid cystic carcinoma,TX,NX,0,0,Unable to calculate,Alive,54
77,Male,8070,Squamous cell carcinoma,T3,NX,1,0,41,Alive,51
67,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,0,Alive,56
67,Male,8290,Oncocytic carcinoma,T2,N0,1,0,0,Alive,48
67,Male,8290,Oncocytic carcinoma,T2,N0,0,0,0,Alive,55
52,Male,8070,Squamous cell carcinoma,T4b,N3b,0,1,64,Salivary Gland,11
37,Male,8200,Adenoid cystic carcinoma,T1,N0,0,0,0,Alive,59
22,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,58
27,Male,8430,Mucoepidermoid carcinoma,T1,N1,0,0,160,Alive,52
32,Male,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,56
62,Male,8140,Adenocarcinoma,T2,N3b,1,1,62,Alive,58
57,Male,8500,Adenocarcinoma,T2,N3b,0,0,0,Salivary Gland,2
57,Male,8033,Undifferentiated carcinoma,88,88,1,0,34,Alive,59
22,Male,8140,Adenocarcinoma,T1,N1,0,0,0,Alive,16
62,Female,8550,Acinar cell carcinoma,T3,N3b,1,1,0,Alive,54
82,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,54
67,Male,8010,Carcinoma NOS,T1,N1,1,0,49,Alive,54
57,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,53
82,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,0,24,Diseases of Heart,15
42,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,27
67,Male,8500,Adenocarcinoma,T4a,N3b,1,1,0,Other Cause of Death,10
57,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,50
90,Male,8070,Squamous cell carcinoma,T2,N2b,1,0,71,Miscellaneous Malignant Cancer,7
77,Male,8982,Myoepithelial carcinoma,T2,N0,1,1,93,Alive,59
57,Male,8071,Squamous cell carcinoma,T2,N3b,1,1,123,Miscellaneous Malignant Cancer,31
90,Female,8071,Squamous cell carcinoma,T3,N0,0,0,Unable to calculate,Salivary Gland,7
67,Male,8140,Adenocarcinoma,T2,N2b,0,0,Unable to calculate,Miscellaneous Malignant Cancer,30
87,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,13,Alive,57
90,Female,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Diseases of Heart,57
82,Male,8550,Acinar cell carcinoma,T2,N0,0,0,51,Alive,53
72,Male,8525,ductal and lobular neoplasms,TX,NX,0,0,Unable to calculate,Lung and Bronchus,41
87,Male,8070,Squamous cell carcinoma,T3,N2b,0,0,26,Larynx,6
72,Female,8550,Acinar cell carcinoma,T1,N0,1,0,11,Alive,57
47,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,10
82,Female,8070,Squamous cell carcinoma,T3,N0,1,0,0,Alive,10
82,Female,8982,Myoepithelial carcinoma,TX,NX,0,0,0,Diseases of Heart,20
52,Male,8200,Adenoid cystic carcinoma,T4b,N0,1,1,49,"Trachea, Mediastinum and Other Respiratory Organs",8
82,Female,8982,Myoepithelial carcinoma,T4a,N0,0,0,16,Alive,6
57,Male,8500,Adenocarcinoma,T2,N1,1,0,Unable to calculate,Alive,51
57,Male,8525,ductal and lobular neoplasms,TX,N0,0,0,0,Alive,57
52,Male,8500,Adenocarcinoma,T1,N2b,1,0,25,Alive,45
87,Female,8525,ductal and lobular neoplasms,T2,N1,1,0,44,Salivary Gland,16
72,Female,8071,Squamous cell carcinoma,T4a,N2b,1,0,38,Miscellaneous Malignant Cancer,32
77,Male,8500,Adenocarcinoma,T3,N0,1,0,0,Alive,7
67,Male,8070,Squamous cell carcinoma,T3,N2b,1,1,0,Alive,44
77,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,68,Alive,47
87,Male,8070,Squamous cell carcinoma,T4a,N2a,1,0,50,Alive,47
57,Female,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,37
62,Female,8070,Squamous cell carcinoma,T2,N0,1,0,35,Alive,46
72,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,47
82,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,1,1,26,Alive,39
67,Male,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,40
72,Male,8070,Squamous cell carcinoma,T2,N0,0,0,Unable to calculate,Alive,0
82,Male,8010,Carcinoma NOS,T2,N0,1,1,48,Alive,43
77,Male,8070,Squamous cell carcinoma,T1,N0,0,0,37,Alive,39
62,Male,8550,Acinar cell carcinoma,T3,N0,1,0,0,Alive,42
77,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,43
72,Male,8070,Squamous cell carcinoma,T1,N2b,1,1,31,Alive,40
52,Male,8550,Acinar cell carcinoma,T3,N0,1,1,0,Alive,41
67,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,39,Alive,41
82,Male,8070,Squamous cell carcinoma,T3,N2b,1,0,40,Miscellaneous Malignant Cancer,9
47,Male,8430,Mucoepidermoid carcinoma,T3,N2a,1,0,0,Alive,38
47,Male,8550,Acinar cell carcinoma,T4a,N0,1,1,1,State DC not available or state DC available but no COD,14
67,Male,8430,Mucoepidermoid carcinoma,T4b,N0,1,1,36,Miscellaneous Malignant Cancer,4
67,Male,8070,Squamous cell carcinoma,T2,N0,0,0,12,Alive,45
52,Female,8070,Squamous cell carcinoma,T1,N0,1,0,0,Alive,47
42,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,47
67,Male,8071,Squamous cell carcinoma,TX,N1,0,0,0,Alive,27
72,Female,8070,Squamous cell carcinoma,T1,N1,0,0,0,Other Cause of Death,5
72,Male,8071,Squamous cell carcinoma,T3,N2b,1,1,39,Alive,37
62,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,36
12,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,39
72,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,37
47,Male,8982,Myoepithelial carcinoma,T1,N0,0,0,21,Alive,37
82,Male,8500,Adenocarcinoma,T4a,N3b,0,0,55,Salivary Gland,11
62,Female,8147,Adenocarcinoma,T1,N1,1,0,0,Alive,14
37,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,1,0,0,Alive,43
47,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,42
57,Male,8500,Adenocarcinoma,T2,N1,1,1,31,Alive,46
52,Female,8200,Adenoid cystic carcinoma,T1,N1,1,0,0,Alive,38
72,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,46
32,Male,8550,Acinar cell carcinoma,TX,NX,0,0,Unable to calculate,Miscellaneous Malignant Cancer,107
7,Female,8147,Adenocarcinoma,T2,N0,0,0,0,Alive,11
87,Male,8070,Squamous cell carcinoma,TX,N1,0,0,Unable to calculate,State DC not available or state DC available but no COD,32
62,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Miscellaneous Malignant Cancer,7
27,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Alive,44
57,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,36
22,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Alive,0
47,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,18
87,Male,8500,Adenocarcinoma,T4a,N3b,1,0,37,Salivary Gland,34
67,Male,8070,Squamous cell carcinoma,T3,N3b,1,1,26,Salivary Gland,8
90,Male,8500,Adenocarcinoma,T2,N0,0,0,35,Other Cause of Death,13
82,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,33,Alive,49
77,Male,8200,Adenoid cystic carcinoma,T4a,N3b,1,1,0,Alive,39
57,Male,8550,Acinar cell carcinoma,T2,N0,1,0,Unable to calculate,Salivary Gland,30
32,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,29
82,Male,8070,Squamous cell carcinoma,T1,N0,0,0,41,Alive,2
82,Male,8550,Acinar cell carcinoma,T2,N3b,0,0,0,Chronic Obstructive Pulmonary Disease and Allied Cond,21
57,Male,8290,Oncocytic carcinoma,T2,N2c,0,0,0,Alive,33
57,Female,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,20
57,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,34
87,Male,8070,Squamous cell carcinoma,TX,NX,0,0,0,Alive,30
52,Male,8941,Carcinoma ex pleomorphic adenoma,T4a,N3b,0,0,0,Soft Tissue including Heart,0
77,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,30
42,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,30
42,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,30
57,Female,8982,Myoepithelial carcinoma,T3,N2b,0,0,0,Lung and Bronchus,4
57,Male,8550,Acinar cell carcinoma,T3,N0,1,0,31,Alive,24
62,Male,8070,Squamous cell carcinoma,T4b,N3b,0,1,16,Miscellaneous Malignant Cancer,4
90,Male,8071,Squamous cell carcinoma,T2,N0,0,0,0,Salivary Gland,16
72,Male,8500,Adenocarcinoma,T2,N0,1,0,43,Cerebrovascular Diseases,8
82,Male,8550,Acinar cell carcinoma,T3,N0,1,0,0,Alive,30
22,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,28
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,23
67,Female,8070,Squamous cell carcinoma,T4b,N2b,0,1,21,Other Oral Cavity and Pharynx,8
77,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,8
62,Female,8982,Myoepithelial carcinoma,T2,N0,0,0,0,Alive,24
82,Male,8500,Adenocarcinoma,T4a,N2b,1,1,27,Alive,22
62,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,22
72,Male,8562,Epithelial-myoepithelial carcinoma,T1,N0,1,0,0,Alive,23
62,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,33
62,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,59,Alive,13
67,Male,8072,Squamous cell carcinoma,T4a,N3b,0,0,0,Miscellaneous Malignant Cancer,20
22,Female,8982,Myoepithelial carcinoma,T2,N0,0,0,0,Alive,12
67,Male,8010,Carcinoma NOS,T3,N1,0,1,73,Salivary Gland,18
62,Female,8500,Adenocarcinoma,T1,N0,1,0,0,Alive,25
37,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,35
57,Female,8041,Small cell carcinoma,T2,N3a,1,1,0,Alive,25
42,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,27
27,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,33
32,Female,8502,Adenocarcinoma,T1,N0,0,0,0,Alive,35
77,Female,8140,Adenocarcinoma,T3,N0,1,0,0,Alive,16
47,Male,8140,Adenocarcinoma,T2,N0,0,0,0,Alive,34
52,Female,8500,Adenocarcinoma,T2,N0,1,0,38,Alive,18
77,Male,8246,Neuroendocrine carcinoma,TX,N2c,1,0,17,Alive,21
27,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,15
42,Female,8500,Adenocarcinoma,T2,N3b,1,1,27,Alive,20
47,Male,8430,Mucoepidermoid carcinoma,TX,NX,0,0,Unable to calculate,Alive,27
90,Male,8070,Squamous cell carcinoma,T2,N0,1,0,35,Alive,15
87,Female,8500,Adenocarcinoma,T4a,N2a,0,0,12,Salivary Gland,4
82,Female,8070,Squamous cell carcinoma,T3,N2b,0,0,46,Alive,14
62,Male,8071,Squamous cell carcinoma,T3,N2a,0,0,0,Alive,12
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,12
72,Female,8071,Squamous cell carcinoma,T3,N1,0,0,42,Alive,14
87,Female,8020,Undifferentiated carcinoma,88,88,0,0,68,Alive,12
82,Male,8140,Adenocarcinoma,T3,N3b,1,0,28,Diseases of Heart,11
82,Male,8033,Undifferentiated carcinoma,88,88,1,0,43,Alive,13
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,180,Alive,16
47,Male,8982,Myoepithelial carcinoma,T1,N0,0,0,0,Alive,21
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,19
72,Female,8147,Adenocarcinoma,T2,N0,1,0,0,Alive,18
67,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,21
32,Female,8940,Mixed tumor,cX,Pathologic,0,0,Unable to calculate,Alive,60
77,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,1,27,Alive,20
87,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,1
87,Female,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,12
67,Female,8500,Adenocarcinoma,T4b,N0,1,0,0,Alive,15
72,Male,8147,Adenocarcinoma,T2,N0,0,0,29,Alive,14
62,Male,8071,Squamous cell carcinoma,T1,N0,1,0,15,Alive,116
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,9
72,Female,8070,Squamous cell carcinoma,T1,N0,0,0,0,Alive,11
37,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,25,Alive,10
87,Female,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,7
62,Female,8500,Adenocarcinoma,T1,N0,1,0,28,Alive,7
52,Male,8500,Adenocarcinoma,T4a,N2b,1,1,33,Alive,10
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,2
47,Male,8200,Adenoid cystic carcinoma,T3,N2b,1,0,33,Alive,11
82,Male,8070,Squamous cell carcinoma,T2,N0,1,0,19,Alive,7
87,Male,8070,Squamous cell carcinoma,T4a,N2b,1,0,35,Alive,7
47,Male,8982,Myoepithelial carcinoma,T2,N0,1,0,0,Alive,11
67,Male,8500,Adenocarcinoma,T3,N0,1,0,22,Alive,18
57,Male,8290,Oncocytic carcinoma,T3,N0,0,0,0,Alive,12
57,Female,8200,Adenoid cystic carcinoma,T3,N0,1,1,0,Alive,16
57,Male,8525,ductal and lobular neoplasms,T1,N0,1,0,0,Alive,12
87,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Miscellaneous Malignant Cancer,2
77,Male,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Alive,0
90,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Salivary Gland,6
77,Female,8071,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,17
87,Male,8071,Squamous cell carcinoma,T1,N0,0,0,Unable to calculate,Alive,21
82,Male,8071,Squamous cell carcinoma,T3,N0,1,0,20,Alive,22
57,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,1
62,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,13
57,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,77,Alive,16
67,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,0,Alive,11
87,Male,8010,Carcinoma NOS,TX,N0,0,0,Unable to calculate,Kidney and Renal Pelvis,0
52,Male,8500,Adenocarcinoma,T3,N1,1,0,35,Alive,6
32,Male,8500,Adenocarcinoma,T2,N0,0,0,43,Alive,8
82,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,6
90,Male,8020,Undifferentiated carcinoma,88,88,1,0,15,Alive,3
62,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,1
47,Male,8982,Myoepithelial carcinoma,T3,N0,0,0,0,Alive,2
87,Male,8010,Carcinoma NOS,T3,N3b,1,0,52,Alive,4
77,Male,8500,Adenocarcinoma,T4a,N0,1,0,60,Alive,1
42,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,1
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,2
52,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,13,Alive,2
72,Male,8010,Carcinoma NOS,T1,N0,0,0,0,Alive,2
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,2
87,Female,8020,Undifferentiated carcinoma,88,88,1,0,34,Alive,3
77,Male,8982,Myoepithelial carcinoma,T2,N0,0,0,0,Alive,17
67,Female,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
42,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,9
90,Female,8071,Squamous cell carcinoma,TX,N0,0,0,Unable to calculate,Alive,1
77,Male,8071,Squamous cell carcinoma,T3,N2a,0,0,26,Alive,11
62,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,9
87,Male,8502,Adenocarcinoma,T2,N0,1,0,0,Alive,5
22,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,10
47,Male,8500,Adenocarcinoma,TX,N2b,1,1,27,Alive,5
47,Female,8502,Adenocarcinoma,T1,N0,0,0,0,Alive,3
67,Male,8140,Adenocarcinoma,T2,N0,0,0,Unable to calculate,Alive,3
67,Male,8200,Adenoid cystic carcinoma,T3,N0,1,0,37,Alive,1
62,Male,8500,Adenocarcinoma,T2,N0,1,0,79,Alive,3
32,Female,8502,Adenocarcinoma,T1,N0,0,0,0,Alive,3
87,Female,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Miscellaneous Malignant Cancer,2
57,Male,8071,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,5
67,Male,8070,Squamous cell carcinoma,T2,N2a,1,1,38,Alive,4
87,Female,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Alive,2
87,Male,8071,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,2
62,Female,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,0
72,Male,8071,Squamous cell carcinoma,T1,N0,1,0,19,Alive,21
82,Male,8071,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,5
77,Male,8083,Squamous cell carcinoma,T3,N0,1,0,23,Alive,6
87,Female,8982,Myoepithelial carcinoma,T2,N0,0,0,111,Alive,0
72,Male,8200,Adenoid cystic carcinoma,TX,NX,0,1,14,Alive,4
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,0
67,Female,8140,Adenocarcinoma,TX,N0,0,0,56,Alive,0
72,Male,8070,Squamous cell carcinoma,T4b,N2b,1,0,40,Alive,14
67,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,1
90,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
87,Female,8550,Acinar cell carcinoma,T2,N0,0,0,Unable to calculate,Alive,18
57,Male,8560,Adenosquamous carcinoma,T2,N0,0,0,141,Diseases of Heart,64
72,Female,8562,Epithelial-myoepithelial carcinoma,T3,N0,0,0,0,"In situ, benign or unknown behavior neoplasm",81
77,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,47
90,Male,8010,Carcinoma NOS,T2,N0,0,0,Unable to calculate,Alive,4
67,Female,8430,Mucoepidermoid carcinoma,T3,N0,1,0,0,Alive,147
72,Female,8550,Acinar cell carcinoma,T3,N0,1,0,39,Alive,38
62,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,0,0,Miscellaneous Malignant Cancer,68
57,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,1,59,Alive,58
72,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Thyroid,55
82,Male,8071,Squamous cell carcinoma,T2,N1,1,0,0,Lip,19
77,Female,8941,Carcinoma ex pleomorphic adenoma,T4a,N3b,1,0,0,Alive,20
17,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,92
62,Female,8430,Mucoepidermoid carcinoma,p2,Pathologic,1,0,0,Alive,64
87,Male,8010,Carcinoma NOS,c4A,Clinical,0,0,Unable to calculate,Cerebrovascular Diseases,5
77,Male,8200,Adenoid cystic carcinoma,T1,N0,0,0,0,Miscellaneous Malignant Cancer,89
87,Male,8070,Squamous cell carcinoma,T4b,N0,1,0,28,Alive,14
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,103
67,Female,8941,Carcinoma ex pleomorphic adenoma,p2,Pathologic,1,0,0,Alive,61
62,Female,8010,Carcinoma NOS,T3,N0,0,1,36,Alive,111
72,Female,8140,Adenocarcinoma,T4a,N1,0,0,95,Alive,0
87,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Soft Tissue including Heart,17
82,Male,8070,Squamous cell carcinoma,T4a,N2b,0,0,34,Miscellaneous Malignant Cancer,2
72,Female,8255,adenomas and adenocarcinomas,T3,N0,1,0,472,Alive,118
67,Female,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
57,Female,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,0,Stomach,134
87,Male,8070,Squamous cell carcinoma,T2,N1,0,0,40,Alive,141
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,53,Intrahepatic Bile Duct,46
77,Male,8430,Mucoepidermoid carcinoma,p4A,Pathologic,1,0,37,Esophagus,47
87,Male,8070,Squamous cell carcinoma,p2,Pathologic,1,0,43,Alive,74
67,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Tongue,6
72,Female,8200,Adenoid cystic carcinoma,p4A,Pathologic,0,0,0,Alive,67
67,Male,8070,Squamous cell carcinoma,TX,N3b,1,0,28,Alive,3
82,Female,8560,Adenosquamous carcinoma,T4a,N0,1,1,97,Alive,96
42,Female,8941,Carcinoma ex pleomorphic adenoma,T3,N0,1,0,5,Miscellaneous Malignant Cancer,17
67,Female,8430,Mucoepidermoid carcinoma,T1,N1,1,0,0,Alive,123
57,Female,8070,Squamous cell carcinoma,T4a,N2b,1,1,107,Salivary Gland,23
57,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,68,Alive,79
57,Male,8070,Squamous cell carcinoma,T1,N0,0,0,0,Alive,106
62,Male,8070,Squamous cell carcinoma,TX,N1,1,0,0,Alive,72
87,Female,8430,Mucoepidermoid carcinoma,p3,Pathologic,1,0,9,Alive,60
67,Male,8290,Oncocytic carcinoma,T1,N0,0,0,0,Salivary Gland,74
67,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,150
47,Female,8430,Mucoepidermoid carcinoma,T3,N0,1,0,56,Alive,120
57,Female,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,153
57,Female,8140,Adenocarcinoma,T3,N2b,1,0,42,Salivary Gland,37
52,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,153
77,Female,8500,Adenocarcinoma,T2,N0,1,0,0,Alive,146
32,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,154
72,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,154
77,Male,8072,Squamous cell carcinoma,T3,N2b,0,0,32,Nasopharynx,11
42,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,154
62,Male,8200,Adenoid cystic carcinoma,T4a,N2c,1,1,66,Salivary Gland,16
62,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Pneumonia and Influenza,92
87,Female,8430,Mucoepidermoid carcinoma,TX,NX,0,0,Unable to calculate,Stomach,1
77,Female,8941,Carcinoma ex pleomorphic adenoma,T1,N0,1,0,0,Alive,151
67,Female,8562,Epithelial-myoepithelial carcinoma,T2,NX,1,0,0,Alive,136
22,Female,8982,Myoepithelial carcinoma,T1,N0,0,0,0,Alive,146
82,Male,8071,Squamous cell carcinoma,T3,N0,1,1,32,Non-Melanoma Skin,3
72,Male,8070,Squamous cell carcinoma,T4a,N1,1,0,50,Other Cause of Death,22
62,Male,8140,Adenocarcinoma,T2,N0,1,0,23,Alive,136
82,Female,8430,Mucoepidermoid carcinoma,T4a,N0,0,0,0,Diseases of Heart,120
77,Male,8070,Squamous cell carcinoma,T1,N1,1,0,20,Alive,139
37,Male,8010,Carcinoma NOS,T4a,N1,1,0,157,Salivary Gland,21
62,Male,8200,Adenoid cystic carcinoma,T4b,N0,1,0,Unable to calculate,Alive,137
57,Male,8070,Squamous cell carcinoma,T1,NX,0,0,Unable to calculate,Salivary Gland,46
77,Female,8200,Adenoid cystic carcinoma,T1,N0,0,0,0,Alive,138
67,Female,8982,Myoepithelial carcinoma,T4a,N0,1,0,0,Salivary Gland,27
72,Male,8070,Squamous cell carcinoma,T4a,N2b,0,0,Unable to calculate,Miscellaneous Malignant Cancer,4
62,Male,8070,Squamous cell carcinoma,T2,N0,1,0,16,Other Cause of Death,127
77,Male,8430,Mucoepidermoid carcinoma,p3,Pathologic,1,0,0,Pancreas,16
37,Male,8200,Adenoid cystic carcinoma,T4a,N0,1,0,0,Miscellaneous Malignant Cancer,100
52,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,1,0,0,Alive,139
62,Male,8500,Adenocarcinoma,T1,N0,0,0,20,Alive,132
82,Female,8070,Squamous cell carcinoma,T4b,NX,0,0,Unable to calculate,Salivary Gland,15
77,Male,8140,Adenocarcinoma,T1,N0,1,0,5,Stomach,70
82,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Miscellaneous Malignant Cancer,33
87,Male,8010,Carcinoma NOS,TX,N0,1,0,37,Liver,23
12,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,133
77,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Esophagus,17
42,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,124
72,Male,8982,Myoepithelial carcinoma,T3,N0,1,0,34,Melanoma of the Skin,26
87,Female,8070,Squamous cell carcinoma,T3,N0,1,0,60,Miscellaneous Malignant Cancer,20
37,Male,8941,Carcinoma ex pleomorphic adenoma,T4a,N2c,0,1,0,Alive,128
57,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,126
37,Female,8430,Mucoepidermoid carcinoma,T2,N2b,0,0,0,Alive,128
82,Male,8140,Adenocarcinoma,T4a,N2b,1,0,75,Miscellaneous Malignant Cancer,7
62,Female,8140,Adenocarcinoma,T2,N1,0,0,23,Salivary Gland,63
57,Female,8940,Mixed tumor,T3,N0,1,0,21,Alive,129
42,Male,8200,Adenoid cystic carcinoma,T2,N1,1,0,0,Alive,123
77,Male,8982,Myoepithelial carcinoma,T2,N0,1,0,0,Diseases of Heart,77
77,Female,8550,Acinar cell carcinoma,p2,Clinical,1,0,0,Alive,63
27,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,126
52,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,131
87,Male,8010,Carcinoma NOS,T4NOS,N1,1,1,165,Pneumonia and Influenza,31
67,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,123
82,Male,8010,Carcinoma NOS,T4a,N2b,1,1,29,Salivary Gland,11
62,Female,8200,Adenoid cystic carcinoma,T4b,N2b,1,0,24,Salivary Gland,28
32,Female,8430,Mucoepidermoid carcinoma,T3,N0,1,0,1,Alive,115
62,Male,8147,Adenocarcinoma,T3,N0,1,0,0,Alive,129
72,Female,8430,Mucoepidermoid carcinoma,T3,N0,1,0,49,Alive,127
52,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,126
72,Male,8140,Adenocarcinoma,T3,N0,1,0,0,Alive,114
77,Male,8041,Small cell carcinoma,p1,Pathologic,1,0,47,Lung and Bronchus,29
82,Male,8010,Carcinoma NOS,T1,N1,1,0,31,Miscellaneous Malignant Cancer,47
62,Male,8070,Squamous cell carcinoma,T3,N1,0,0,Unable to calculate,Non-Melanoma Skin,18
72,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,33,Alive,18
47,Female,8070,Squamous cell carcinoma,T4b,N0,1,1,375,Salivary Gland,62
42,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,118
47,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,123
67,Male,8200,Adenoid cystic carcinoma,TX,NX,1,0,16,Alive,130
90,Male,8071,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Diseases of Heart,20
67,Female,8070,Squamous cell carcinoma,T3,N3,1,1,41,Alive,113
57,Male,8140,Adenocarcinoma,T1,N1,1,0,0,Alive,114
62,Male,8430,Mucoepidermoid carcinoma,TX,NX,1,1,Unable to calculate,Diseases of Heart,119
37,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,60
77,Male,8140,Adenocarcinoma,T1,N2b,0,0,41,Salivary Gland,29
82,Female,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
62,Male,8070,Squamous cell carcinoma,TX,N2b,1,1,24,Alive,113
62,Male,8140,Adenocarcinoma,T2,N2b,1,1,0,Salivary Gland,12
87,Male,8070,Squamous cell carcinoma,T4a,N0,1,0,108,Salivary Gland,18
57,Male,8070,Squamous cell carcinoma,T3,N2a,0,0,Unable to calculate,Bones and Joints,0
67,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,110
62,Male,8140,Adenocarcinoma,T4a,N2b,1,1,20,Salivary Gland,44
77,Female,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,48,Alive,111
90,Male,8070,Squamous cell carcinoma,T4a,N0,1,0,13,Salivary Gland,21
72,Male,8562,Epithelial-myoepithelial carcinoma,T3,N0,0,0,0,Diseases of Heart,33
52,Female,8550,Acinar cell carcinoma,T1,N0,0,1,0,Alive,119
87,Male,8140,Adenocarcinoma,TX,NX,1,0,40,Alive,4
17,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,116
27,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,29
37,Female,8022,Undifferentiated carcinoma,TX,N0,1,0,0,Alive,111
12,Female,8550,Acinar cell carcinoma,TX,NX,1,0,0,Alive,118
47,Female,8070,Squamous cell carcinoma,T4a,N2b,0,0,28,Salivary Gland,13
72,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N2b,1,1,0,Alive,107
87,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,0,0,75,Alive,66
62,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,153,Lung and Bronchus,33
72,Male,8070,Squamous cell carcinoma,T3,N2b,0,0,90,Salivary Gland,28
47,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,95
87,Female,8980,complex mixed and stromal neoplasms,T3,N0,0,0,27,Liver,4
37,Male,8502,Adenocarcinoma,T2,N0,1,0,0,Alive,105
42,Female,8550,Acinar cell carcinoma,T1,N0,0,0,21,Alive,101
42,Male,8550,Acinar cell carcinoma,T3,N0,0,0,38,Alive,103
87,Female,8147,Adenocarcinoma,T3,N0,1,0,0,Cerebrovascular Diseases,36
87,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,58,Salivary Gland,12
87,Female,8200,Adenoid cystic carcinoma,T4a,N2b,0,1,111,Salivary Gland,16
22,Female,8502,Adenocarcinoma,T2,N0,0,0,0,Alive,98
52,Female,8941,Carcinoma ex pleomorphic adenoma,T3,N0,1,1,0,Alive,81
22,Male,8140,Adenocarcinoma,T1,N0,0,0,0,Alive,90
82,Male,8070,Squamous cell carcinoma,T4a,N1,1,0,3,Alzheimers (ICD-9 and 10 only),28
57,Male,8550,Acinar cell carcinoma,T1,N0,0,0,33,Alive,105
67,Female,8140,Adenocarcinoma,TX,NX,0,0,0,Alive,102
32,Male,8502,Adenocarcinoma,T1,N0,0,0,0,Other Cause of Death,36
72,Male,8290,Oncocytic carcinoma,T1,N0,0,0,0,Other Cause of Death,67
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,88
47,Male,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,87
87,Male,8070,Squamous cell carcinoma,T4a,N0,0,0,17,Chronic Obstructive Pulmonary Disease and Allied Cond,58
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,94
87,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,0,0,0,Lung and Bronchus,77
87,Female,8562,Epithelial-myoepithelial carcinoma,T3,N0,0,0,0,Alive,55
67,Female,8502,Adenocarcinoma,T1,N0,0,0,166,Alive,38
47,Male,8430,Mucoepidermoid carcinoma,p2,Pathologic,0,0,0,Alive,83
82,Female,8200,Adenoid cystic carcinoma,T3,N2b,0,0,Unable to calculate,Diabetes Mellitus,3
62,Female,8071,Squamous cell carcinoma,T3,N2b,1,0,0,Alive,90
22,Female,8550,Acinar cell carcinoma,T2,N0,1,0,29,Alive,33
42,Female,8440,Adenocarcinoma,T2,N1,1,1,21,Alive,88
52,Female,8140,Adenocarcinoma,T2,N0,1,0,0,Alive,89
27,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,30,Alive,90
32,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,0,Alive,94
27,Male,8430,Mucoepidermoid carcinoma,p2,Pathologic,0,0,0,Alive,80
72,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,79
52,Male,8010,Carcinoma NOS,T3,N2b,1,1,14,Alive,84
62,Male,8200,Adenoid cystic carcinoma,TX,NX,0,0,Unable to calculate,Alive,92
72,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,43,Alive,83
87,Female,8140,Adenocarcinoma,c4B,Clinical,0,0,Unable to calculate,Salivary Gland,1
72,Male,8941,Carcinoma ex pleomorphic adenoma,p2,Clinical,1,0,0,Alive,77
52,Female,8020,Undifferentiated carcinoma,c3,Clinical,1,1,28,Salivary Gland,22
37,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,70
37,Female,8550,Acinar cell carcinoma,p1,Pathologic,0,0,169,Alive,12
57,Male,8200,Adenoid cystic carcinoma,p3,Pathologic,1,0,21,Alive,76
62,Male,8140,Adenocarcinoma,p4A,Clinical,1,1,0,Alive,76
67,Male,8430,Mucoepidermoid carcinoma,p3,Clinical,1,0,78,Alive,81
72,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,85
77,Male,8010,Carcinoma NOS,p2,Pathologic,0,0,13,Alive,73
47,Female,8430,Mucoepidermoid carcinoma,p2,Clinical,1,0,0,Alive,74
47,Male,8941,Carcinoma ex pleomorphic adenoma,p1,Pathologic,1,0,0,Alive,72
67,Male,8980,complex mixed and stromal neoplasms,p3,Pathologic,1,1,0,Salivary Gland,22
87,Male,8070,Squamous cell carcinoma,c4A,Clinical,0,0,Unable to calculate,Pneumonia and Influenza,3
22,Male,8502,Adenocarcinoma,p1,Pathologic,1,0,0,Alive,77
82,Male,8500,Adenocarcinoma,T1,N0,1,0,0,Alive,7
72,Male,8140,Adenocarcinoma,c1,Clinical,0,0,Unable to calculate,Salivary Gland,10
67,Male,8941,Carcinoma ex pleomorphic adenoma,p2,Pathologic,0,0,0,Alive,81
77,Female,8941,Carcinoma ex pleomorphic adenoma,p1,Pathologic,1,0,0,Alive,71
87,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
47,Female,8200,Adenoid cystic carcinoma,p4A,Pathologic,1,0,0,Alive,72
82,Male,8070,Squamous cell carcinoma,p2,Pathologic,1,0,16,Diseases of Heart,57
82,Female,8070,Squamous cell carcinoma,cX,Clinical,1,0,0,Alive,69
32,Female,8430,Mucoepidermoid carcinoma,p2,Pathologic,0,0,0,Alive,73
67,Female,8550,Acinar cell carcinoma,p2,Pathologic,1,0,14,Alive,73
77,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Other Cause of Death,30
72,Female,8070,Squamous cell carcinoma,T1,N1,1,0,27,Alive,25
32,Male,8430,Mucoepidermoid carcinoma,p3,Pathologic,0,0,0,Alive,83
12,Female,8502,Adenocarcinoma,p1,Clinical,0,0,0,Alive,76
62,Male,8502,Adenocarcinoma,p1,Pathologic,0,0,0,Alive,73
77,Female,8147,Adenocarcinoma,p2,Pathologic,0,0,0,Alive,65
47,Female,8200,Adenoid cystic carcinoma,p3,Pathologic,1,0,62,Salivary Gland,48
62,Female,8500,Adenocarcinoma,p3,Pathologic,1,1,6,Salivary Gland,56
37,Male,8200,Adenoid cystic carcinoma,p1,Pathologic,0,0,59,Alive,64
72,Male,8940,Mixed tumor,c1,Clinical,0,0,0,Alive,66
52,Male,8430,Mucoepidermoid carcinoma,p2,Pathologic,0,0,0,Alive,67
67,Female,8550,Acinar cell carcinoma,p1,Clinical,1,0,19,Alive,63
27,Female,8200,Adenoid cystic carcinoma,p3,Clinical,0,0,0,Alive,55
62,Male,8071,Squamous cell carcinoma,T1,N0,1,0,7,Alive,85
57,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Other Cause of Death,0
72,Female,8000,unspecified neoplasms,cX,Clinical,0,0,Unable to calculate,"In situ, benign or unknown behavior neoplasm",0
72,Female,8070,Squamous cell carcinoma,c2,Clinical,0,0,Unable to calculate,Alive,62
82,Male,8070,Squamous cell carcinoma,T4a,N1,0,0,75,Cerebrovascular Diseases,35
72,Male,8070,Squamous cell carcinoma,T4a,N2b,1,1,59,Alive,54
77,Female,8500,Adenocarcinoma,T4a,N1,1,0,64,Alive,56
52,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N1,1,0,Unable to calculate,Alive,55
62,Female,8500,Adenocarcinoma,p3,Pathologic,0,0,35,Alive,62
67,Male,8502,Adenocarcinoma,T1,N0,0,0,63,Alive,57
62,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,0,Alive,61
82,Male,8430,Mucoepidermoid carcinoma,TX,N0,1,0,63,Alive,1
87,Male,8941,Carcinoma ex pleomorphic adenoma,p2,Clinical,0,0,0,Alive,67
52,Male,8562,Epithelial-myoepithelial carcinoma,p3,Pathologic,1,1,14,Alive,71
62,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,64
57,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,54
77,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,53
82,Male,8200,Adenoid cystic carcinoma,TX,NX,0,0,Unable to calculate,Alive,55
37,Male,8200,Adenoid cystic carcinoma,TX,N0,0,0,Unable to calculate,Miscellaneous Malignant Cancer,1
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,51
62,Male,8140,Adenocarcinoma,T2,N3b,0,0,40,Salivary Gland,16
52,Female,8140,Adenocarcinoma,p3,Pathologic,0,0,41,Alive,69
52,Female,8200,Adenoid cystic carcinoma,p1,Pathologic,0,0,6,Alive,51
12,Female,8550,Acinar cell carcinoma,p2,Pathologic,0,0,0,Alive,44
27,Male,8200,Adenoid cystic carcinoma,T4a,N0,1,0,73,Alive,57
62,Male,8550,Acinar cell carcinoma,T3,N0,0,0,0,Salivary Gland,18
27,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,46
52,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,1
72,Male,8010,Carcinoma NOS,T2,N2b,0,1,24,Alive,49
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,47
77,Male,8010,Carcinoma NOS,T4a,N0,1,1,0,Salivary Gland,36
82,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,53
62,Male,8010,Carcinoma NOS,T3,N0,0,1,5,Salivary Gland,3
82,Male,8070,Squamous cell carcinoma,T3,N3b,0,0,0,Non-Melanoma Skin,6
42,Female,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,0,Alive,58
77,Male,8941,Carcinoma ex pleomorphic adenoma,T1,N0,1,0,0,Alive,49
77,Male,8070,Squamous cell carcinoma,T1,N0,0,0,16,Alive,51
72,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,48
27,Female,8502,Adenocarcinoma,T3,N0,0,0,0,Alive,1
57,Female,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,53
62,Male,8070,Squamous cell carcinoma,T3,N0,0,0,0,Alive,55
62,Male,8070,Squamous cell carcinoma,T3,N3b,1,1,33,Salivary Gland,2
42,Female,8550,Acinar cell carcinoma,T2,N0,1,0,26,Alive,47
27,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,52
87,Male,8200,Adenoid cystic carcinoma,TX,NX,0,0,Unable to calculate,Alive,5
32,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,45
52,Female,8502,Adenocarcinoma,T1,N0,0,0,52,Alive,43
72,Male,8200,Adenoid cystic carcinoma,T3,N0,0,0,0,Alive,46
72,Male,8070,Squamous cell carcinoma,T3,N3b,1,1,0,Alive,45
82,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,43
62,Male,8941,Carcinoma ex pleomorphic adenoma,T4a,N1,1,1,49,Miscellaneous Malignant Cancer,28
67,Male,8140,Adenocarcinoma,T3,N0,0,0,0,Alive,44
77,Male,8200,Adenoid cystic carcinoma,TX,NX,0,0,Unable to calculate,Alive,47
62,Female,8070,Squamous cell carcinoma,T4a,N2a,0,0,8,Alive,41
57,Male,8010,Carcinoma NOS,T2,N0,0,0,0,Alive,40
42,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,24,Alive,41
52,Male,8550,Acinar cell carcinoma,T2,N2b,0,0,0,Alive,48
90,Male,8140,Adenocarcinoma,T4a,N2b,1,0,37,Prostate,36
82,Female,8070,Squamous cell carcinoma,T3,N3b,1,0,78,Alive,42
90,Female,8550,Acinar cell carcinoma,T3,N0,0,0,76,Diseases of Heart,26
67,Female,8083,Squamous cell carcinoma,T4a,N0,1,0,21,Cerebrovascular Diseases,9
62,Male,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,46
17,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,47
62,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,40
77,Male,8562,Epithelial-myoepithelial carcinoma,T3,N3b,1,1,25,Alive,27
62,Female,8147,Adenocarcinoma,T1,N0,1,0,0,Alive,39
87,Male,8500,Adenocarcinoma,T2,N0,1,0,0,Diseases of Heart,37
77,Male,8500,Adenocarcinoma,T3,N0,1,0,0,Alive,33
62,Female,8525,ductal and lobular neoplasms,T1,N0,1,0,5,Alive,34
72,Male,8010,Carcinoma NOS,T4a,N0,1,0,25,Salivary Gland,16
77,Male,8010,Carcinoma NOS,T2,N0,0,0,Unable to calculate,Diseases of Heart,17
62,Female,8982,Myoepithelial carcinoma,TX,NX,0,0,Unable to calculate,Alive,11
67,Male,8500,Adenocarcinoma,T4a,N2b,1,0,48,Alive,3
47,Male,8200,Adenoid cystic carcinoma,T2,N2b,1,0,0,Alive,39
72,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,58,Alive,33
62,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,33
57,Female,8982,Myoepithelial carcinoma,T3,N0,1,0,0,Alive,33
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,30
52,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,25
82,Female,8140,Adenocarcinoma,T1,N0,1,0,91,Alive,25
72,Female,8982,Myoepithelial carcinoma,T1,N3b,1,0,0,Alive,29
87,Female,8500,Adenocarcinoma,T4a,N2c,1,0,61,Salivary Gland,14
42,Female,8502,Adenocarcinoma,T3,N0,1,0,41,Alive,22
62,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,25
57,Male,8200,Adenoid cystic carcinoma,T4a,N1,1,0,56,Alive,22
42,Female,8502,Adenocarcinoma,T3,N1,0,0,0,Alive,28
87,Male,8010,Carcinoma NOS,T3,N2b,0,0,Unable to calculate,Salivary Gland,2
47,Female,8550,Acinar cell carcinoma,T1,N0,0,0,32,Alive,20
27,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,19
22,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,33
87,Male,8010,Carcinoma NOS,T4a,N2c,1,0,29,Salivary Gland,4
57,Male,8430,Mucoepidermoid carcinoma,T2,N1,0,0,58,Alive,16
47,Male,8562,Epithelial-myoepithelial carcinoma,T3,N0,0,0,0,Alive,10
67,Female,8010,Carcinoma NOS,T4a,N2c,1,1,73,Alive,18
62,Male,8982,Myoepithelial carcinoma,T2,N0,1,0,0,Alive,16
72,Female,8140,Adenocarcinoma,T3,N1,1,0,43,Alive,14
67,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,298,Alive,20
22,Male,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,215,Alive,70
77,Male,8070,Squamous cell carcinoma,TX,N1,0,0,42,Alive,20
72,Male,8500,Adenocarcinoma,T1,N2b,1,0,36,Alive,12
82,Male,8070,Squamous cell carcinoma,T1,N0,0,0,66,Alive,8
72,Male,8290,Oncocytic carcinoma,T2,N0,1,0,0,Alive,10
67,Male,8200,Adenoid cystic carcinoma,T4a,N3b,1,0,40,Alive,9
17,Female,8430,Mucoepidermoid carcinoma,TX,NX,0,0,Unable to calculate,Alive,149
72,Female,8071,Squamous cell carcinoma,T4b,N0,1,0,112,Lung and Bronchus,23
72,Male,8500,Adenocarcinoma,T1,N0,1,0,63,Alive,10
62,Male,8070,Squamous cell carcinoma,TX,N2c,1,0,33,Alive,6
72,Female,8941,Carcinoma ex pleomorphic adenoma,T1,N1,1,0,147,Alive,7
32,Male,8502,Adenocarcinoma,T3,N0,0,0,0,Alive,15
82,Male,8070,Squamous cell carcinoma,T2,N0,0,0,Unable to calculate,Miscellaneous Malignant Cancer,18
77,Female,8000,unspecified neoplasms,T3,N0,1,0,83,Other Cause of Death,6
62,Male,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Lung and Bronchus,0
52,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,0
77,Male,8500,Adenocarcinoma,T2,N3b,1,0,93,Alive,7
47,Female,8982,Myoepithelial carcinoma,T2,N0,1,0,0,Alive,2
77,Female,8562,Epithelial-myoepithelial carcinoma,T3,N2b,1,0,53,Alive,3
90,Male,8200,Adenoid cystic carcinoma,T2,N1,0,0,Unable to calculate,Salivary Gland,2
27,Female,8082,squamous cell neoplasms,T2,N2b,1,0,0,Alive,3
57,Male,8200,Adenoid cystic carcinoma,T3,N0,0,1,141,Alive,4
52,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,3
72,Female,8982,Myoepithelial carcinoma,TX,N0,0,0,0,Alive,4
67,Male,8140,Adenocarcinoma,cX,Clinical,0,0,28,Miscellaneous Malignant Cancer,24
82,Female,8071,Squamous cell carcinoma,T4a,N3b,1,0,34,Alive,3
82,Male,8430,Mucoepidermoid carcinoma,T4a,N0,0,0,33,Diseases of Heart,23
77,Female,8070,Squamous cell carcinoma,T3,N0,0,0,0,Diseases of Heart,47
77,Female,8941,Carcinoma ex pleomorphic adenoma,T4a,N0,1,0,25,Breast,29
72,Male,8500,Adenocarcinoma,c1,Clinical,0,0,0,Chronic Lymphocytic Leukemia,21
82,Female,8246,Neuroendocrine carcinoma,T3,N0,1,0,45,Other Cause of Death,4
82,Male,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Salivary Gland,12
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,26,Alive,144
37,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,0,0,0,Alive,51
72,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,"Other Diseases of Arteries, Arterioles, Capillaries",20
87,Male,8070,Squamous cell carcinoma,T1,NX,1,0,0,Miscellaneous Malignant Cancer,21
72,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,95
87,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Other Cause of Death,43
87,Male,8070,Squamous cell carcinoma,TX,N2a,1,0,18,Alive,26
62,Female,8562,Epithelial-myoepithelial carcinoma,T3,N0,0,0,0,Alive,3
87,Male,8000,unspecified neoplasms,T2,N0,0,0,Unable to calculate,Non-Melanoma Skin,7
52,Female,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,0,Alive,74
72,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,0,Breast,35
82,Male,8070,Squamous cell carcinoma,T3,N1,1,0,41,Alive,104
57,Male,8941,Carcinoma ex pleomorphic adenoma,T1,N0,1,0,0,Chronic Obstructive Pulmonary Disease and Allied Cond,92
62,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,25,Alive,40
72,Male,8070,Squamous cell carcinoma,T4a,N2b,1,1,28,Miscellaneous Malignant Cancer,14
82,Female,8070,Squamous cell carcinoma,T3,N0,0,0,Unable to calculate,Miscellaneous Malignant Cancer,3
77,Male,8010,Carcinoma NOS,T4a,N0,1,0,52,Other Cause of Death,127
57,Female,8200,Adenoid cystic carcinoma,TX,N0,1,0,0,Alive,145
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,38
72,Male,8430,Mucoepidermoid carcinoma,T4a,N1,1,0,101,Alive,22
67,Male,8200,Adenoid cystic carcinoma,p4A,Pathologic,1,0,0,Alive,82
90,Male,8246,Neuroendocrine carcinoma,T4a,N2b,1,0,27,Salivary Gland,5
72,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,10
72,Male,8430,Mucoepidermoid carcinoma,T2,N3b,1,0,21,Alive,16
87,Female,8140,Adenocarcinoma,p1,Clinical,1,0,0,Diseases of Heart,5
82,Male,8070,Squamous cell carcinoma,T3,N1,1,0,80,Lung and Bronchus,17
42,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,14,Alive,142
62,Male,8500,Adenocarcinoma,T2,N2a,1,1,41,Alive,84
87,Male,8070,Squamous cell carcinoma,T2,N0,1,1,22,Diseases of Heart,46
82,Female,8430,Mucoepidermoid carcinoma,p3,Clinical,1,0,4,Alive,63
67,Male,8140,Adenocarcinoma,T2,N0,1,0,61,Alive,153
87,Male,8094,Basal cell carcinoma,T3,N1,1,0,Unable to calculate,Chronic Obstructive Pulmonary Disease and Allied Cond,39
72,Female,8147,Adenocarcinoma,TX,N0,0,0,0,Alive,142
67,Male,8070,Squamous cell carcinoma,T2,N2b,1,1,0,Non-Hodgkin Lymphoma,12
57,Female,8562,Epithelial-myoepithelial carcinoma,TX,N1,0,0,0,Alive,1
67,Male,8000,unspecified neoplasms,T2,N1,0,0,Unable to calculate,Chronic Obstructive Pulmonary Disease and Allied Cond,0
82,Male,8070,Squamous cell carcinoma,p2,Pathologic,1,0,26,Alive,83
82,Female,8140,Adenocarcinoma,T4a,N0,1,0,0,Salivary Gland,38
87,Male,8070,Squamous cell carcinoma,T1,N0,1,0,45,Lung and Bronchus,21
77,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,1,0,0,Alzheimers (ICD-9 and 10 only),126
37,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,124
72,Female,8562,Epithelial-myoepithelial carcinoma,T4a,N0,1,0,38,Alive,40
77,Male,8500,Adenocarcinoma,p1,Clinical,1,0,0,Myeloma,41
87,Male,8070,Squamous cell carcinoma,T3,N1,1,0,14,Other Cause of Death,12
77,Male,8200,Adenoid cystic carcinoma,TX,N1,1,0,0,Lung and Bronchus,23
72,Female,8430,Mucoepidermoid carcinoma,T4a,N0,0,0,0,Alive,127
87,Male,8140,Adenocarcinoma,T4a,N0,1,0,0,Hypertension without Heart Disease,21
82,Female,8082,squamous cell neoplasms,T3,N2b,0,0,25,Hypertension without Heart Disease,20
77,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Other Cause of Death,Unknown
77,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Alive,2
32,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,106
82,Male,8440,Adenocarcinoma,cX,Clinical,0,0,19,Alive,58
77,Male,8140,Adenocarcinoma,p1,Pathologic,1,0,24,Alive,66
27,Female,8450,"cystic, mucinous and serous neoplasms",T1,N0,0,0,0,Alive,132
82,Male,8070,Squamous cell carcinoma,c4B,Clinical,0,0,0,Salivary Gland,1
82,Male,8070,Squamous cell carcinoma,T2,N0,0,0,Unable to calculate,Salivary Gland,5
77,Male,8070,Squamous cell carcinoma,T3,N0,0,0,36,Non-Melanoma Skin,2
82,Male,8070,Squamous cell carcinoma,T2,N2b,0,0,31,Diseases of Heart,5
52,Female,8430,Mucoepidermoid carcinoma,p3,Pathologic,1,0,101,Alive,73
82,Male,8070,Squamous cell carcinoma,T2,N1,1,0,34,Diseases of Heart,7
90,Female,8982,Myoepithelial carcinoma,TX,NX,0,0,Unable to calculate,Diseases of Heart,31
37,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,43,Alive,152
90,Male,8550,Acinar cell carcinoma,T3,N0,0,0,0,Alive,20
67,Male,8430,Mucoepidermoid carcinoma,TX,N0,0,0,0,Alive,49
87,Male,8562,Epithelial-myoepithelial carcinoma,T3,N0,1,0,47,Diseases of Heart,36
87,Female,8480,Mucinous adenocarcinoma,T2,N0,1,0,43,Salivary Gland,3
87,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,58
77,Male,8010,Carcinoma NOS,T4a,NX,0,0,Unable to calculate,Non-Hodgkin Lymphoma,1
90,Male,8070,Squamous cell carcinoma,T2,N0,1,0,0,Non-Melanoma Skin,3
82,Female,8140,Adenocarcinoma,T3,N0,1,0,0,Alive,30
52,Male,8502,Adenocarcinoma,T1,N0,0,0,0,Alive,38
62,Male,8980,complex mixed and stromal neoplasms,T3,N0,1,0,0,Alive,141
87,Male,8500,Adenocarcinoma,TX,NX,1,1,0,Lung and Bronchus,15
82,Male,8070,Squamous cell carcinoma,p4A,Pathologic,1,0,76,Lung and Bronchus,34
77,Male,8070,Squamous cell carcinoma,T3,N0,1,0,53,Miscellaneous Malignant Cancer,21
87,Female,8070,Squamous cell carcinoma,T1,N0,0,1,14,Non-Hodgkin Lymphoma,35
82,Male,8070,Squamous cell carcinoma,T3,N0,0,0,62,Alive,37
47,Female,8562,Epithelial-myoepithelial carcinoma,p1,Clinical,1,0,0,Alive,83
77,Male,8450,"cystic, mucinous and serous neoplasms",T1,N0,0,0,0,Other Cause of Death,94
52,Female,8083,Squamous cell carcinoma,p2,Pathologic,0,0,0,Alive,66
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Chronic Obstructive Pulmonary Disease and Allied Cond,112
82,Male,8071,Squamous cell carcinoma,T4a,N3b,1,0,41,Alive,7
77,Male,8941,Carcinoma ex pleomorphic adenoma,T1,N0,0,0,62,Alive,95
67,Male,8941,Carcinoma ex pleomorphic adenoma,T4a,N2b,1,0,13,Salivary Gland,127
67,Male,8070,Squamous cell carcinoma,TX,N0,0,0,0,Alive,14
77,Male,8500,Adenocarcinoma,T2,N2b,1,0,22,Salivary Gland,11
87,Male,8070,Squamous cell carcinoma,T1,N0,1,0,21,Alive,7
77,Male,8070,Squamous cell carcinoma,T3,N2c,0,1,35,Cerebrovascular Diseases,15
57,Male,8500,Adenocarcinoma,T3,N0,1,0,0,Alive,85
62,Male,8941,Carcinoma ex pleomorphic adenoma,T1,N0,1,0,0,Lung and Bronchus,59
42,Male,8010,Carcinoma NOS,T1,N1,1,0,0,Alive,117
82,Male,8022,Undifferentiated carcinoma,c2,Clinical,1,0,55,Salivary Gland,11
72,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Breast,43
90,Female,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
82,Male,8430,Mucoepidermoid carcinoma,T1,N2b,0,0,0,Salivary Gland,13
52,Male,8147,Adenocarcinoma,T2,N0,1,0,0,Alive,148
72,Male,8070,Squamous cell carcinoma,T4a,N1,1,0,16,Alzheimers (ICD-9 and 10 only),96
87,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,0,Other Cause of Death,121
72,Male,8070,Squamous cell carcinoma,T2,N0,1,0,28,Alive,86
67,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,53
82,Male,8246,Neuroendocrine carcinoma,T2,N2b,1,1,30,Diseases of Heart,1
67,Male,8430,Mucoepidermoid carcinoma,T4a,N1,1,1,16,Salivary Gland,4
87,Male,8070,Squamous cell carcinoma,T2,N2b,0,0,13,Salivary Gland,24
42,Male,8941,Carcinoma ex pleomorphic adenoma,T1,N0,0,0,0,Alive,155
82,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,121
87,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alzheimers (ICD-9 and 10 only),82
57,Male,8073,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,109
82,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Diabetes Mellitus,55
87,Male,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,33,Accidents and Adverse Effects,46
57,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,150
67,Male,8140,Adenocarcinoma,T3,N1,1,1,46,Esophagus,62
72,Male,8941,Carcinoma ex pleomorphic adenoma,T1,N1,1,0,0,Lung and Bronchus,21
27,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,144
72,Male,8070,Squamous cell carcinoma,TX,N0,0,0,Unable to calculate,Accidents and Adverse Effects,21
62,Male,8140,Adenocarcinoma,T1,NX,0,0,0,Alive,52
52,Male,8550,Acinar cell carcinoma,T1,N0,1,0,38,Alive,148
47,Female,8072,Squamous cell carcinoma,T3,N2b,1,0,25,Miscellaneous Malignant Cancer,45
37,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,146
62,Male,8550,Acinar cell carcinoma,T2,N0,0,0,54,Alive,144
72,Female,8200,Adenoid cystic carcinoma,T4NOS,N0,1,0,0,"Symptoms, Signs and Ill-Defined Conditions",110
77,Male,8200,Adenoid cystic carcinoma,T1,N0,0,0,0,Lung and Bronchus,145
87,Male,8070,Squamous cell carcinoma,T2,N0,0,0,0,Other Cause of Death,8
52,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,11,Miscellaneous Malignant Cancer,135
67,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,21,Miscellaneous Malignant Cancer,18
72,Male,8071,Squamous cell carcinoma,T1,N1,1,0,22,Other Cause of Death,119
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,11,Chronic Obstructive Pulmonary Disease and Allied Cond,111
77,Female,8070,Squamous cell carcinoma,T4a,N0,0,0,0,Other Cause of Death,65
52,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,153
67,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Miscellaneous Malignant Cancer,80
87,Male,8070,Squamous cell carcinoma,T4a,N1,0,0,34,Cerebrovascular Diseases,5
52,Male,8430,Mucoepidermoid carcinoma,T1,N2b,1,1,28,Salivary Gland,43
77,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Lung and Bronchus,105
77,Female,8090,Basal cell carcinoma,T2,N0,1,0,40,Diseases of Heart,135
67,Male,8940,Mixed tumor,T1,N0,1,0,0,Alive,153
37,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,27
77,Female,8200,Adenoid cystic carcinoma,T4b,N0,1,0,181,Gum and Other Mouth,70
62,Female,8430,Mucoepidermoid carcinoma,T3,N0,1,0,29,Salivary Gland,67
62,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,1,0,0,Miscellaneous Malignant Cancer,15
72,Male,8070,Squamous cell carcinoma,T4b,N3,1,1,0,Salivary Gland,5
62,Male,8430,Mucoepidermoid carcinoma,T4b,N2b,1,0,49,Miscellaneous Malignant Cancer,21
77,Male,8070,Squamous cell carcinoma,T3,N1,1,0,7,Alive,137
62,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,141
87,Female,8550,Acinar cell carcinoma,T1,N0,1,0,0,Other Infectious and Parasitic Diseases including HIV,97
57,Female,8200,Adenoid cystic carcinoma,T1,N0,0,0,0,Alive,140
47,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,12
27,Female,8550,Acinar cell carcinoma,T2,N0,1,0,40,Alive,143
82,Male,8070,Squamous cell carcinoma,T3,N2b,1,0,52,Alive,18
67,Male,8070,Squamous cell carcinoma,T2,N3b,1,0,37,Alive,52
67,Female,8290,Oncocytic carcinoma,T1,N0,0,0,4,Alive,140
87,Male,8072,Squamous cell carcinoma,T3,N1,1,0,21,Salivary Gland,4
47,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,1,8,Salivary Gland,31
57,Male,8560,Adenosquamous carcinoma,T4a,N2b,1,0,0,Alive,134
77,Male,8071,Squamous cell carcinoma,T2,N1,0,0,0,Salivary Gland,29
87,Male,8010,Carcinoma NOS,TX,N1,0,0,0,Salivary Gland,0
42,Female,8200,Adenoid cystic carcinoma,T3,N2b,1,0,1,Alive,135
87,Male,8070,Squamous cell carcinoma,T1,N0,0,0,23,Diseases of Heart,92
27,Female,8550,Acinar cell carcinoma,T2,N0,0,0,88,Alive,135
67,Male,8070,Squamous cell carcinoma,T3,N0,1,1,27,Miscellaneous Malignant Cancer,57
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,149
52,Male,8440,Adenocarcinoma,T1,N0,0,0,32,Alive,133
27,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,42,Alive,114
57,Female,8550,Acinar cell carcinoma,T3,N0,1,0,17,Alive,9
62,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,133
77,Male,8310,Adenocarcinoma,TX,N0,1,0,41,Miscellaneous Malignant Cancer,5
82,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,18,Alive,133
32,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,124
52,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,132
77,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Other Cause of Death,121
72,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Chronic Obstructive Pulmonary Disease and Allied Cond,134
62,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,0,Alive,132
72,Male,8430,Mucoepidermoid carcinoma,T4a,N1,1,0,70,Alive,133
52,Male,8140,Adenocarcinoma,T3,N2b,0,0,Unable to calculate,Non-Melanoma Skin,7
72,Female,8140,Adenocarcinoma,T3,N1,0,0,0,Salivary Gland,16
77,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Other Cause of Death,70
72,Male,8147,Adenocarcinoma,T2,N0,0,0,0,Alive,131
17,Female,8071,Squamous cell carcinoma,T3,N0,1,1,30,Alive,130
22,Female,8440,Adenocarcinoma,TX,N0,0,0,0,Alive,140
27,Male,8430,Mucoepidermoid carcinoma,T4a,N2b,1,0,0,Alive,130
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,128
87,Female,8200,Adenoid cystic carcinoma,TX,NX,1,0,Unable to calculate,Miscellaneous Malignant Cancer,55
62,Female,8010,Carcinoma NOS,T3,N2b,1,0,40,Alive,127
90,Male,8147,Adenocarcinoma,T4a,N0,0,0,0,Salivary Gland,46
67,Male,8070,Squamous cell carcinoma,T4b,N1,1,1,46,Non-Melanoma Skin,48
57,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,129
32,Female,8430,Mucoepidermoid carcinoma,T4a,N1,1,0,0,Alive,130
62,Female,8140,Adenocarcinoma,T4a,N2NOS,0,1,14,Salivary Gland,32
62,Female,8140,Adenocarcinoma,T2,N0,0,0,25,Alive,127
37,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,76
37,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,124
67,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,1,0,0,Alive,58
47,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,38,Diseases of Heart,108
67,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,0,19,Salivary Gland,23
67,Female,8941,Carcinoma ex pleomorphic adenoma,T3,N0,1,0,0,Alive,122
72,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,124
82,Female,8140,Adenocarcinoma,TX,N0,0,0,Unable to calculate,Miscellaneous Malignant Cancer,3
57,Female,8070,Squamous cell carcinoma,T3,N2b,1,1,13,Alive,122
77,Male,8070,Squamous cell carcinoma,T2,N0,1,0,16,Non-Melanoma Skin,25
52,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,148
82,Male,8140,Adenocarcinoma,T4a,N2c,1,0,11,Salivary Gland,4
52,Female,8200,Adenoid cystic carcinoma,T2,N0,1,1,41,Alive,123
42,Female,8140,Adenocarcinoma,T1,N0,1,0,0,Alive,123
52,Female,8147,Adenocarcinoma,T3,N0,0,0,0,Alive,129
47,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,54,Chronic Liver Disease and Cirrhosis,24
67,Female,8550,Acinar cell carcinoma,T2,N0,0,0,24,Alive,123
72,Male,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,84
22,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,128
37,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,117
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Chronic Obstructive Pulmonary Disease and Allied Cond,87
42,Male,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,118
57,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,92
82,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,119
72,Male,8010,Carcinoma NOS,TX,N0,0,1,66,Diseases of Heart,15
72,Male,8070,Squamous cell carcinoma,T1,N0,1,0,Unable to calculate,Diseases of Heart,83
67,Male,8022,Undifferentiated carcinoma,T2,N0,0,0,0,Alzheimers (ICD-9 and 10 only),71
52,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Accidents and Adverse Effects,122
57,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,126
32,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,116
52,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,117
72,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,0,Alive,68
77,Female,8070,Squamous cell carcinoma,T2,N0,1,0,48,Colon excluding Rectum,6
47,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,0,0,0,Alive,114
47,Male,8010,Carcinoma NOS,T3,N2b,1,1,0,Salivary Gland,48
77,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alzheimers (ICD-9 and 10 only),68
62,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,114
57,Male,8140,Adenocarcinoma,T2,N2b,1,1,16,Alive,111
52,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Miscellaneous Malignant Cancer,57
77,Male,8070,Squamous cell carcinoma,T3,N1,1,0,10,Diseases of Heart,12
52,Male,8980,complex mixed and stromal neoplasms,T2,N0,1,0,0,Alive,128
77,Female,8010,Carcinoma NOS,T4b,N2b,1,1,26,Salivary Gland,6
72,Male,8074,Squamous cell carcinoma,T3,N0,1,1,0,Aortic Aneurysm and Dissection,7
72,Male,8070,Squamous cell carcinoma,T3,N2b,0,1,0,Stomach and Duodenal Ulcers,1
67,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,1,0,0,"In situ, benign or unknown behavior neoplasm",35
57,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,75,Alive,109
57,Male,8941,Carcinoma ex pleomorphic adenoma,T1,N0,0,0,0,Other Cause of Death,99
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,118
27,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,116
57,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,115
12,Female,8260,Adenocarcinoma,TX,N0,0,0,0,Alive,115
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,5,Lung and Bronchus,55
72,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,0,0,0,Alive,19
90,Female,8071,Squamous cell carcinoma,T2,N1,1,0,5,Lung and Bronchus,6
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,113
77,Female,8200,Adenoid cystic carcinoma,T2,N2b,1,0,56,Alive,113
82,Male,8070,Squamous cell carcinoma,T4a,N2b,1,0,20,State DC not available or state DC available but no COD,32
72,Female,8140,Adenocarcinoma,T1,N0,1,0,0,Alive,94
72,Male,8500,Adenocarcinoma,T3,N2b,1,0,38,Chronic Obstructive Pulmonary Disease and Allied Cond,64
82,Female,8147,Adenocarcinoma,T3,N1,1,0,33,Stomach,69
17,Female,8550,Acinar cell carcinoma,T1,N0,0,0,58,Alive,124
47,Male,8082,squamous cell neoplasms,T1,N0,1,0,0,Alive,107
47,Female,8140,Adenocarcinoma,TX,N2b,1,0,81,Alive,113
67,Male,8010,Carcinoma NOS,T4a,N2b,1,0,36,Salivary Gland,41
62,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,108
57,Male,8010,Carcinoma NOS,TX,NX,0,1,64,Salivary Gland,46
72,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,26,Alive,104
62,Male,8200,Adenoid cystic carcinoma,T1,N0,0,0,25,Alive,117
82,Female,8562,Epithelial-myoepithelial carcinoma,T1,N1,1,0,0,Alive,107
87,Male,8070,Squamous cell carcinoma,T4a,N2b,1,0,65,Salivary Gland,9
72,Female,8982,Myoepithelial carcinoma,T3,N0,0,0,0,Diseases of Heart,7
87,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,35,Diseases of Heart,31
82,Male,8070,Squamous cell carcinoma,T1,N0,1,0,0,Alive,108
72,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,113
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,106
90,Female,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,5
27,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,117
67,Female,8941,Carcinoma ex pleomorphic adenoma,T1,N0,1,0,0,Alive,104
57,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N2b,1,1,0,Salivary Gland,41
87,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,24,Salivary Gland,1
87,Female,8010,Carcinoma NOS,T3,N2b,1,0,0,Diseases of Heart,6
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,115
82,Male,8070,Squamous cell carcinoma,T4a,N0,1,1,Unable to calculate,Salivary Gland,10
77,Male,8070,Squamous cell carcinoma,T3,N1,1,0,52,Miscellaneous Malignant Cancer,14
67,Male,8140,Adenocarcinoma,TX,N0,0,0,0,Alive,102
72,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Chronic Obstructive Pulmonary Disease and Allied Cond,62
62,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Diseases of Heart,79
82,Female,8290,Oncocytic carcinoma,T3,N0,0,0,0,Other Cause of Death,42
72,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,102
57,Female,8440,Adenocarcinoma,TX,N0,0,0,0,Alive,85
22,Female,8480,Mucinous adenocarcinoma,T3,N0,0,0,26,Alive,99
57,Female,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,101
82,Male,8140,Adenocarcinoma,T4a,N2b,1,0,9,Accidents and Adverse Effects,26
90,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Hypertension without Heart Disease,7
82,Female,8140,Adenocarcinoma,T1,N0,1,0,22,Alive,99
62,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,101
67,Female,8941,Carcinoma ex pleomorphic adenoma,T3,N1,1,0,0,Alive,98
62,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,97
67,Male,8940,Mixed tumor,T1,N0,1,0,42,Alive,106
77,Male,8140,Adenocarcinoma,T4a,N2b,1,0,39,Salivary Gland,58
67,Female,8200,Adenoid cystic carcinoma,T3,N1,1,0,0,Tongue,90
67,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,106
67,Male,8140,Adenocarcinoma,TX,N2c,0,1,0,Miscellaneous Malignant Cancer,14
57,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,3,Colon excluding Rectum,8
37,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,100
62,Male,8246,Neuroendocrine carcinoma,T3,N0,1,1,0,Alive,95
37,Male,8941,Carcinoma ex pleomorphic adenoma,T1,N0,0,0,0,Alive,95
77,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,94
67,Female,8940,Mixed tumor,T3,N2b,1,0,0,Brain and Other Nervous System,15
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,95
90,Female,8070,Squamous cell carcinoma,T3,N0,0,0,Unable to calculate,Salivary Gland,5
77,Male,8022,Undifferentiated carcinoma,T4a,N2b,1,0,55,Salivary Gland,38
77,Male,8246,Neuroendocrine carcinoma,T3,N2b,1,0,47,Soft Tissue including Heart,9
57,Female,8070,Squamous cell carcinoma,T4a,N2b,1,1,43,Salivary Gland,14
72,Female,8550,Acinar cell carcinoma,T3,N0,1,0,34,Alive,37
62,Female,8200,Adenoid cystic carcinoma,T0,N0,1,1,18,Chronic Lymphocytic Leukemia,18
77,Male,8140,Adenocarcinoma,T4b,N2a,1,1,0,Alive,95
62,Male,8430,Mucoepidermoid carcinoma,T3,N1,0,0,30,Miscellaneous Malignant Cancer,10
90,Male,8246,Neuroendocrine carcinoma,TX,N2b,0,0,25,Salivary Gland,14
72,Male,8070,Squamous cell carcinoma,T1,N1,0,0,14,Alive,98
32,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,94
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,94
57,Male,8246,Neuroendocrine carcinoma,T2,N0,1,0,13,Alive,90
82,Male,8941,Carcinoma ex pleomorphic adenoma,T4a,N2b,1,0,16,Salivary Gland,15
87,Male,8000,unspecified neoplasms,p3,Pathologic,0,0,44,"Aleukemic, Subleukemic and NOS",18
90,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,0,60,"In situ, benign or unknown behavior neoplasm",70
42,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,87
57,Male,8010,Carcinoma NOS,T4b,N2b,1,1,0,Salivary Gland,44
87,Male,8046,"epithelial neoplasms, NOS",T4a,N2b,1,1,43,Salivary Gland,10
77,Female,8430,Mucoepidermoid carcinoma,T3,N0,0,0,59,Alive,93
77,Male,8070,Squamous cell carcinoma,T2,N2c,1,1,60,Miscellaneous Malignant Cancer,8
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,22,Alive,86
32,Female,8940,Mixed tumor,T2,N2b,0,0,0,Alive,85
32,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,84
87,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N2b,1,0,73,Salivary Gland,30
90,Male,8500,Adenocarcinoma,T4a,N2b,0,0,0,Cerebrovascular Diseases,10
77,Male,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Alive,92
52,Male,8502,Adenocarcinoma,T1,N1,1,0,0,Alive,92
90,Female,8070,Squamous cell carcinoma,T4a,N2a,1,0,0,Alive,6
87,Female,8147,Adenocarcinoma,T1,NX,0,0,0,Alive,95
52,Male,8941,Carcinoma ex pleomorphic adenoma,T1,N0,0,0,0,Alive,85
32,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,7,Alive,95
67,Male,8070,Squamous cell carcinoma,T3,N0,0,0,34,Bones and Joints,53
52,Female,8140,Adenocarcinoma,T1,NX,0,0,0,Alive,89
67,Male,8070,Squamous cell carcinoma,T1,N0,1,0,8,Lung and Bronchus,17
72,Male,8070,Squamous cell carcinoma,T3,N2b,1,1,14,Non-Melanoma Skin,8
67,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,45,Alive,84
62,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,36,Alive,92
82,Female,8070,Squamous cell carcinoma,T2,N1,0,0,0,Alive,5
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,89
82,Female,8310,Adenocarcinoma,T1,N0,0,0,25,Alive,91
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,93
62,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,0,0,0,Alive,84
62,Male,8982,Myoepithelial carcinoma,T3,N0,0,0,0,Alive,45
77,Male,8070,Squamous cell carcinoma,T3,N0,1,0,41,Alive,14
32,Male,8550,Acinar cell carcinoma,T3,N0,0,0,0,Chronic Liver Disease and Cirrhosis,54
77,Male,8070,Squamous cell carcinoma,T3,N3b,1,1,21,Miscellaneous Malignant Cancer,2
47,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,86
57,Male,8941,Carcinoma ex pleomorphic adenoma,T4a,N2b,1,1,6,Salivary Gland,52
72,Female,8200,Adenoid cystic carcinoma,T1,N1,1,0,19,Alive,86
52,Female,8550,Acinar cell carcinoma,T1,N0,0,0,15,Alive,92
87,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Pneumonia and Influenza,33
62,Male,8070,Squamous cell carcinoma,T3,N0,1,0,36,Alive,84
62,Male,8010,Carcinoma NOS,p4B,Clinical,1,1,28,Salivary Gland,52
32,Male,8430,Mucoepidermoid carcinoma,p2,Pathologic,0,0,0,Alive,77
62,Male,8070,Squamous cell carcinoma,p4A,Pathologic,1,1,38,Salivary Gland,21
67,Female,8000,unspecified neoplasms,c1,Clinical,0,1,Unable to calculate,Lung and Bronchus,7
77,Male,8941,Carcinoma ex pleomorphic adenoma,p1,Pathologic,1,0,0,Alive,79
87,Female,8147,Adenocarcinoma,cX,Clinical,0,0,Unable to calculate,Diseases of Heart,2
62,Male,8562,Epithelial-myoepithelial carcinoma,p2,Pathologic,0,0,0,Alive,83
82,Female,8200,Adenoid cystic carcinoma,p1,Pathologic,0,0,0,Alive,81
87,Male,8070,Squamous cell carcinoma,T2,N0,0,0,0,Diseases of Heart,32
77,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,50
87,Female,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,0,Alive,73
82,Male,8070,Squamous cell carcinoma,c1,Pathologic,1,0,40,Alive,79
57,Male,8430,Mucoepidermoid carcinoma,c2,Clinical,0,0,0,Alive,12
87,Female,8550,Acinar cell carcinoma,p2,Pathologic,1,0,0,Salivary Gland,14
67,Female,8562,Epithelial-myoepithelial carcinoma,p4A,Pathologic,1,1,0,Miscellaneous Malignant Cancer,70
87,Female,8200,Adenoid cystic carcinoma,p3,Pathologic,1,0,33,Miscellaneous Malignant Cancer,12
62,Male,8140,Adenocarcinoma,p3,Pathologic,1,0,33,Alive,78
72,Male,8070,Squamous cell carcinoma,T2,N0,0,0,28,Diseases of Heart,69
52,Female,8550,Acinar cell carcinoma,p3,Pathologic,1,0,0,Alive,75
62,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,80
82,Male,8070,Squamous cell carcinoma,p3,Pathologic,1,0,0,Cerebrovascular Diseases,63
57,Male,8980,complex mixed and stromal neoplasms,p4A,Pathologic,1,0,0,Lung and Bronchus,70
62,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,76
72,Female,8200,Adenoid cystic carcinoma,p2,Pathologic,0,0,41,Alive,79
72,Male,8070,Squamous cell carcinoma,p4A,Pathologic,1,1,0,Alive,75
47,Male,8550,Acinar cell carcinoma,p3,Pathologic,1,0,0,Alive,79
17,Male,8200,Adenoid cystic carcinoma,p1,Pathologic,1,0,39,Alive,77
77,Male,8070,Squamous cell carcinoma,p2,Pathologic,1,0,0,Alive,77
67,Male,8140,Adenocarcinoma,p3,Pathologic,1,1,0,Alive,73
77,Male,8022,Undifferentiated carcinoma,pX,Pathologic,0,0,0,Alive,79
82,Male,8980,complex mixed and stromal neoplasms,p3,Pathologic,1,0,44,Other Cause of Death,19
32,Male,8550,Acinar cell carcinoma,p2,Pathologic,0,0,0,Alive,72
57,Female,8430,Mucoepidermoid carcinoma,TX,NX,0,0,0,Alive,19
52,Female,8200,Adenoid cystic carcinoma,p1,Pathologic,1,0,2,Alive,72
87,Male,8070,Squamous cell carcinoma,p3,Pathologic,1,0,0,Miscellaneous Malignant Cancer,22
87,Male,8070,Squamous cell carcinoma,p2,Pathologic,1,0,30,Pneumonia and Influenza,21
90,Female,8070,Squamous cell carcinoma,c3,Clinical,0,0,Unable to calculate,Salivary Gland,5
90,Male,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
67,Male,8200,Adenoid cystic carcinoma,p4A,Pathologic,1,0,187,Alive,67
62,Male,8070,Squamous cell carcinoma,p2,Pathologic,1,0,21,Alive,71
37,Male,8550,Acinar cell carcinoma,p3,Clinical,1,0,14,Alive,70
87,Male,8070,Squamous cell carcinoma,p4A,Clinical,0,0,35,Alive,69
82,Female,8140,Adenocarcinoma,c2,Clinical,1,0,20,Salivary Gland,2
52,Female,8200,Adenoid cystic carcinoma,p3,Pathologic,1,0,0,Alive,79
82,Male,8070,Squamous cell carcinoma,T4a,N2b,0,0,0,Alive,46
87,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Miscellaneous Malignant Cancer,Unknown
22,Female,8550,Acinar cell carcinoma,p1,Pathologic,1,0,0,Alive,70
42,Female,8200,Adenoid cystic carcinoma,p1,Pathologic,1,0,0,Alive,69
47,Male,8290,Oncocytic carcinoma,p1,Clinical,0,0,0,Alive,72
57,Male,8500,Adenocarcinoma,p2,Pathologic,1,0,0,Alive,55
87,Male,8140,Adenocarcinoma,cX,Clinical,0,0,19,Colon excluding Rectum,3
77,Female,8200,Adenoid cystic carcinoma,p3,Pathologic,1,0,27,Alive,66
87,Male,8500,Adenocarcinoma,p4A,Pathologic,1,0,0,Other Cause of Death,11
52,Male,8982,Myoepithelial carcinoma,c2,Clinical,1,0,0,Alive,64
42,Female,8147,Adenocarcinoma,p2,Clinical,0,0,0,Alive,80
52,Female,8941,Carcinoma ex pleomorphic adenoma,p4A,Pathologic,1,1,53,Salivary Gland,44
17,Male,8550,Acinar cell carcinoma,p2,Pathologic,0,0,29,Alive,63
67,Female,8550,Acinar cell carcinoma,p2,Pathologic,1,0,0,Alive,76
82,Female,8140,Adenocarcinoma,c0,Clinical,0,0,0,Alive,61
37,Female,8941,Carcinoma ex pleomorphic adenoma,p2,Pathologic,1,0,0,Alive,81
7,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,67
77,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,7
87,Female,8941,Carcinoma ex pleomorphic adenoma,p3,Pathologic,1,0,0,Salivary Gland,44
87,Female,8070,Squamous cell carcinoma,T4a,N0,1,0,23,Salivary Gland,9
57,Female,8550,Acinar cell carcinoma,p2,Pathologic,1,0,29,Alive,67
42,Male,8200,Adenoid cystic carcinoma,p4A,Pathologic,1,1,28,Alive,71
32,Female,8550,Acinar cell carcinoma,p1,Pathologic,0,0,0,Alive,70
67,Female,8941,Carcinoma ex pleomorphic adenoma,pX,Pathologic,0,0,0,Alive,63
67,Female,8550,Acinar cell carcinoma,c3,Clinical,1,0,34,Alive,60
87,Female,8200,Adenoid cystic carcinoma,p3,Clinical,1,0,0,Alive,72
77,Male,8082,squamous cell neoplasms,p2,Pathologic,1,0,34,Alive,73
77,Female,8041,Small cell carcinoma,p3,Pathologic,1,1,29,Alive,61
62,Male,8147,Adenocarcinoma,p1,Pathologic,1,0,0,Alive,61
52,Male,8140,Adenocarcinoma,p2,Pathologic,1,0,12,Alive,70
72,Male,8500,Adenocarcinoma,cX,Clinical,1,0,148,Other Cause of Death,36
52,Female,8147,Adenocarcinoma,p1,Clinical,0,0,0,Alive,83
47,Male,8200,Adenoid cystic carcinoma,p2,Pathologic,1,0,0,Alive,69
82,Male,8070,Squamous cell carcinoma,p3,Pathologic,1,0,13,Miscellaneous Malignant Cancer,11
27,Male,8550,Acinar cell carcinoma,p1,Pathologic,0,0,54,Alive,60
77,Male,8070,Squamous cell carcinoma,p2,Pathologic,0,0,29,Accidents and Adverse Effects,37
77,Male,8246,Neuroendocrine carcinoma,p3,Pathologic,1,0,97,Miscellaneous Malignant Cancer,9
72,Female,8550,Acinar cell carcinoma,p1,Clinical,0,0,0,Alive,64
57,Male,8430,Mucoepidermoid carcinoma,cX,Clinical,0,0,0,Alive,66
77,Female,8941,Carcinoma ex pleomorphic adenoma,p2,Pathologic,1,0,15,Alive,70
67,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,0,Alive,74
87,Female,8012,"epithelial neoplasms, NOS",88,88,1,0,20,Salivary Gland,10
32,Male,8550,Acinar cell carcinoma,T2,N0,1,0,14,Salivary Gland,13
72,Female,8550,Acinar cell carcinoma,T4a,N3b,1,0,33,Miscellaneous Malignant Cancer,26
77,Female,8041,Small cell carcinoma,T3,N0,1,1,57,Salivary Gland,26
82,Female,8041,Small cell carcinoma,T2,N0,1,0,13,Salivary Gland,8
90,Male,8246,Neuroendocrine carcinoma,T2,N0,0,0,Unable to calculate,Salivary Gland,20
82,Male,8083,Squamous cell carcinoma,p2,Clinical,1,0,26,Alive,62
67,Male,8550,Acinar cell carcinoma,T2,N3b,1,0,19,Miscellaneous Malignant Cancer,46
82,Male,8070,Squamous cell carcinoma,p1,Pathologic,1,0,21,Alive,69
77,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,29,Alive,48
57,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,56
77,Female,8430,Mucoepidermoid carcinoma,T1,N1,1,0,0,Alive,55
62,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,70,Alive,54
72,Female,8200,Adenoid cystic carcinoma,T4a,N0,0,0,0,Alive,49
57,Male,8000,unspecified neoplasms,T2,N0,1,0,41,Cerebrovascular Diseases,24
77,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,61,Alive,59
57,Female,8500,Adenocarcinoma,T2,N3b,0,1,35,Alive,48
57,Male,8070,Squamous cell carcinoma,T4b,N0,1,1,146,Alive,49
57,Male,8070,Squamous cell carcinoma,T3,N3b,1,0,57,Salivary Gland,33
57,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,55
72,Female,8140,Adenocarcinoma,T2,N2b,1,0,20,Alive,45
67,Male,8500,Adenocarcinoma,T2,N0,1,0,0,Alive,45
67,Female,8550,Acinar cell carcinoma,T0,N1,0,0,0,Alive,55
77,Male,8072,Squamous cell carcinoma,T3,N1,1,0,0,Alive,57
82,Male,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,55
42,Female,8825,fibromatous neoplasms,T1,N0,0,0,0,Alive,56
57,Male,8070,Squamous cell carcinoma,T1,N0,1,0,20,Alive,55
52,Male,8941,Carcinoma ex pleomorphic adenoma,T1,N0,0,0,34,Alive,44
87,Male,8010,Carcinoma NOS,TX,N1,0,0,2,Diseases of Heart,29
57,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,58
67,Female,8562,Epithelial-myoepithelial carcinoma,T3,NX,0,0,49,Alive,51
62,Female,8200,Adenoid cystic carcinoma,T1,N0,0,0,0,Alive,41
57,Male,8200,Adenoid cystic carcinoma,TX,N0,0,0,0,Suicide and Self-Inflicted Injury,8
77,Male,8982,Myoepithelial carcinoma,T2,N0,1,0,56,Alive,39
72,Male,8010,Carcinoma NOS,T4b,N3b,1,0,0,Salivary Gland,15
77,Male,8802,Sarcoma,T0,N1,1,0,Unable to calculate,Alive,52
77,Male,8200,Adenoid cystic carcinoma,T2,N0,0,0,0,Alive,43
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,42,Alive,56
77,Male,8010,Carcinoma NOS,T2,N2b,1,0,56,Cerebrovascular Diseases,18
62,Female,8802,Sarcoma,T3,N0,1,1,31,Alive,48
82,Male,8071,Squamous cell carcinoma,T3,N0,0,0,0,Alive,50
77,Male,8041,Small cell carcinoma,T2,N3b,1,1,58,Alive,49
90,Female,8941,Carcinoma ex pleomorphic adenoma,T3,N0,0,0,0,Diseases of Heart,30
72,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,13
77,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,53,Alive,46
32,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,58
87,Male,8070,Squamous cell carcinoma,T3,N0,0,0,27,Other Cause of Death,6
90,Male,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Accidents and Adverse Effects,18
62,Female,8010,Carcinoma NOS,T4a,N2b,0,0,Unable to calculate,Salivary Gland,2
62,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,54
72,Male,8070,Squamous cell carcinoma,T4a,N3b,1,1,121,Alive,50
90,Male,8070,Squamous cell carcinoma,T3,N0,0,0,82,Other Cause of Death,9
87,Male,8070,Squamous cell carcinoma,TX,NX,1,0,70,Lung and Bronchus,9
72,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,48
87,Female,8010,Carcinoma NOS,T2,N0,0,0,43,Alzheimers (ICD-9 and 10 only),27
67,Male,8041,Small cell carcinoma,T2,N2b,1,0,120,Alive,43
57,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,44
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,27,Alive,47
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,41,Alive,47
67,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,Unable to calculate,Alive,43
62,Female,8502,Adenocarcinoma,T1,N0,1,0,12,Alive,47
72,Male,8070,Squamous cell carcinoma,T2,N0,1,0,4,Alive,36
52,Female,8147,Adenocarcinoma,T2,N0,1,0,0,Alive,37
72,Male,8070,Squamous cell carcinoma,T2,N0,0,0,Unable to calculate,Other Infectious and Parasitic Diseases including HIV,2
87,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,47
82,Female,8010,Carcinoma NOS,T2,N1,1,0,21,Alive,41
57,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,38
87,Female,8500,Adenocarcinoma,T2,N0,0,0,44,Alive,39
82,Female,8071,Squamous cell carcinoma,T3,N0,0,0,Unable to calculate,Diseases of Heart,1
90,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,27,Alzheimers (ICD-9 and 10 only),30
82,Male,8140,Adenocarcinoma,T4a,N2a,1,0,85,Miscellaneous Malignant Cancer,6
67,Female,8941,Carcinoma ex pleomorphic adenoma,T1,N0,1,0,0,Chronic Obstructive Pulmonary Disease and Allied Cond,47
32,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,33
72,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,33
72,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N3b,1,0,14,"Symptoms, Signs and Ill-Defined Conditions",17
77,Female,8070,Squamous cell carcinoma,TX,NX,0,0,0,Miscellaneous Malignant Cancer,97
52,Female,8200,Adenoid cystic carcinoma,T3,N0,0,0,0,Alive,39
82,Male,8070,Squamous cell carcinoma,T1,N2b,1,0,0,Alive,52
67,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,22,Alive,51
67,Male,8200,Adenoid cystic carcinoma,T2,N0,1,1,0,Alive,13
82,Male,8010,Carcinoma NOS,T4a,N0,0,0,8,Other Cause of Death,25
90,Male,8071,Squamous cell carcinoma,T2,N0,0,0,0,Salivary Gland,8
62,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,35
77,Female,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,42
42,Male,8562,Epithelial-myoepithelial carcinoma,T1,N0,1,0,0,Alive,40
62,Female,8140,Adenocarcinoma,T3,N0,0,0,0,Alive,43
47,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Miscellaneous Malignant Cancer,46
57,Male,8140,Adenocarcinoma,T0,N3b,1,1,0,Salivary Gland,22
82,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Non-Melanoma Skin,43
22,Male,8023,"epithelial neoplasms, NOS",88,88,1,1,25,Alive,47
72,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
67,Male,8500,Adenocarcinoma,T4a,N3b,1,1,0,Salivary Gland,31
87,Male,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
87,Female,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Non-Melanoma Skin,1
67,Male,8070,Squamous cell carcinoma,T4b,N1,0,0,35,Alive,43
42,Female,8147,Adenocarcinoma,p1,Clinical,0,0,0,Alive,67
72,Male,8010,Carcinoma NOS,T3,N0,1,0,0,Alive,55
52,Male,8010,Carcinoma NOS,TX,N2b,1,0,Unable to calculate,Alive,30
67,Male,8010,Carcinoma NOS,T1,N0,1,0,14,Alive,30
82,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,0,0,0,Other Cause of Death,27
62,Male,8500,Adenocarcinoma,T4a,N0,1,0,0,Brain and Other Nervous System,24
82,Male,8811,fibromatous neoplasms,T3,N1,0,1,0,Soft Tissue including Heart,9
82,Female,8500,Adenocarcinoma,T3,N0,0,0,0,Salivary Gland,2
32,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,43
57,Male,8982,Myoepithelial carcinoma,T1,N0,1,0,0,Alive,29
72,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,15
72,Male,8071,Squamous cell carcinoma,T4a,N2b,0,0,0,Miscellaneous Malignant Cancer,7
77,Male,8074,Squamous cell carcinoma,T4a,N0,1,0,36,Chronic Liver Disease and Cirrhosis,25
77,Male,8070,Squamous cell carcinoma,TX,N1,0,0,20,Alive,38
82,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Salivary Gland,2
67,Male,8430,Mucoepidermoid carcinoma,TX,NX,0,0,0,Alive,42
90,Female,8147,Adenocarcinoma,T2,N0,1,0,24,Alive,38
62,Male,8430,Mucoepidermoid carcinoma,T4a,N3b,1,1,62,Alive,38
37,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,Unable to calculate,Alive,34
67,Male,8500,Adenocarcinoma,T3,N0,1,0,40,Alive,36
47,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,61,Alive,37
72,Female,8147,Adenocarcinoma,T1,N0,1,0,24,Alive,49
87,Male,8140,Adenocarcinoma,T4a,N0,1,0,63,Alive,31
52,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,276,Alive,20
67,Female,8941,Carcinoma ex pleomorphic adenoma,T3,N3b,0,0,0,Salivary Gland,5
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,26
72,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N3b,0,1,0,Salivary Gland,11
47,Male,8941,Carcinoma ex pleomorphic adenoma,T1,N0,1,0,0,Alive,24
57,Male,8147,Adenocarcinoma,T3,N2b,1,0,73,Alive,30
67,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N2b,0,0,0,Alive,33
82,Male,8071,Squamous cell carcinoma,T3,N1,1,0,76,Alive,36
82,Male,8010,Carcinoma NOS,T3,N2b,1,1,42,Alive,22
77,Male,8140,Adenocarcinoma,T3,NX,1,0,52,Alive,32
77,Female,8140,Adenocarcinoma,T2,N3b,1,0,0,Alive,21
72,Male,8070,Squamous cell carcinoma,T1,N1,0,0,20,Alive,22
72,Male,8070,Squamous cell carcinoma,T4a,N2b,1,0,35,Alive,33
37,Male,8430,Mucoepidermoid carcinoma,T0,N3b,1,0,0,Alive,28
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,44,Alive,49
62,Female,8010,Carcinoma NOS,T2,N0,0,0,0,Alive,34
57,Male,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,24
57,Female,8562,Epithelial-myoepithelial carcinoma,T2,N1,0,0,28,Alive,33
67,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,12
62,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,"Nose, Nasal Cavity and Middle Ear",5
47,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,29
77,Male,8070,Squamous cell carcinoma,T4a,N1,1,0,25,Other Cause of Death,15
57,Male,8070,Squamous cell carcinoma,T1,N0,1,0,22,Alive,24
72,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,55,Alive,24
72,Male,8980,complex mixed and stromal neoplasms,T2,N1,0,0,97,Alive,18
52,Male,8500,Adenocarcinoma,T3,N3b,1,1,0,Alive,28
72,Female,8500,Adenocarcinoma,T1,N3b,1,1,0,Alive,24
62,Male,8561,Adenosquamous carcinoma,88,88,0,0,68,Alive,27
47,Male,8010,Carcinoma NOS,T3,N3b,1,1,47,Alive,22
72,Male,8010,Carcinoma NOS,T3,N0,1,0,151,Alive,21
32,Female,8550,Acinar cell carcinoma,T1,N0,0,0,38,Alive,20
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,23
77,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,24
57,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,31
77,Male,9120,blood vessel tumors,88,88,1,0,41,Alive,27
57,Male,8562,Epithelial-myoepithelial carcinoma,T3,N0,0,0,28,Alive,27
67,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,26
17,Male,8550,Acinar cell carcinoma,T2,N1,0,0,44,Alive,24
42,Male,8200,Adenoid cystic carcinoma,T3,N3b,1,0,131,Alive,20
52,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,25
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,7
72,Male,8941,Carcinoma ex pleomorphic adenoma,T4a,N1,1,0,78,Alive,13
77,Male,8500,Adenocarcinoma,T4a,N3b,1,1,0,Alive,9
57,Female,8550,Acinar cell carcinoma,T2,N1,1,0,60,Alive,19
77,Male,8550,Acinar cell carcinoma,T4a,N3b,1,0,57,Alive,19
90,Male,8550,Acinar cell carcinoma,T3,N1,1,0,95,Lung and Bronchus,13
67,Female,8982,Myoepithelial carcinoma,T1,N0,0,0,0,Alive,38
67,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,34
67,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,15
67,Female,8140,Adenocarcinoma,T2,N0,1,0,0,Alive,12
42,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,25
42,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,27,Alive,13
67,Male,8500,Adenocarcinoma,T3,N3b,1,1,52,Alive,16
87,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,53,Alive,22
47,Male,8550,Acinar cell carcinoma,T2,N0,1,0,62,Alive,23
67,Female,8502,Adenocarcinoma,T1,N0,0,0,0,Alive,14
90,Female,8070,Squamous cell carcinoma,T4a,N0,1,0,48,Alive,9
67,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,0,0,0,Alive,9
77,Male,8500,Adenocarcinoma,T3,N2b,0,1,25,Alive,9
62,Male,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,27,Alive,15
82,Female,8525,ductal and lobular neoplasms,T2,N0,0,0,13,Alive,22
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,20
77,Male,8070,Squamous cell carcinoma,T4a,N3b,1,0,109,Salivary Gland,21
82,Female,8550,Acinar cell carcinoma,T2,N0,0,0,72,Alive,21
62,Male,8070,Squamous cell carcinoma,T4a,N2b,0,0,51,Alive,14
67,Male,8070,Squamous cell carcinoma,T2,N0,0,0,0,Alive,19
67,Female,8082,squamous cell neoplasms,T3,N2b,1,0,0,Alive,19
77,Male,8010,Carcinoma NOS,T4a,N2c,0,0,60,Salivary Gland,6
72,Male,8070,Squamous cell carcinoma,T1,N0,1,0,0,Alive,8
62,Male,8200,Adenoid cystic carcinoma,T1,N0,0,0,29,Alive,14
87,Male,8041,Small cell carcinoma,T1,N0,0,0,120,Alive,15
42,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,41,Alive,16
42,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,19
77,Male,8070,Squamous cell carcinoma,T4a,N2b,1,0,98,Alive,13
67,Male,8500,Adenocarcinoma,T1,N1,1,0,50,Alive,10
82,Male,8550,Acinar cell carcinoma,T3,N0,0,0,Unable to calculate,Alive,9
72,Male,8071,Squamous cell carcinoma,T2,N1,0,0,29,State DC not available or state DC available but no COD,12
57,Female,8041,Small cell carcinoma,T3,N2b,1,0,49,Alive,14
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,29,Alive,12
77,Male,8070,Squamous cell carcinoma,TX,N0,0,0,0,Alive,12
67,Male,8070,Squamous cell carcinoma,TX,N2a,0,0,11,Alive,13
72,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,Unable to calculate,Alive,20
37,Male,8982,Myoepithelial carcinoma,T2,N0,0,0,0,Alive,21
87,Male,8070,Squamous cell carcinoma,T1,NX,0,0,0,Alive,20
67,Male,8070,Squamous cell carcinoma,T3,N0,0,0,0,Alive,17
37,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,16
77,Female,8430,Mucoepidermoid carcinoma,TX,N0,1,0,103,Alive,3
77,Male,8070,Squamous cell carcinoma,T4a,N3b,1,0,71,Alive,14
77,Male,8070,Squamous cell carcinoma,T3,N2b,1,1,0,Alive,20
87,Male,8070,Squamous cell carcinoma,T4a,N0,0,0,46,Alive,19
82,Male,8500,Adenocarcinoma,T3,N0,1,0,0,Alive,20
57,Female,8550,Acinar cell carcinoma,T1,N0,0,0,61,Alive,6
72,Male,8550,Acinar cell carcinoma,T1,N0,1,0,20,Alive,25
87,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Other Cause of Death,10
77,Male,8041,Small cell carcinoma,T4a,N2b,1,1,33,Alive,17
67,Female,8562,Epithelial-myoepithelial carcinoma,T3,N0,1,0,85,Alive,14
62,Male,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Alive,11
72,Female,8140,Adenocarcinoma,T1,NX,0,0,0,Alive,11
82,Male,8070,Squamous cell carcinoma,T3,N0,0,0,111,Alive,12
77,Male,8500,Adenocarcinoma,T4a,N1,1,0,54,Alive,4
82,Male,8070,Squamous cell carcinoma,T1,N0,0,0,Unable to calculate,Alive,8
67,Male,8430,Mucoepidermoid carcinoma,T4a,N2b,1,1,0,Alive,10
67,Female,8800,Sarcoma,TX,N0,0,0,0,Alive,2
62,Male,8010,Carcinoma NOS,T1,N0,0,0,Unable to calculate,Alive,8
90,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,0
62,Female,8090,Basal cell carcinoma,88,88,0,0,0,Alive,0
87,Male,8246,Neuroendocrine carcinoma,T2,N2b,0,0,Unable to calculate,Alive,9
77,Female,8200,Adenoid cystic carcinoma,TX,N0,0,0,0,Alive,1
72,Male,8070,Squamous cell carcinoma,T2,N0,1,0,58,Alive,4
90,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,11
47,Female,8562,Epithelial-myoepithelial carcinoma,T1,N2b,1,0,0,Alive,3
12,Male,8502,Adenocarcinoma,TX,NX,0,0,0,Alive,3
72,Male,8500,Adenocarcinoma,T1,N2c,0,0,Unable to calculate,Salivary Gland,1
62,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,33,Alive,0
42,Male,8941,Carcinoma ex pleomorphic adenoma,T2,NX,0,0,26,Alive,0
82,Male,8041,Small cell carcinoma,T3,N1,1,1,66,Alive,2
67,Female,8550,Acinar cell carcinoma,T4a,N1,1,0,85,Alive,2
77,Female,8500,Adenocarcinoma,T1,N0,0,0,0,Alive,8
72,Male,8071,Squamous cell carcinoma,T4a,N0,1,0,66,Alive,5
47,Female,8500,Adenocarcinoma,T3,N2b,1,1,0,Alive,7
87,Male,8071,Squamous cell carcinoma,TX,N0,0,0,0,Alive,5
87,Female,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,0
82,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,7
87,Female,8071,Squamous cell carcinoma,T2,N3b,0,0,Unable to calculate,Alive,4
57,Female,8550,Acinar cell carcinoma,T3,N2b,1,0,41,Alive,11
72,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,6
47,Male,8200,Adenoid cystic carcinoma,T2,NX,0,0,0,Alive,33
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,6
87,Female,8070,Squamous cell carcinoma,T4a,N0,0,0,24,Alive,4
32,Male,8430,Mucoepidermoid carcinoma,T4b,N3b,0,0,65,Alive,2
77,Female,8550,Acinar cell carcinoma,T4a,N0,1,0,0,Alive,4
47,Male,8561,Adenosquamous carcinoma,88,88,0,0,Unable to calculate,Alive,16
72,Male,8070,Squamous cell carcinoma,T2,N0,1,0,47,Alive,16
62,Female,8562,Epithelial-myoepithelial carcinoma,T4a,N0,0,0,0,Alive,2
62,Female,8147,Adenocarcinoma,TX,NX,0,0,0,Alive,8
87,Male,9120,blood vessel tumors,88,88,1,0,8,Alive,4
67,Male,8070,Squamous cell carcinoma,T2,N0,1,0,35,Alive,0
82,Female,8083,Squamous cell carcinoma,T2,N1,0,0,0,Salivary Gland,33
62,Male,8140,Adenocarcinoma,T4a,N2b,1,1,55,Salivary Gland,27
90,Male,8010,Carcinoma NOS,T2,N0,1,0,48,Salivary Gland,11
90,Male,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Other Cause of Death,0
67,Female,8430,Mucoepidermoid carcinoma,TX,NX,0,0,Unable to calculate,Alive,55
90,Male,8070,Squamous cell carcinoma,cX,Clinical,1,0,32,Non-Melanoma Skin,15
77,Male,8070,Squamous cell carcinoma,TX,N0,0,0,Unable to calculate,Alive,52
67,Female,8200,Adenoid cystic carcinoma,T1,N0,0,0,106,Alive,36
52,Male,8200,Adenoid cystic carcinoma,T2,N0,0,0,0,Alive,151
82,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,80,Miscellaneous Malignant Cancer,90
72,Female,8070,Squamous cell carcinoma,T1,N2c,1,0,31,Other Cause of Death,37
90,Male,8010,Carcinoma NOS,TX,N0,0,0,Unable to calculate,Miscellaneous Malignant Cancer,10
90,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
77,Male,8070,Squamous cell carcinoma,T3,N3b,0,0,0,Non-Hodgkin Lymphoma,0
77,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Septicemia,57
90,Male,8070,Squamous cell carcinoma,TX,N0,0,0,Unable to calculate,Salivary Gland,6
82,Male,8070,Squamous cell carcinoma,T3,N1,0,0,10,Diseases of Heart,116
87,Male,8021,Undifferentiated carcinoma,T3,N0,0,0,0,State DC not available or state DC available but no COD,100
82,Male,8070,Squamous cell carcinoma,T2,N1,0,0,25,Other Cause of Death,37
62,Female,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Miscellaneous Malignant Cancer,8
77,Male,8070,Squamous cell carcinoma,T2,N2b,0,0,18,Alive,114
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,95
77,Male,8070,Squamous cell carcinoma,T4a,N0,1,0,0,Salivary Gland,9
82,Male,8430,Mucoepidermoid carcinoma,T4b,N1,0,0,Unable to calculate,Miscellaneous Malignant Cancer,0
52,Male,8140,Adenocarcinoma,T1,N2b,1,0,53,Alive,129
90,Male,8430,Mucoepidermoid carcinoma,T3,N1,1,0,28,Salivary Gland,14
87,Female,8430,Mucoepidermoid carcinoma,T4a,N2b,1,0,19,Alzheimers (ICD-9 and 10 only),75
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,79
82,Male,8070,Squamous cell carcinoma,TX,N0,0,0,Unable to calculate,Alive,17
57,Female,8430,Mucoepidermoid carcinoma,TX,N0,0,0,0,Alive,122
72,Male,8070,Squamous cell carcinoma,T1,N0,0,0,0,Alive,147
62,Female,8502,Adenocarcinoma,p2,Pathologic,1,0,147,Miscellaneous Malignant Cancer,57
67,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,52,Kidney and Renal Pelvis,96
52,Male,8070,Squamous cell carcinoma,T1,N0,1,1,47,Alive,19
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,20,Alive,133
82,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,50,Diseases of Heart,13
77,Male,8070,Squamous cell carcinoma,c2,Clinical,0,0,0,Salivary Gland,2
87,Male,8200,Adenoid cystic carcinoma,TX,N0,1,0,27,Lung and Bronchus,13
77,Male,8010,Carcinoma NOS,T1,N0,0,0,27,Alive,105
72,Male,8070,Squamous cell carcinoma,T4a,N0,0,0,62,Prostate,41
87,Female,8070,Squamous cell carcinoma,TX,N1,0,0,Unable to calculate,Diseases of Heart,12
62,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Pancreas,46
67,Male,8070,Squamous cell carcinoma,T2,N0,0,0,0,Melanoma of the Skin,13
77,Male,8430,Mucoepidermoid carcinoma,T4a,N2b,0,0,0,Alive,16
82,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,43
72,Male,8010,Carcinoma NOS,T1,N0,1,0,0,Alive,149
82,Male,8070,Squamous cell carcinoma,T3,N1,0,0,28,Salivary Gland,9
52,Male,8140,Adenocarcinoma,T4a,N0,0,1,Unable to calculate,Prostate,3
62,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,147
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,50,Alive,147
62,Male,8550,Acinar cell carcinoma,T3,N0,1,0,50,Alive,144
67,Female,8070,Squamous cell carcinoma,TX,N0,0,0,65,Alive,145
62,Female,8147,Adenocarcinoma,T2,N0,0,0,0,Alive,148
82,Female,8500,Adenocarcinoma,T3,N0,0,0,0,"In situ, benign or unknown behavior neoplasm",6
77,Male,8010,Carcinoma NOS,T4a,N2b,1,0,40,Alive,117
90,Female,8070,Squamous cell carcinoma,T3,N2b,1,1,0,Diseases of Heart,42
87,Male,8070,Squamous cell carcinoma,TX,N0,0,0,37,Esophagus,11
47,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,146
17,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,147
67,Female,8071,Squamous cell carcinoma,T4a,N2b,0,1,50,Alive,148
72,Male,8070,Squamous cell carcinoma,TX,N0,0,0,Unable to calculate,Chronic Obstructive Pulmonary Disease and Allied Cond,47
47,Male,8010,Carcinoma NOS,T3,N2b,0,1,27,Diseases of Heart,6
62,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,0,Alive,150
90,Male,8075,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Non-Melanoma Skin,7
47,Male,8200,Adenoid cystic carcinoma,T1,N0,0,0,0,Alive,153
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,35
47,Male,8200,Adenoid cystic carcinoma,TX,NX,0,0,Unable to calculate,Alive,154
77,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,4,Alive,146
77,Female,8940,Mixed tumor,T3,N0,1,0,0,Stomach,56
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,143
52,Male,8550,Acinar cell carcinoma,T2,N0,1,0,0,Miscellaneous Malignant Cancer,83
57,Male,8070,Squamous cell carcinoma,T4a,N2b,1,1,56,Bones and Joints,44
82,Male,8000,unspecified neoplasms,TX,N0,0,0,Unable to calculate,Melanoma of the Skin,10
67,Male,8070,Squamous cell carcinoma,TX,N1,0,0,96,Urinary Bladder,82
72,Male,8200,Adenoid cystic carcinoma,T3,N0,1,0,46,Alive,135
82,Male,8070,Squamous cell carcinoma,TX,N0,0,0,Unable to calculate,Nasopharynx,37
52,Male,8500,Adenocarcinoma,T3,N1,0,0,0,Salivary Gland,10
22,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,135
67,Male,8200,Adenoid cystic carcinoma,TX,NX,0,1,18,Diseases of Heart,134
42,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,49,Alive,138
52,Male,8140,Adenocarcinoma,T3,N2b,0,0,50,Bones and Joints,5
77,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Other Cause of Death,78
57,Female,8010,Carcinoma NOS,T1,N1,0,1,112,Lung and Bronchus,9
62,Male,8140,Adenocarcinoma,TX,N0,0,0,Unable to calculate,Alive,142
42,Male,8550,Acinar cell carcinoma,T3,N0,1,0,0,Alive,133
52,Male,8070,Squamous cell carcinoma,T4a,N1,1,1,20,Other Endocrine including Thymus,7
87,Female,8140,Adenocarcinoma,T2,N0,0,0,0,Cerebrovascular Diseases,14
52,Male,8140,Adenocarcinoma,T4b,N0,1,1,32,Lung and Bronchus,65
67,Male,8010,Carcinoma NOS,TX,N2b,1,1,37,Alive,140
62,Male,8070,Squamous cell carcinoma,TX,N2b,1,1,39,Alive,136
57,Male,8200,Adenoid cystic carcinoma,T4a,N1,0,0,Unable to calculate,Miscellaneous Malignant Cancer,13
72,Female,8550,Acinar cell carcinoma,T1,N0,1,0,39,Alive,128
82,Female,8010,Carcinoma NOS,T2,N2b,0,1,81,Salivary Gland,27
72,Male,8500,Adenocarcinoma,p4A,Pathologic,1,0,25,Chronic Obstructive Pulmonary Disease and Allied Cond,23
62,Male,8430,Mucoepidermoid carcinoma,TX,N0,1,1,20,Salivary Gland,5
52,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,1,0,0,Alive,126
72,Male,8430,Mucoepidermoid carcinoma,T4a,N0,1,1,131,Alive,128
77,Male,8041,Small cell carcinoma,p4A,Clinical,0,1,96,Alive,66
87,Male,8010,Carcinoma NOS,T2,N0,0,0,Unable to calculate,Cerebrovascular Diseases,55
67,Male,8430,Mucoepidermoid carcinoma,T4a,N1,1,1,58,Alive,121
72,Female,8310,Adenocarcinoma,T2,N0,0,0,36,Alive,119
57,Female,8140,Adenocarcinoma,T3,N2b,1,1,96,Non-Hodgkin Lymphoma,93
57,Male,8551,Acinar cell carcinoma,T2,N0,0,0,0,Alive,125
72,Male,8140,Adenocarcinoma,T2,N0,0,0,0,Alive,135
72,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,128
62,Male,8010,Carcinoma NOS,T4b,N2b,1,1,0,Salivary Gland,12
77,Male,8430,Mucoepidermoid carcinoma,TX,N0,0,0,4,Stomach and Duodenal Ulcers,25
77,Male,8070,Squamous cell carcinoma,T1,N1,1,1,17,Alive,81
90,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Accidents and Adverse Effects,5
62,Male,8123,Transitional cell carcinoma,T4a,N3,0,0,Unable to calculate,Salivary Gland,1
62,Female,8070,Squamous cell carcinoma,T4a,N0,1,1,27,Alive,128
67,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,54
57,Female,8000,unspecified neoplasms,T3,N0,0,0,Unable to calculate,Alive,125
57,Male,8147,Adenocarcinoma,TX,N0,0,0,64,Alive,142
62,Male,8070,Squamous cell carcinoma,T4a,N0,1,1,0,Salivary Gland,37
77,Male,8010,Carcinoma NOS,T3,N1,1,0,27,Salivary Gland,3
67,Male,8290,Oncocytic carcinoma,T3,N2b,1,0,42,Alive,125
82,Male,8010,Carcinoma NOS,T4b,N0,0,0,21,Stomach and Duodenal Ulcers,1
47,Female,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,10
67,Female,8200,Adenoid cystic carcinoma,T1,N0,0,0,35,Alive,100
47,Male,8430,Mucoepidermoid carcinoma,TX,NX,0,0,Unable to calculate,Alive,121
72,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,39
42,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,124
82,Male,8140,Adenocarcinoma,T1,N0,1,0,0,Other Cause of Death,15
90,Female,8070,Squamous cell carcinoma,T3,N0,0,0,13,Diseases of Heart,2
67,Female,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
77,Male,8430,Mucoepidermoid carcinoma,T4a,N2b,1,0,27,Miscellaneous Malignant Cancer,14
77,Male,8010,Carcinoma NOS,T1,N0,1,0,42,Diseases of Heart,70
62,Male,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,116
77,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,119
57,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,118
47,Female,8070,Squamous cell carcinoma,TX,NX,1,1,34,Miscellaneous Malignant Cancer,13
42,Male,8500,Adenocarcinoma,T4a,N2b,0,0,0,Salivary Gland,24
82,Male,8041,Small cell carcinoma,T3,N3b,1,1,76,Alive,51
57,Male,8550,Acinar cell carcinoma,T1,N0,0,0,Unable to calculate,Acute Myeloid Leukemia,31
87,Female,8070,Squamous cell carcinoma,T1,N1,1,0,83,Other Cause of Death,19
87,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Non-Melanoma Skin,0
62,Male,8070,Squamous cell carcinoma,TX,NX,0,0,0,Other Cause of Death,3
67,Male,8500,Adenocarcinoma,T3,N2b,1,1,0,Alive,107
57,Female,8200,Adenoid cystic carcinoma,T3,N1,1,0,0,Alive,106
67,Male,8010,Carcinoma NOS,T4a,N0,1,0,56,Salivary Gland,9
37,Female,8200,Adenoid cystic carcinoma,T2,N0,0,0,0,Alive,116
72,Male,8010,Carcinoma NOS,T3,N0,0,0,70,Non-Melanoma Skin,36
37,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,45,Alive,107
72,Female,8070,Squamous cell carcinoma,TX,N0,0,0,27,Alive,116
62,Female,8550,Acinar cell carcinoma,T3,N0,1,0,60,Alive,100
67,Male,8070,Squamous cell carcinoma,T3,N2a,1,1,36,Pancreas,32
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,20,Alive,107
72,Male,8140,Adenocarcinoma,T1,N3,1,1,75,Bones and Joints,14
57,Female,8200,Adenoid cystic carcinoma,T3,N0,0,0,0,Alive,102
52,Male,8200,Adenoid cystic carcinoma,T3,N0,0,0,49,Alive,102
77,Male,8010,Carcinoma NOS,T4a,N2b,1,1,29,Salivary Gland,47
62,Male,8200,Adenoid cystic carcinoma,T4a,N2a,1,1,7,Salivary Gland,12
57,Female,8550,Acinar cell carcinoma,TX,N0,0,0,30,Alive,112
77,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
77,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,67,Alive,1
82,Female,8010,Carcinoma NOS,T4a,N0,1,0,143,Alive,1
82,Male,8070,Squamous cell carcinoma,T2,N0,0,0,Unable to calculate,Alive,14
72,Male,8010,Carcinoma NOS,T3,N1,1,1,22,"In situ, benign or unknown behavior neoplasm",19
47,Female,8200,Adenoid cystic carcinoma,TX,NX,0,0,Unable to calculate,Salivary Gland,27
62,Female,8500,Adenocarcinoma,TX,N0,1,0,57,Alive,101
62,Male,8982,Myoepithelial carcinoma,T1,N0,1,0,0,Alive,96
32,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,0,0,Alive,66
72,Female,8046,"epithelial neoplasms, NOS",TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
37,Male,8200,Adenoid cystic carcinoma,T4a,N0,1,1,0,Miscellaneous Malignant Cancer,58
82,Male,8140,Adenocarcinoma,TX,NX,1,1,23,Suicide and Self-Inflicted Injury,5
72,Male,8200,Adenoid cystic carcinoma,T2,N1,1,0,0,Alive,113
72,Male,8041,Small cell carcinoma,T2,N1,1,1,54,Alive,15
67,Female,8070,Squamous cell carcinoma,TX,N0,0,0,27,Alive,104
62,Male,8430,Mucoepidermoid carcinoma,T4b,N0,0,0,Unable to calculate,Septicemia,0
72,Female,8500,Adenocarcinoma,T4a,NX,0,1,0,State DC not available or state DC available but no COD,31
77,Male,8140,Adenocarcinoma,T1,N0,1,0,0,Alive,107
82,Male,8140,Adenocarcinoma,TX,N0,0,0,0,Salivary Gland,18
87,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,30,Pneumonia and Influenza,47
72,Female,8072,Squamous cell carcinoma,T4b,NX,0,0,Unable to calculate,Salivary Gland,0
42,Female,8430,Mucoepidermoid carcinoma,T4a,N0,0,0,41,Alive,21
77,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,49,Alive,85
32,Female,8200,Adenoid cystic carcinoma,TX,N0,1,0,30,Alive,86
82,Male,8000,unspecified neoplasms,T2,N3,1,0,60,Salivary Gland,11
72,Male,8070,Squamous cell carcinoma,T4a,N2b,1,0,285,Chronic Obstructive Pulmonary Disease and Allied Cond,37
82,Female,8430,Mucoepidermoid carcinoma,T3,N2b,1,0,34,Alive,95
67,Female,8982,Myoepithelial carcinoma,T3,N0,1,0,52,Salivary Gland,3
62,Female,8982,Myoepithelial carcinoma,T2,N0,0,0,48,Alive,37
67,Male,8982,Myoepithelial carcinoma,T2,N0,1,0,0,Salivary Gland,78
72,Male,8940,Mixed tumor,p3,Pathologic,1,0,12,Alive,81
90,Female,8070,Squamous cell carcinoma,T2,N0,0,0,20,Salivary Gland,5
42,Female,8200,Adenoid cystic carcinoma,T1,N1,1,0,0,Alive,98
90,Male,8200,Adenoid cystic carcinoma,c2,Clinical,0,0,Unable to calculate,Non-Melanoma Skin,30
82,Male,8140,Adenocarcinoma,T2,N0,1,0,71,Thyroid,5
57,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
52,Male,8430,Mucoepidermoid carcinoma,TX,NX,1,1,Unable to calculate,Alive,137
42,Male,8082,squamous cell neoplasms,TX,NX,0,0,Unable to calculate,Alive,136
47,Female,8550,Acinar cell carcinoma,p2,Pathologic,0,0,0,Alive,82
42,Female,8550,Acinar cell carcinoma,TX,N0,0,0,1,Alive,2
67,Male,8010,Carcinoma NOS,T4a,N0,1,1,7,Alive,54
82,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Miscellaneous Malignant Cancer,9
52,Female,8200,Adenoid cystic carcinoma,TX,NX,0,0,Unable to calculate,Alive,87
72,Male,8500,Adenocarcinoma,cX,Clinical,0,1,17,Salivary Gland,35
72,Female,8200,Adenoid cystic carcinoma,T3,N1,0,0,0,Salivary Gland,11
77,Female,8200,Adenoid cystic carcinoma,c3,Clinical,1,0,0,Salivary Gland,6
47,Female,8430,Mucoepidermoid carcinoma,p2,Pathologic,1,0,0,Alive,77
32,Male,8560,Adenosquamous carcinoma,p2,Pathologic,0,0,0,Alive,75
52,Male,8000,unspecified neoplasms,c3,Clinical,0,1,40,Alive,74
90,Male,8070,Squamous cell carcinoma,p2,Pathologic,0,0,0,Salivary Gland,3
67,Male,8070,Squamous cell carcinoma,T3,N1,1,1,14,Salivary Gland,8
62,Male,8140,Adenocarcinoma,T2,N0,1,0,0,Salivary Gland,46
72,Male,8070,Squamous cell carcinoma,p3,Pathologic,1,1,38,Alive,79
82,Male,8010,Carcinoma NOS,cX,Clinical,0,1,104,Salivary Gland,13
72,Female,8070,Squamous cell carcinoma,TX,N1,0,0,Unable to calculate,Non-Melanoma Skin,13
90,Female,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
62,Male,8010,Carcinoma NOS,T4b,N2c,1,1,42,Salivary Gland,44
77,Male,8070,Squamous cell carcinoma,T2,N0,0,0,43,Other Cause of Death,62
52,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
87,Female,8071,Squamous cell carcinoma,TX,N2b,0,0,Unable to calculate,Oropharynx,6
82,Male,8070,Squamous cell carcinoma,p3,Pathologic,1,0,21,Other Cause of Death,58
82,Male,8070,Squamous cell carcinoma,cX,Clinical,1,0,3,Salivary Gland,0
72,Male,8200,Adenoid cystic carcinoma,p1,Pathologic,1,0,113,Hypertension without Heart Disease,58
87,Male,8070,Squamous cell carcinoma,T4a,NX,1,0,28,Alive,101
37,Female,8201,Adenocarcinoma,p1,Clinical,0,0,0,Alive,14
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,49
72,Female,8550,Acinar cell carcinoma,p3,Pathologic,1,0,0,Diseases of Heart,10
52,Male,8010,Carcinoma NOS,c4B,Clinical,1,1,43,Other Cause of Death,59
47,Female,8200,Adenoid cystic carcinoma,p4A,Pathologic,1,0,2,Alive,65
72,Female,8430,Mucoepidermoid carcinoma,p3,Pathologic,0,0,127,Kidney and Renal Pelvis,27
90,Female,8200,Adenoid cystic carcinoma,c3,Clinical,0,0,Unable to calculate,Miscellaneous Malignant Cancer,4
62,Male,8071,Squamous cell carcinoma,p3,Pathologic,1,0,36,Alive,74
62,Male,8070,Squamous cell carcinoma,p1,Pathologic,1,1,0,Alive,61
52,Male,8430,Mucoepidermoid carcinoma,p2,Pathologic,0,0,0,Alive,69
90,Male,8430,Mucoepidermoid carcinoma,p4A,Clinical,0,0,36,Cerebrovascular Diseases,8
72,Male,8070,Squamous cell carcinoma,p3,Pathologic,1,0,55,Diseases of Heart,61
87,Male,8010,Carcinoma NOS,p3,Pathologic,0,0,30,Salivary Gland,3
77,Male,8070,Squamous cell carcinoma,T2,N2b,1,1,42,Alive,16
77,Male,8070,Squamous cell carcinoma,p2,Pathologic,1,0,3,Salivary Gland,38
72,Male,8140,Adenocarcinoma,p1,Clinical,0,0,106,Alive,65
77,Male,8140,Adenocarcinoma,p3,Pathologic,1,0,0,Alive,64
52,Female,8140,Adenocarcinoma,p1,Clinical,1,0,365,Alive,81
47,Male,8140,Adenocarcinoma,cX,Clinical,0,1,27,Prostate,15
87,Male,8070,Squamous cell carcinoma,p4A,Pathologic,0,0,0,Miscellaneous Malignant Cancer,6
62,Male,8550,Acinar cell carcinoma,p3,Pathologic,1,0,37,Salivary Gland,25
82,Male,8246,Neuroendocrine carcinoma,p2,Clinical,0,0,68,Cerebrovascular Diseases,45
57,Male,8290,Oncocytic carcinoma,p1,Pathologic,1,1,44,Alive,70
82,Female,8500,Adenocarcinoma,pX,Pathologic,0,0,0,Diseases of Heart,18
72,Male,8070,Squamous cell carcinoma,p1,Pathologic,0,0,0,Alive,74
57,Female,8550,Acinar cell carcinoma,p1,Pathologic,1,0,0,Alive,60
77,Male,8070,Squamous cell carcinoma,p3,Pathologic,0,0,51,Non-Melanoma Skin,10
32,Female,8550,Acinar cell carcinoma,p1,Pathologic,0,0,36,Alive,65
37,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,1,0,Alive,52
77,Male,8070,Squamous cell carcinoma,T2,N0,0,0,Unable to calculate,Non-Melanoma Skin,7
62,Male,8070,Squamous cell carcinoma,TX,N1,0,0,Unable to calculate,Lung and Bronchus,4
62,Female,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Salivary Gland,1
72,Male,8140,Adenocarcinoma,p2,Pathologic,0,0,76,Salivary Gland,40
37,Male,8500,Adenocarcinoma,T3,N2a,1,1,99,Alive,48
57,Male,8550,Acinar cell carcinoma,T3,N0,1,0,0,Alive,55
62,Male,8500,Adenocarcinoma,T3,N0,1,0,84,Alive,56
17,Female,8430,Mucoepidermoid carcinoma,TX,N0,1,0,0,Alive,49
47,Male,8500,Adenocarcinoma,T4b,N2c,1,1,68,Diseases of Heart,5
62,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,0,Alive,65
67,Female,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,31,Alive,62
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,51
82,Male,8041,Small cell carcinoma,T0,N2a,1,0,49,Alive,55
47,Female,8550,Acinar cell carcinoma,T3,NX,0,0,0,Alive,47
90,Male,8430,Mucoepidermoid carcinoma,T4a,N2a,0,0,45,Salivary Gland,5
57,Male,8550,Acinar cell carcinoma,T4b,N2b,1,1,0,Salivary Gland,27
90,Female,8041,Small cell carcinoma,T3,N0,0,0,0,Hypertension without Heart Disease,10
72,Male,8525,ductal and lobular neoplasms,T4a,N0,0,0,37,Alive,43
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,55
82,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,18,Alive,58
27,Male,8550,Acinar cell carcinoma,T1,N0,0,0,95,Alive,45
87,Male,8070,Squamous cell carcinoma,T2,N0,1,0,21,Salivary Gland,11
82,Male,8010,Carcinoma NOS,T3,N0,0,0,0,Alive,52
67,Male,8004,unspecified neoplasms,88,88,0,0,Unable to calculate,Lung and Bronchus,32
62,Male,8562,Epithelial-myoepithelial carcinoma,TX,NX,0,0,Unable to calculate,Alive,99
90,Male,8070,Squamous cell carcinoma,TX,N2b,1,0,59,"In situ, benign or unknown behavior neoplasm",13
67,Male,8070,Squamous cell carcinoma,T2,N0,0,0,13,Alive,55
72,Male,8500,Adenocarcinoma,T3,N3b,1,1,0,Alive,47
67,Male,8140,Adenocarcinoma,T2,N0,0,0,Unable to calculate,Alive,47
72,Female,8550,Acinar cell carcinoma,T1,N2a,0,0,0,Alive,39
57,Male,8147,Adenocarcinoma,T2,N0,1,0,27,Alive,46
72,Female,8200,Adenoid cystic carcinoma,T3,N0,0,0,0,Alive,35
57,Male,8550,Acinar cell carcinoma,T1,NX,0,0,0,Alive,143
77,Female,8010,Carcinoma NOS,T3,N3b,0,0,0,Alive,49
67,Male,8941,Carcinoma ex pleomorphic adenoma,T1,N3b,1,0,114,Alive,45
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,40
87,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Salivary Gland,1
72,Female,8147,Adenocarcinoma,T1,N0,1,0,68,Alive,39
77,Male,8500,Adenocarcinoma,T3,N2b,1,1,8,Alive,43
27,Female,8430,Mucoepidermoid carcinoma,T3,N0,0,0,42,Alive,37
82,Male,8070,Squamous cell carcinoma,T3,N2b,0,0,0,Stomach and Duodenal Ulcers,21
82,Male,8072,Squamous cell carcinoma,p4A,Pathologic,0,0,0,Alive,64
72,Male,8071,Squamous cell carcinoma,T2,N0,0,0,0,Alive,54
42,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,40
52,Female,8140,Adenocarcinoma,T4a,N3b,1,1,50,Alive,46
62,Male,8070,Squamous cell carcinoma,T4b,N3a,1,1,54,Oropharynx,22
82,Male,8500,Adenocarcinoma,T3,N2b,1,0,17,Alive,28
72,Male,8070,Squamous cell carcinoma,c2,Clinical,1,1,24,Alive,79
52,Male,8550,Acinar cell carcinoma,p3,Pathologic,0,0,0,Lung and Bronchus,76
22,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,44
67,Male,8500,Adenocarcinoma,T1,N3b,1,1,0,Alive,27
52,Female,8500,Adenocarcinoma,T2,N0,1,0,21,Alive,26
77,Male,8140,Adenocarcinoma,T2,N1,0,0,0,Alive,0
52,Male,8550,Acinar cell carcinoma,T3,N0,0,0,111,Alive,7
77,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,33
67,Female,8200,Adenoid cystic carcinoma,T2,N0,0,0,0,Alive,27
42,Female,8720,Melanoma,88,88,0,0,0,Alive,31
67,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,14,Alive,0
67,Male,8500,Adenocarcinoma,T3,N3b,1,1,0,Salivary Gland,9
72,Male,8070,Squamous cell carcinoma,T3,N3b,1,1,0,Diseases of Heart,6
32,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,29
67,Female,8500,Adenocarcinoma,T3,N2b,1,0,15,Alive,24
72,Female,8982,Myoepithelial carcinoma,T3,N2a,1,1,4,Salivary Gland,41
77,Male,8010,Carcinoma NOS,T1,N0,0,0,30,Alive,28
67,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Salivary Gland,8
62,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,26
37,Female,9133,blood vessel tumors,T1,N0,0,0,0,Alive,27
62,Male,8430,Mucoepidermoid carcinoma,TX,N0,0,0,135,Alive,25
42,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,Unable to calculate,Alive,30
87,Male,8013,Neuroendocrine carcinoma,T4a,N0,0,0,Unable to calculate,"Nephritis, Nephrotic Syndrome and Nephrosis",1
87,Female,8200,Adenoid cystic carcinoma,TX,N0,0,0,Unable to calculate,Salivary Gland,12
32,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,30
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,18
90,Male,8562,Epithelial-myoepithelial carcinoma,T3,NX,1,0,240,Alive,25
82,Male,8500,Adenocarcinoma,T2,N0,1,0,21,Alive,20
47,Female,8430,Mucoepidermoid carcinoma,TX,NX,0,0,Unable to calculate,Alive,28
72,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,33
77,Male,8000,unspecified neoplasms,T2,N0,1,0,13,Alive,26
72,Male,8140,Adenocarcinoma,TX,NX,0,1,41,State DC not available or state DC available but no COD,11
67,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,1,0,0,Alive,29
67,Male,8070,Squamous cell carcinoma,T0,N2a,1,0,0,Alive,29
77,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,28
57,Male,8070,Squamous cell carcinoma,T4a,N0,1,0,34,Alive,23
32,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,8
57,Male,8070,Squamous cell carcinoma,T4a,N2b,0,0,0,Alive,0
72,Male,8070,Squamous cell carcinoma,T4a,N1,0,0,64,Alive,20
72,Male,8574,Adenocarcinoma with neuroendocrine differentiation,88,88,0,0,Unable to calculate,Non-Melanoma Skin,13
27,Male,8500,Adenocarcinoma,TX,N1,1,0,0,Alive,18
77,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,17
82,Male,8070,Squamous cell carcinoma,TX,N2a,0,0,0,Non-Melanoma Skin,9
62,Male,8500,Adenocarcinoma,T3,N2b,1,1,112,Alive,19
62,Male,8071,Squamous cell carcinoma,T3,N3b,0,0,0,Miscellaneous Malignant Cancer,23
77,Male,8082,squamous cell neoplasms,TX,N2a,1,0,0,Alive,22
37,Male,8430,Mucoepidermoid carcinoma,T3,N2b,1,1,0,Alive,12
87,Male,8430,Mucoepidermoid carcinoma,T3,N3b,1,0,37,Alive,14
72,Male,8070,Squamous cell carcinoma,T4a,N1,1,0,83,Non-Melanoma Skin,5
82,Male,8070,Squamous cell carcinoma,T2,N0,0,0,0,Alive,17
90,Male,8070,Squamous cell carcinoma,T3,N0,0,0,0,Non-Melanoma Skin,2
87,Male,8070,Squamous cell carcinoma,T1,N0,0,0,0,Alive,17
57,Male,8140,Adenocarcinoma,T3,N0,0,0,Unable to calculate,Alive,20
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,81,Alive,20
62,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,16
72,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,57,Alive,22
82,Male,8720,Melanoma,88,88,0,0,Unable to calculate,State DC not available or state DC available but no COD,0
57,Male,8561,Adenosquamous carcinoma,88,88,0,0,Unable to calculate,Alive,3
7,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,27
82,Male,8071,Squamous cell carcinoma,T4a,N1,0,0,32,Salivary Gland,4
62,Male,8982,Myoepithelial carcinoma,T3,N0,0,0,0,Alive,9
77,Male,8140,Adenocarcinoma,TX,NX,0,1,71,Lung and Bronchus,14
57,Female,8941,Carcinoma ex pleomorphic adenoma,T3,N3b,0,0,55,Alive,9
82,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,16
87,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Alive,23
27,Female,8502,Adenocarcinoma,T2,N0,0,0,0,Alive,6
57,Male,8140,Adenocarcinoma,T2,N0,1,0,25,Alive,20
27,Female,8550,Acinar cell carcinoma,TX,N0,0,0,0,Alive,16
77,Male,8140,Adenocarcinoma,TX,N0,0,0,0,Alive,17
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,10
67,Male,8147,Adenocarcinoma,T2,N0,0,0,0,Alive,12
72,Male,8070,Squamous cell carcinoma,T2,N3b,1,1,22,Alive,12
67,Male,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,1
72,Male,8071,Squamous cell carcinoma,T4a,N0,1,0,0,Alive,5
82,Male,8000,unspecified neoplasms,TX,N0,0,0,26,Alive,2
82,Female,8200,Adenoid cystic carcinoma,T2,N3b,0,0,69,Alive,3
82,Male,8562,Epithelial-myoepithelial carcinoma,T3,N0,1,0,0,Alive,2
67,Male,8070,Squamous cell carcinoma,T3,N3b,1,0,46,Alive,22
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,13
17,Female,8082,squamous cell neoplasms,T2,N0,0,0,2,Alive,0
67,Male,8070,Squamous cell carcinoma,T3,N1,0,0,54,Suicide and Self-Inflicted Injury,19
67,Male,8502,Adenocarcinoma,T2,N0,1,0,0,Alive,10
67,Female,8200,Adenoid cystic carcinoma,T1,N0,0,0,0,Alive,2
87,Female,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,2
32,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,0
67,Male,8500,Adenocarcinoma,TX,N1,0,1,55,Alive,4
62,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,36
52,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,10
77,Male,8083,Squamous cell carcinoma,T4a,N0,0,1,136,Alive,3
82,Male,8982,Myoepithelial carcinoma,T3,N0,1,0,0,Alive,8
52,Female,8070,Squamous cell carcinoma,TX,N3b,0,0,0,Alive,7
72,Female,8070,Squamous cell carcinoma,T4a,N3b,0,0,42,Alive,1
87,Female,8070,Squamous cell carcinoma,T4a,N0,0,0,Unable to calculate,Alive,2
72,Female,8500,Adenocarcinoma,T2,N0,0,0,34,Alive,11
72,Female,8200,Adenoid cystic carcinoma,T3,N0,0,0,0,Alive,5
82,Male,8071,Squamous cell carcinoma,T4a,N1,1,0,29,Alive,2
72,Female,8562,Epithelial-myoepithelial carcinoma,TX,N0,0,0,0,Alive,6
62,Male,8070,Squamous cell carcinoma,T2,N1,0,0,0,Alive,5
32,Female,8550,Acinar cell carcinoma,T3,N1,0,0,27,Alive,0
72,Male,8070,Squamous cell carcinoma,T2,N0,1,1,30,Alive,5
52,Male,8010,Carcinoma NOS,T4a,N1,1,0,22,Alive,31
42,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,25
77,Male,8070,Squamous cell carcinoma,T1,N1,0,0,0,Alive,1
67,Male,8200,Adenoid cystic carcinoma,T2,N2b,1,0,0,Alive,114
72,Male,8000,unspecified neoplasms,T4b,N0,1,0,26,Salivary Gland,38
90,Female,8140,Adenocarcinoma,c2,Clinical,1,0,56,Salivary Gland,14
67,Male,8140,Adenocarcinoma,p4A,Pathologic,1,0,56,Diseases of Heart,47
77,Male,8941,Carcinoma ex pleomorphic adenoma,p4B,Pathologic,0,0,0,Diseases of Heart,18
62,Female,8550,Acinar cell carcinoma,TX,N1,1,0,0,Alive,88
67,Male,8941,Carcinoma ex pleomorphic adenoma,TX,N2b,1,0,0,Breast,51
32,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,89
67,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Salivary Gland,25
82,Female,8550,Acinar cell carcinoma,T3,N1,1,0,36,Other Biliary,16
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,152
62,Female,8500,Adenocarcinoma,T1,N3b,1,0,14,Alive,39
90,Male,8140,Adenocarcinoma,T3,N0,0,0,0,Miscellaneous Malignant Cancer,3
77,Female,8140,Adenocarcinoma,T1,N0,1,0,0,Salivary Gland,112
72,Male,8010,Carcinoma NOS,T1,N0,1,0,0,Alive,28
87,Female,8502,Adenocarcinoma,T2,N0,0,0,0,Salivary Gland,15
82,Male,8010,Carcinoma NOS,T1,N2b,1,0,0,Salivary Gland,40
62,Female,8430,Mucoepidermoid carcinoma,T0,N1,0,0,0,Alive,146
90,Male,8010,Carcinoma NOS,c2,Clinical,0,0,Unable to calculate,Salivary Gland,2
87,Male,8140,Adenocarcinoma,T4a,N0,1,0,15,Other Cause of Death,12
90,Male,8070,Squamous cell carcinoma,c2,Clinical,0,0,Unable to calculate,Diseases of Heart,6
77,Male,8070,Squamous cell carcinoma,T4a,N0,1,1,49,Other Cause of Death,69
67,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,46
82,Male,8140,Adenocarcinoma,p2,Pathologic,0,0,23,Accidents and Adverse Effects,24
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,102
52,Female,8430,Mucoepidermoid carcinoma,T1,N2b,1,0,0,Alive,126
82,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Salivary Gland,10
67,Male,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,17
77,Female,8200,Adenoid cystic carcinoma,TX,NX,0,1,34,Salivary Gland,6
82,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,0,Other Cause of Death,12
57,Female,8550,Acinar cell carcinoma,T1,N0,1,0,85,Alive,90
67,Female,8430,Mucoepidermoid carcinoma,TX,N0,0,0,0,Alive,85
90,Female,8070,Squamous cell carcinoma,T4a,N1,1,0,15,Diseases of Heart,41
82,Male,8070,Squamous cell carcinoma,T1,N0,1,0,0,Non-Melanoma Skin,12
77,Male,8500,Adenocarcinoma,T3,N0,1,0,0,Other Cause of Death,109
87,Male,8070,Squamous cell carcinoma,T4b,N1,1,0,0,Salivary Gland,3
90,Male,8070,Squamous cell carcinoma,p3,Pathologic,1,0,32,Diseases of Heart,62
67,Female,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,0,Pneumonia and Influenza,84
82,Male,8500,Adenocarcinoma,T3,N2a,1,0,31,Salivary Gland,10
67,Male,8041,Small cell carcinoma,c3,Clinical,1,1,0,Alive,71
82,Male,8070,Squamous cell carcinoma,T3,N2b,1,0,0,Salivary Gland,4
82,Male,8500,Adenocarcinoma,T2,NX,1,0,33,Alive,114
57,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Myeloma,103
62,Female,8440,Adenocarcinoma,T1,N0,0,0,0,Alive,155
72,Male,8070,Squamous cell carcinoma,p3,Pathologic,1,0,0,Miscellaneous Malignant Cancer,20
47,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,118
72,Female,8430,Mucoepidermoid carcinoma,T3,N0,1,0,55,Alive,47
67,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,75,Alive,52
62,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,112
77,Male,8070,Squamous cell carcinoma,T2,N0,1,0,21,Diseases of Heart,23
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,109
87,Male,8430,Mucoepidermoid carcinoma,p2,Pathologic,1,0,0,Stomach,15
90,Female,8550,Acinar cell carcinoma,p4A,Pathologic,0,0,0,Alive,75
87,Male,8010,Carcinoma NOS,T4a,N0,0,0,Unable to calculate,Salivary Gland,0
62,Male,8550,Acinar cell carcinoma,p3,Pathologic,1,0,32,Salivary Gland,22
87,Male,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Miscellaneous Malignant Cancer,26
37,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,2
87,Male,8046,"epithelial neoplasms, NOS",T3,N1,1,0,78,Diseases of Heart,2
67,Male,8070,Squamous cell carcinoma,T4b,N2b,1,1,Unable to calculate,Non-Hodgkin Lymphoma,54
67,Female,8290,Oncocytic carcinoma,T3,N2b,1,1,0,Alzheimers (ICD-9 and 10 only),123
82,Male,8140,Adenocarcinoma,T2,N2b,1,0,0,Salivary Gland,14
72,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Breast,4
90,Male,8070,Squamous cell carcinoma,T4a,N0,1,0,15,Alive,19
67,Female,8500,Adenocarcinoma,T3,N2b,0,0,45,Alive,144
42,Female,8430,Mucoepidermoid carcinoma,T1,NX,0,0,0,Alive,42
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,126
67,Female,8500,Adenocarcinoma,T1,N1,0,0,0,Salivary Gland,77
77,Female,8140,Adenocarcinoma,TX,N0,1,0,102,Salivary Gland,4
77,Male,8500,Adenocarcinoma,T4a,N3b,1,0,13,Diseases of Heart,13
82,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,27
77,Male,8550,Acinar cell carcinoma,p2,Pathologic,1,0,46,Alive,78
82,Male,8550,Acinar cell carcinoma,T3,N0,0,0,91,Alive,18
62,Female,8070,Squamous cell carcinoma,cX,Clinical,0,1,10,Miscellaneous Malignant Cancer,22
67,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,86
27,Female,8430,Mucoepidermoid carcinoma,T2,N1,1,0,0,Alive,22
27,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,22
67,Female,8010,Carcinoma NOS,TX,NX,0,0,0,Alive,1
90,Female,8550,Acinar cell carcinoma,T2,N0,0,0,34,Alive,36
87,Female,8500,Adenocarcinoma,T4a,N2b,0,0,25,Salivary Gland,6
37,Male,8140,Adenocarcinoma,T4a,NX,0,1,106,Pneumonia and Influenza,13
77,Male,8247,Neuroendocrine carcinoma,T2,N2b,1,1,0,Non-Melanoma Skin,14
90,Male,8140,Adenocarcinoma,T1,N3b,1,0,21,Alive,24
87,Male,8071,Squamous cell carcinoma,T1,N2c,0,0,28,"Aleukemic, Subleukemic and NOS",30
47,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,"Symptoms, Signs and Ill-Defined Conditions",71
72,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,91
72,Male,8070,Squamous cell carcinoma,T1,N0,0,0,0,Other Cause of Death,83
77,Male,8010,Carcinoma NOS,T4a,N0,1,0,50,Alive,58
67,Female,8550,Acinar cell carcinoma,TX,N0,0,0,0,Alive,121
87,Female,8070,Squamous cell carcinoma,T4b,NX,0,0,0,Miscellaneous Malignant Cancer,0
62,Female,8502,Adenocarcinoma,p1,Pathologic,1,0,0,Alive,83
87,Male,8070,Squamous cell carcinoma,T4a,N1,1,0,0,Non-Melanoma Skin,3
52,Female,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,136
72,Female,8562,Epithelial-myoepithelial carcinoma,p1,Pathologic,0,0,0,Alive,68
72,Female,8562,Epithelial-myoepithelial carcinoma,p3,Clinical,1,0,0,Alive,72
77,Male,8070,Squamous cell carcinoma,p3,Pathologic,1,1,14,"Nephritis, Nephrotic Syndrome and Nephrosis",54
72,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,84
72,Female,8140,Adenocarcinoma,p3,Pathologic,1,0,96,Salivary Gland,44
72,Male,8147,Adenocarcinoma,T3,N0,1,0,0,Alive,53
72,Male,8200,Adenoid cystic carcinoma,T1,N0,0,0,0,Alive,139
72,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,55
62,Male,8010,Carcinoma NOS,T4a,N2b,1,0,0,Non-Melanoma Skin,35
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,0
87,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,0,0,0,Diseases of Heart,51
72,Male,8500,Adenocarcinoma,T4a,N0,1,0,49,Alive,134
87,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,Unable to calculate,Miscellaneous Malignant Cancer,5
77,Male,8290,Oncocytic carcinoma,p2,Pathologic,1,0,0,Alive,66
67,Female,8430,Mucoepidermoid carcinoma,p2,Clinical,0,0,0,Alive,49
67,Male,8200,Adenoid cystic carcinoma,T4a,N2b,0,0,24,Salivary Gland,80
87,Male,8430,Mucoepidermoid carcinoma,T3,N2b,1,0,24,Miscellaneous Malignant Cancer,5
77,Male,8013,Neuroendocrine carcinoma,TX,N1,1,1,15,Salivary Gland,0
52,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,0,0,102,Miscellaneous Malignant Cancer,54
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,140
72,Female,8140,Adenocarcinoma,T2,N0,0,0,0,Salivary Gland,20
77,Male,8070,Squamous cell carcinoma,T4a,N1,1,0,23,Salivary Gland,5
77,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,21
82,Female,8010,Carcinoma NOS,TX,NX,0,0,Unable to calculate,Ovary,17
62,Male,8147,Adenocarcinoma,T1,N0,1,0,0,Alive,16
72,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,0
72,Male,8070,Squamous cell carcinoma,T3,N0,1,0,0,Alive,150
62,Male,8140,Adenocarcinoma,T3,N2b,0,1,0,Salivary Gland,13
67,Male,8500,Adenocarcinoma,T1,N0,1,0,25,Alive,24
62,Male,8550,Acinar cell carcinoma,T3,N0,1,0,38,Alive,40
67,Male,8082,squamous cell neoplasms,T2,N0,1,0,27,Nasopharynx,75
57,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,22,Alive,153
57,Female,8070,Squamous cell carcinoma,T4a,NX,1,0,0,Pneumonia and Influenza,76
77,Male,8071,Squamous cell carcinoma,T2,N0,1,0,0,Other Cause of Death,11
62,Female,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,0,Alive,154
57,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,109
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,Unable to calculate,Alive,155
42,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,154
47,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,93
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Diseases of Heart,106
52,Male,8046,"epithelial neoplasms, NOS",T4a,N1,1,0,43,Salivary Gland,31
67,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,122
82,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Lung and Bronchus,1
52,Female,8550,Acinar cell carcinoma,TX,N0,0,0,0,Alive,155
57,Female,8550,Acinar cell carcinoma,p4A,Pathologic,1,0,0,Alive,61
67,Female,8140,Adenocarcinoma,T4a,N2b,0,0,28,Salivary Gland,9
57,Female,8140,Adenocarcinoma,T4a,N2b,1,0,0,Salivary Gland,75
67,Male,8430,Mucoepidermoid carcinoma,T3,NX,1,0,6,Tongue,0
32,Male,8550,Acinar cell carcinoma,T4a,N1,0,0,26,Salivary Gland,42
82,Male,8070,Squamous cell carcinoma,T3,N3b,0,0,0,Miscellaneous Malignant Cancer,5
77,Male,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,152
62,Female,8041,Small cell carcinoma,T3,N1,1,1,0,"In situ, benign or unknown behavior neoplasm",50
67,Male,8560,Adenosquamous carcinoma,p3,Pathologic,1,0,10,Liver,12
90,Female,8562,Epithelial-myoepithelial carcinoma,TX,N0,0,0,0,Cerebrovascular Diseases,6
72,Male,8562,Epithelial-myoepithelial carcinoma,T1,N0,1,0,158,Alive,46
57,Male,8070,Squamous cell carcinoma,T4a,N2b,0,0,42,Alive,149
62,Male,8502,Adenocarcinoma,T3,N0,0,0,0,Alive,18
32,Male,8982,Myoepithelial carcinoma,T2,N0,0,0,0,Alive,151
67,Male,8500,Adenocarcinoma,T2,N2b,1,0,13,Alive,88
47,Female,8982,Myoepithelial carcinoma,T3,N0,1,0,2,Alive,151
52,Male,8500,Adenocarcinoma,T2,N0,1,0,32,Salivary Gland,22
62,Female,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,150
62,Male,8012,"epithelial neoplasms, NOS",TX,NX,0,0,Unable to calculate,Alive,0
37,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,150
52,Female,8430,Mucoepidermoid carcinoma,TX,N0,0,0,63,"In situ, benign or unknown behavior neoplasm",97
82,Male,8010,Carcinoma NOS,T2,N2b,1,1,40,Salivary Gland,18
90,Female,8941,Carcinoma ex pleomorphic adenoma,T4a,N0,0,0,0,Salivary Gland,10
67,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,29
57,Male,8070,Squamous cell carcinoma,T4a,N0,1,0,14,Other Cause of Death,84
57,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Diabetes Mellitus,116
27,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,151
67,Female,8140,Adenocarcinoma,T4a,N2b,1,0,0,Salivary Gland,46
77,Male,8010,Carcinoma NOS,TX,NX,0,0,13,Aortic Aneurysm and Dissection,2
72,Male,8140,Adenocarcinoma,TX,N1,1,0,0,Salivary Gland,15
57,Female,8010,Carcinoma NOS,T1,N0,0,0,0,Alive,147
72,Female,8941,Carcinoma ex pleomorphic adenoma,T3,NX,1,0,0,Alive,146
77,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N2b,1,0,0,State DC not available or state DC available but no COD,25
67,Female,8430,Mucoepidermoid carcinoma,p2,Pathologic,1,0,0,Alive,68
82,Male,8010,Carcinoma NOS,T2,N2b,1,0,0,Salivary Gland,134
42,Female,8083,Squamous cell carcinoma,T1,N0,1,0,36,Alive,144
67,Female,8490,Signet ring cell carcinoma,T1,N0,1,0,0,Alive,145
57,Male,8440,Adenocarcinoma,T2,N1,0,0,0,Alive,146
52,Female,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,145
52,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,0,Alive,69
72,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,20,Diseases of Heart,144
57,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,144
57,Male,8010,Carcinoma NOS,T4a,N2b,1,0,14,Salivary Gland,21
72,Male,8430,Mucoepidermoid carcinoma,T3,N2b,1,0,18,Salivary Gland,55
62,Female,8500,Adenocarcinoma,T4a,N2b,1,0,0,Salivary Gland,23
57,Male,8070,Squamous cell carcinoma,T3,N2b,1,1,38,Alive,141
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,141
87,Male,8430,Mucoepidermoid carcinoma,T3,N2b,1,0,68,Salivary Gland,9
12,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,133
62,Female,8200,Adenoid cystic carcinoma,TX,NX,1,0,65,Other Cause of Death,34
47,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,0,0,0,Alive,6
72,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Tongue,9
22,Female,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,141
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,38
57,Male,8982,Myoepithelial carcinoma,T4a,N0,1,0,20,Diseases of Heart,114
67,Male,8290,Oncocytic carcinoma,T3,N0,1,0,0,Alive,140
62,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,139
67,Male,8430,Mucoepidermoid carcinoma,T4a,N1,1,0,14,Alive,7
82,Male,8500,Adenocarcinoma,T2,N3b,0,0,28,Salivary Gland,1
12,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,144
42,Male,8550,Acinar cell carcinoma,T3,N0,1,0,0,Alive,138
62,Male,8500,Adenocarcinoma,T1,N0,1,1,0,Salivary Gland,31
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,125
17,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Salivary Gland,130
62,Female,8070,Squamous cell carcinoma,T4a,N0,1,0,61,Alive,30
67,Male,8010,Carcinoma NOS,TX,N2b,0,1,34,Salivary Gland,23
77,Male,8140,Adenocarcinoma,T4b,N2b,1,0,97,Salivary Gland,9
52,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,30,Alive,136
67,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,28,Salivary Gland,56
57,Female,8550,Acinar cell carcinoma,p1,Pathologic,0,0,0,Alive,67
62,Female,8140,Adenocarcinoma,T3,N1,1,0,130,Salivary Gland,9
62,Female,8070,Squamous cell carcinoma,T0,N2b,1,1,0,Alive,136
17,Male,8430,Mucoepidermoid carcinoma,T4a,N0,0,0,0,Alive,135
87,Male,8070,Squamous cell carcinoma,T3,N0,0,0,61,Other Cause of Death,28
72,Female,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,135
62,Male,8147,Adenocarcinoma,T2,N0,0,0,0,Alive,135
82,Male,8500,Adenocarcinoma,T2,N0,1,0,25,Prostate,70
57,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,20,Alive,134
77,Female,8140,Adenocarcinoma,T3,N0,1,0,49,Salivary Gland,51
90,Female,8070,Squamous cell carcinoma,p4A,Pathologic,1,0,13,Miscellaneous Malignant Cancer,14
82,Male,8041,Small cell carcinoma,TX,N2b,1,1,29,Urinary Bladder,80
17,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,134
62,Female,8941,Carcinoma ex pleomorphic adenoma,TX,N0,1,0,50,Salivary Gland,9
82,Male,8140,Adenocarcinoma,T3,N2b,1,0,18,State DC not available or state DC available but no COD,29
47,Male,8082,squamous cell neoplasms,T3,N2b,1,1,115,Other Cause of Death,11
87,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Miscellaneous Malignant Cancer,1
17,Female,8550,Acinar cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,134
57,Female,8070,Squamous cell carcinoma,T4a,N2b,1,0,28,Salivary Gland,21
67,Male,8010,Carcinoma NOS,T1,N0,1,0,1,Salivary Gland,13
82,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,1,0,0,Alive,129
82,Male,8140,Adenocarcinoma,T3,N0,1,0,129,Miscellaneous Malignant Cancer,55
42,Female,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,129
57,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,128
72,Male,8070,Squamous cell carcinoma,T4a,N0,1,0,68,Salivary Gland,9
77,Male,8147,Adenocarcinoma,T3,N0,0,0,0,"Nephritis, Nephrotic Syndrome and Nephrosis",60
57,Male,8140,Adenocarcinoma,T2,N0,1,0,0,Alive,128
72,Male,8140,Adenocarcinoma,T2,N1,1,0,0,Alive,128
62,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,128
77,Female,8140,Adenocarcinoma,T3,N2b,1,0,32,Salivary Gland,22
62,Male,8500,Adenocarcinoma,T2,N0,1,0,0,Alive,133
62,Male,8200,Adenoid cystic carcinoma,T2,N1,1,0,6,Salivary Gland,4
82,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,0,0,0,Alive,127
57,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,0,0,0,Alive,126
82,Male,8010,Carcinoma NOS,T3,N2b,1,1,0,Diseases of Heart,12
42,Female,8430,Mucoepidermoid carcinoma,TX,N1,1,0,0,Alive,127
87,Female,8140,Adenocarcinoma,TX,N0,0,0,1,Lung and Bronchus,91
42,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,126
67,Male,8941,Carcinoma ex pleomorphic adenoma,T4b,N0,1,0,0,Salivary Gland,39
47,Female,8071,Squamous cell carcinoma,T2,N0,1,0,0,Alive,125
42,Male,8502,Adenocarcinoma,T1,N0,0,0,0,Alive,126
77,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,2
87,Female,8071,Squamous cell carcinoma,T3,N0,1,0,32,Non-Melanoma Skin,17
42,Male,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,125
90,Female,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,19,Cerebrovascular Diseases,22
77,Male,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,8
67,Female,8140,Adenocarcinoma,T4b,N0,1,0,20,Other Endocrine including Thymus,1
72,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,1,0,37,Diseases of Heart,35
37,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,123
67,Female,8941,Carcinoma ex pleomorphic adenoma,T1,N0,0,0,0,Alive,97
77,Female,8010,Carcinoma NOS,T4a,NX,0,0,Unable to calculate,Salivary Gland,2
22,Male,8550,Acinar cell carcinoma,T2,N0,0,0,17,Alive,122
57,Male,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,122
57,Male,8430,Mucoepidermoid carcinoma,T3,N1,1,0,37,Gum and Other Mouth,55
57,Male,8070,Squamous cell carcinoma,T2,N0,0,0,28,Alive,121
67,Male,8140,Adenocarcinoma,T3,N2b,0,0,0,Salivary Gland,21
37,Male,8070,Squamous cell carcinoma,T3,N2b,0,0,15,Alive,96
22,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,121
37,Female,8147,Adenocarcinoma,T3,N0,1,0,0,Alive,121
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,120
62,Female,8941,Carcinoma ex pleomorphic adenoma,T1,N0,1,0,79,Alive,125
67,Female,8041,Small cell carcinoma,T2,N1,1,1,20,Salivary Gland,6
52,Female,8500,Adenocarcinoma,T1,N0,1,0,0,Alive,120
62,Male,8070,Squamous cell carcinoma,T3,N1,0,0,0,Miscellaneous Malignant Cancer,30
67,Male,8500,Adenocarcinoma,T2,N0,1,0,0,Alive,20
90,Female,8140,Adenocarcinoma,T3,N0,1,0,28,Salivary Gland,5
52,Female,8200,Adenoid cystic carcinoma,T1,N0,0,0,0,Alive,120
52,Female,8032,Undifferentiated carcinoma,T3,N0,0,0,0,Alive,120
52,Male,8440,Adenocarcinoma,T1,N0,0,0,122,Alive,120
87,Female,8070,Squamous cell carcinoma,T4a,N1,0,0,Unable to calculate,Miscellaneous Malignant Cancer,10
72,Male,8147,Adenocarcinoma,T2,N0,0,0,0,Alive,119
72,Male,8200,Adenoid cystic carcinoma,T4b,N0,1,0,47,Miscellaneous Malignant Cancer,53
77,Male,8070,Squamous cell carcinoma,T2,N0,1,0,18,Alive,10
77,Male,8070,Squamous cell carcinoma,T4a,N2b,1,0,44,Other Cause of Death,4
57,Female,8550,Acinar cell carcinoma,T3,N0,1,0,7,Salivary Gland,34
57,Female,8550,Acinar cell carcinoma,TX,N0,0,0,0,Alive,118
87,Male,8070,Squamous cell carcinoma,TX,N2b,0,0,Unable to calculate,Miscellaneous Malignant Cancer,2
67,Male,8562,Epithelial-myoepithelial carcinoma,T1,N0,1,0,0,Cerebrovascular Diseases,59
72,Male,8200,Adenoid cystic carcinoma,TX,N0,0,0,60,Miscellaneous Malignant Cancer,51
22,Male,8200,Adenoid cystic carcinoma,T1,N1,1,1,40,Alive,118
77,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,0,0,0,Other Cause of Death,87
67,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,0,0,0,Alive,116
87,Male,8041,Small cell carcinoma,T1,N0,0,0,0,Other Cause of Death,28
42,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,116
82,Male,8201,Adenocarcinoma,T1,N0,0,0,0,Alive,115
87,Male,8070,Squamous cell carcinoma,T3,N0,1,0,29,Non-Hodgkin Lymphoma,6
72,Female,8070,Squamous cell carcinoma,T3,NX,1,0,0,Lung and Bronchus,72
90,Male,8070,Squamous cell carcinoma,T3,N2b,0,0,167,Prostate,34
47,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,0,0,Miscellaneous Malignant Cancer,105
90,Female,8070,Squamous cell carcinoma,TX,NX,1,0,28,Salivary Gland,7
57,Male,8982,Myoepithelial carcinoma,T2,N0,1,0,0,Diseases of Heart,94
72,Male,8550,Acinar cell carcinoma,T4b,N1,0,0,16,Salivary Gland,10
67,Male,8041,Small cell carcinoma,T2,N0,1,1,16,Lung and Bronchus,19
52,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,112
77,Male,8070,Squamous cell carcinoma,T4a,N0,1,0,0,Cerebrovascular Diseases,3
87,Male,8070,Squamous cell carcinoma,T4a,N2b,0,0,22,Salivary Gland,4
52,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,112
90,Male,8010,Carcinoma NOS,T2,N0,0,0,Unable to calculate,Salivary Gland,28
52,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,114
77,Male,8070,Squamous cell carcinoma,T1,N0,0,0,236,Other Cause of Death,20
62,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,22
52,Male,8440,Adenocarcinoma,T1,N0,0,0,0,Alive,111
67,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,110
57,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,110
62,Female,8140,Adenocarcinoma,T1,N0,0,0,49,Alive,110
52,Female,8430,Mucoepidermoid carcinoma,T4b,N0,1,0,0,Alive,110
62,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,0,0,Salivary Gland,38
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,109
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Diseases of Heart,97
47,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,110
47,Female,8550,Acinar cell carcinoma,T3,N2b,1,0,37,Alive,108
67,Male,8070,Squamous cell carcinoma,TX,N2b,1,0,3,Miscellaneous Malignant Cancer,7
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,23,Alive,111
87,Female,8041,Small cell carcinoma,T2,NX,0,0,Unable to calculate,Salivary Gland,1
72,Male,8941,Carcinoma ex pleomorphic adenoma,T1,N0,0,0,0,Alive,108
52,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,108
82,Male,8070,Squamous cell carcinoma,T2,N0,1,0,36,Alzheimers (ICD-9 and 10 only),95
72,Male,8982,Myoepithelial carcinoma,T3,N0,1,0,0,Salivary Gland,19
82,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Diseases of Heart,5
32,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,"Symptoms, Signs and Ill-Defined Conditions",35
77,Female,8071,Squamous cell carcinoma,T3,N1,0,0,38,Salivary Gland,5
77,Male,8070,Squamous cell carcinoma,T1,N0,0,0,26,Alive,45
32,Male,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,0,Alive,60
72,Male,8550,Acinar cell carcinoma,T4a,N0,1,0,0,Other Cause of Death,94
52,Female,8070,Squamous cell carcinoma,T4b,N0,0,0,22,Non-Melanoma Skin,14
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,107
82,Male,8200,Adenoid cystic carcinoma,T2,N0,0,1,45,Miscellaneous Malignant Cancer,22
82,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,107
87,Female,8140,Adenocarcinoma,T4a,N0,1,0,59,Salivary Gland,18
32,Male,8200,Adenoid cystic carcinoma,T4a,N0,1,0,21,Alive,105
47,Male,8440,Adenocarcinoma,T3,N0,0,0,0,Alive,106
52,Female,8550,Acinar cell carcinoma,T2,N0,1,0,45,Alive,104
52,Male,8550,Acinar cell carcinoma,T2,N0,0,0,46,Alive,104
62,Male,8500,Adenocarcinoma,T4a,N3b,1,0,0,Salivary Gland,12
67,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,105
72,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,103
62,Female,8502,Adenocarcinoma,T1,N0,0,0,0,Alive,104
67,Male,8500,Adenocarcinoma,T3,N0,0,0,0,Alive,104
72,Female,8430,Mucoepidermoid carcinoma,T4a,N1,1,0,60,Alive,103
87,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,0,186,Diseases of Heart,91
67,Male,8140,Adenocarcinoma,T4a,N2b,1,0,0,Salivary Gland,13
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,104
52,Female,8982,Myoepithelial carcinoma,T4a,N1,1,1,28,Salivary Gland,36
82,Female,8147,Adenocarcinoma,T3,N0,1,0,0,Alive,105
42,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,102
57,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,102
57,Female,8550,Acinar cell carcinoma,T2,N0,1,0,99,Alive,38
67,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,104
22,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,102
57,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,101
32,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,101
72,Male,8500,Adenocarcinoma,T2,N0,0,0,14,Diabetes Mellitus,54
62,Male,8070,Squamous cell carcinoma,T3,N0,1,0,0,Alive,99
47,Female,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,41,Alive,99
37,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,101
42,Male,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,99
67,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,94
77,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,1,0,Alive,98
27,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,88
67,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,0,Alive,98
67,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,99
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,24,Alive,99
62,Female,8502,Adenocarcinoma,T1,N0,1,0,13,Alive,55
72,Female,8550,Acinar cell carcinoma,T1,N0,0,0,63,Alive,98
67,Male,8140,Adenocarcinoma,TX,NX,0,0,Unable to calculate,Alive,11
77,Male,8033,Undifferentiated carcinoma,p4A,Pathologic,0,0,119,Liver,36
37,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,97
37,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,96
52,Female,8200,Adenoid cystic carcinoma,T1,N0,0,0,0,Alive,96
62,Male,8502,Adenocarcinoma,T1,N0,0,0,0,Diseases of Heart,20
72,Male,8071,Squamous cell carcinoma,T2,N1,1,0,22,Alive,99
62,Female,8140,Adenocarcinoma,T1,N0,1,0,0,Alive,96
77,Female,8247,Neuroendocrine carcinoma,T1,N1,0,0,143,Other Cause of Death,59
27,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,95
72,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,95
22,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,94
37,Male,8200,Adenoid cystic carcinoma,T2,N0,0,0,0,Alive,68
82,Male,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,48,"Nephritis, Nephrotic Syndrome and Nephrosis",88
67,Male,8070,Squamous cell carcinoma,T4a,N0,0,0,9,Miscellaneous Malignant Cancer,5
72,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,0,0,0,Alive,93
90,Male,8070,Squamous cell carcinoma,T3,N3b,0,0,0,Miscellaneous Malignant Cancer,5
67,Male,8941,Carcinoma ex pleomorphic adenoma,T4a,N2b,1,0,28,Alive,93
47,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,83
77,Female,8090,Basal cell carcinoma,T2,N0,1,0,0,Salivary Gland,49
82,Female,8070,Squamous cell carcinoma,T1,N2b,1,0,81,Cerebrovascular Diseases,53
42,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,92
82,Female,8550,Acinar cell carcinoma,T3,N0,1,0,0,Salivary Gland,57
90,Male,8071,Squamous cell carcinoma,T2,N1,0,0,35,Pneumonia and Influenza,44
82,Male,8500,Adenocarcinoma,T1,N0,1,0,157,Alive,91
72,Male,8140,Adenocarcinoma,T4a,N2b,1,1,0,"Nose, Nasal Cavity and Middle Ear",83
47,Male,8020,Undifferentiated carcinoma,T4a,N2b,1,1,0,Salivary Gland,69
52,Male,8430,Mucoepidermoid carcinoma,T4b,N0,1,0,0,Alive,91
62,Male,8010,Carcinoma NOS,T2,N0,0,0,22,Alive,14
42,Male,8502,Adenocarcinoma,T2,N0,0,0,0,Alive,91
72,Male,8247,Neuroendocrine carcinoma,T4a,N2b,1,0,29,Non-Melanoma Skin,6
62,Male,8070,Squamous cell carcinoma,TX,N2a,0,0,39,Alive,91
22,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,84,Alive,90
82,Male,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,89
52,Male,8502,Adenocarcinoma,T3,N0,0,0,0,Alive,90
82,Male,8041,Small cell carcinoma,T2,N1,1,0,0,Alive,86
52,Male,8071,Squamous cell carcinoma,T4a,N2c,0,1,18,Miscellaneous Malignant Cancer,3
82,Female,8550,Acinar cell carcinoma,T1,N1,0,0,54,Alive,90
62,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,88
57,Male,8082,squamous cell neoplasms,T2,N0,1,1,0,Alive,88
52,Male,8941,Carcinoma ex pleomorphic adenoma,T4a,N2b,1,1,0,Salivary Gland,60
82,Female,8550,Acinar cell carcinoma,T2,N2b,1,0,0,Non-Melanoma Skin,13
42,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,88
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,88
62,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,0,0,Alive,87
47,Male,8200,Adenoid cystic carcinoma,TX,NX,0,0,Unable to calculate,Salivary Gland,12
17,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,0,Alive,65
67,Male,8247,Neuroendocrine carcinoma,TX,NX,0,0,Unable to calculate,Salivary Gland,13
52,Female,8940,Mixed tumor,T3,N0,1,0,0,Alive,87
82,Male,8070,Squamous cell carcinoma,T4b,N2b,1,1,0,Miscellaneous Malignant Cancer,31
67,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,86
82,Male,8070,Squamous cell carcinoma,T2,N0,0,0,0,Alive,86
47,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,86
77,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,86
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Cerebrovascular Diseases,41
87,Male,8041,Small cell carcinoma,T4a,N2b,1,0,47,Diseases of Heart,9
77,Male,8500,Adenocarcinoma,TX,NX,0,1,62,Salivary Gland,7
72,Male,8550,Acinar cell carcinoma,p2,Pathologic,1,0,0,Prostate,13
42,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,84
82,Male,8070,Squamous cell carcinoma,T3,N0,1,0,0,Diabetes Mellitus,36
37,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,84
72,Male,8071,Squamous cell carcinoma,p4A,Pathologic,1,0,22,Non-Melanoma Skin,64
67,Female,8502,Adenocarcinoma,p1,Clinical,1,0,0,Alive,83
72,Male,8071,Squamous cell carcinoma,p3,Pathologic,0,0,52,Hypertension without Heart Disease,63
72,Female,8140,Adenocarcinoma,p4A,Pathologic,0,0,56,Miscellaneous Malignant Cancer,5
67,Female,8550,Acinar cell carcinoma,T4b,N2b,1,1,38,Salivary Gland,49
52,Female,8430,Mucoepidermoid carcinoma,p2,Pathologic,1,0,0,Salivary Gland,50
57,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,47
57,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,81
87,Male,8070,Squamous cell carcinoma,pX,Pathologic,0,0,0,Chronic Obstructive Pulmonary Disease and Allied Cond,42
72,Female,8046,"epithelial neoplasms, NOS",c4B,Clinical,1,0,54,Salivary Gland,18
72,Male,8247,Neuroendocrine carcinoma,p3,Pathologic,1,1,24,Alive,81
37,Male,8430,Mucoepidermoid carcinoma,c3,Clinical,0,0,Unable to calculate,Suicide and Self-Inflicted Injury,3
87,Male,8070,Squamous cell carcinoma,p3,Pathologic,0,0,70,Alzheimers (ICD-9 and 10 only),54
67,Female,8200,Adenoid cystic carcinoma,p4A,Pathologic,1,0,35,Salivary Gland,57
62,Male,8430,Mucoepidermoid carcinoma,p2,Pathologic,1,1,0,Alive,81
37,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,38,Alive,80
87,Male,8070,Squamous cell carcinoma,c1,Clinical,1,1,51,Miscellaneous Malignant Cancer,4
72,Female,8550,Acinar cell carcinoma,p2,Pathologic,1,0,0,Alive,79
47,Male,8430,Mucoepidermoid carcinoma,p3,Pathologic,0,0,0,Alive,79
82,Male,8940,Mixed tumor,p2,Pathologic,0,0,78,Alive,79
90,Male,8070,Squamous cell carcinoma,T2,N3b,1,0,48,Salivary Gland,7
57,Female,8147,Adenocarcinoma,p3,Pathologic,1,0,0,Alive,78
90,Female,8140,Adenocarcinoma,p2,Pathologic,0,0,24,Cervix Uteri,26
42,Female,8550,Acinar cell carcinoma,p1,Pathologic,1,0,0,Alive,80
32,Male,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,80,Alive,78
32,Male,8430,Mucoepidermoid carcinoma,p1,Clinical,1,0,0,Alive,77
27,Female,8200,Adenoid cystic carcinoma,p3,Pathologic,0,0,0,Salivary Gland,29
77,Male,8430,Mucoepidermoid carcinoma,T3,N3b,1,1,157,Alive,53
72,Female,8500,Adenocarcinoma,p1,Pathologic,0,0,21,Alive,76
62,Female,8941,Carcinoma ex pleomorphic adenoma,p2,Pathologic,0,0,23,Salivary Gland,22
47,Female,8200,Adenoid cystic carcinoma,p1,Clinical,1,0,0,Alive,75
87,Female,8430,Mucoepidermoid carcinoma,c3,Clinical,0,0,14,Salivary Gland,1
77,Female,8010,Carcinoma NOS,p4A,Pathologic,1,0,40,Salivary Gland,9
52,Male,8072,Squamous cell carcinoma,p3,Clinical,0,0,6,Tongue,9
52,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,84,Alive,79
82,Male,8147,Adenocarcinoma,p2,Pathologic,0,0,15,Alzheimers (ICD-9 and 10 only),44
32,Female,8200,Adenoid cystic carcinoma,p1,Pathologic,0,0,0,Alive,75
47,Female,8550,Acinar cell carcinoma,p2,Pathologic,0,0,0,Alive,76
77,Female,8502,Adenocarcinoma,T2,N0,0,0,Unable to calculate,Ovary,34
37,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,52,Alive,36
22,Female,8502,Adenocarcinoma,p2,Clinical,1,0,0,Alive,75
77,Male,8140,Adenocarcinoma,p3,Pathologic,1,0,53,Diseases of Heart,39
77,Male,8082,squamous cell neoplasms,p2,Pathologic,1,0,0,State DC not available or state DC available but no COD,40
82,Male,8070,Squamous cell carcinoma,p2,Pathologic,1,1,36,Pneumonia and Influenza,50
42,Female,8562,Epithelial-myoepithelial carcinoma,p2,Clinical,0,0,0,Alive,75
87,Male,8000,unspecified neoplasms,cX,Clinical,1,0,20,Diseases of Heart,18
42,Male,8430,Mucoepidermoid carcinoma,p2,Pathologic,1,0,77,Alive,10
22,Female,8550,Acinar cell carcinoma,p1,Pathologic,0,0,35,Alive,73
62,Female,8430,Mucoepidermoid carcinoma,p2,Pathologic,1,0,0,Alive,72
52,Male,8562,Epithelial-myoepithelial carcinoma,p1,Pathologic,1,0,0,Salivary Gland,38
82,Female,8430,Mucoepidermoid carcinoma,p2,Pathologic,1,0,0,Alive,74
47,Male,8550,Acinar cell carcinoma,p1,Pathologic,1,0,0,Alive,73
22,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,0,Alive,72
52,Female,8200,Adenoid cystic carcinoma,p4A,Pathologic,1,0,39,Alive,72
62,Male,8941,Carcinoma ex pleomorphic adenoma,p3,Pathologic,1,0,0,Alive,72
52,Male,8430,Mucoepidermoid carcinoma,p2,Pathologic,1,0,35,Alive,72
67,Male,8430,Mucoepidermoid carcinoma,c4A,Clinical,1,0,15,Salivary Gland,27
52,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,71
57,Female,8550,Acinar cell carcinoma,p2,Pathologic,0,0,0,Alive,71
37,Female,8440,Adenocarcinoma,p1,Pathologic,0,0,0,Alive,70
57,Female,8550,Acinar cell carcinoma,p3,Pathologic,1,0,0,Alive,70
72,Male,8430,Mucoepidermoid carcinoma,p3,Pathologic,1,0,48,Miscellaneous Malignant Cancer,4
52,Male,8941,Carcinoma ex pleomorphic adenoma,p2,Pathologic,1,0,50,Alive,70
42,Female,8430,Mucoepidermoid carcinoma,p3,Pathologic,0,0,Unable to calculate,Alive,72
37,Male,8430,Mucoepidermoid carcinoma,p2,Clinical,1,0,28,Alive,69
22,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,68
52,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,43
42,Female,8941,Carcinoma ex pleomorphic adenoma,p2,Pathologic,1,0,17,Alive,68
57,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,68
67,Male,8562,Epithelial-myoepithelial carcinoma,p2,Pathologic,1,0,0,Alive,68
57,Male,8500,Adenocarcinoma,p1,Pathologic,1,1,67,Salivary Gland,65
47,Male,8200,Adenoid cystic carcinoma,p2,Pathologic,1,0,0,Alive,69
62,Male,8550,Acinar cell carcinoma,p2,Pathologic,1,0,25,Alive,68
67,Male,8147,Adenocarcinoma,p1,Pathologic,0,0,0,Alive,68
67,Female,8982,Myoepithelial carcinoma,p3,Clinical,1,0,0,Alive,68
82,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,37
37,Male,8430,Mucoepidermoid carcinoma,p3,Pathologic,1,0,0,Alive,68
22,Male,8550,Acinar cell carcinoma,p1,Clinical,0,0,0,Alive,67
42,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,71
72,Female,8013,Neuroendocrine carcinoma,T3,N0,1,1,0,Alive,46
42,Male,8500,Adenocarcinoma,p2,Pathologic,1,0,0,Alive,67
62,Female,8200,Adenoid cystic carcinoma,p2,Pathologic,1,0,0,Alive,67
22,Female,8550,Acinar cell carcinoma,p1,Clinical,0,0,106,Alive,67
52,Male,8140,Adenocarcinoma,p4A,Pathologic,1,0,15,Salivary Gland,16
37,Female,8550,Acinar cell carcinoma,p2,Pathologic,0,0,0,Alive,66
67,Male,8941,Carcinoma ex pleomorphic adenoma,p3,Pathologic,1,0,0,Alive,66
62,Male,8010,Carcinoma NOS,p4A,Pathologic,1,0,54,Alive,66
42,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,65
62,Male,8562,Epithelial-myoepithelial carcinoma,p4A,Pathologic,0,0,162,Alive,65
32,Female,8430,Mucoepidermoid carcinoma,p2,Pathologic,0,0,0,Alive,17
77,Female,8550,Acinar cell carcinoma,p2,Clinical,0,0,0,Alive,68
62,Female,8550,Acinar cell carcinoma,p3,Pathologic,0,0,0,Salivary Gland,20
67,Female,8200,Adenoid cystic carcinoma,T2,NX,1,0,0,Alive,1
62,Male,8562,Epithelial-myoepithelial carcinoma,p2,Clinical,1,0,0,Alive,66
67,Male,8200,Adenoid cystic carcinoma,p2,Pathologic,1,0,0,Alive,66
37,Male,8982,Myoepithelial carcinoma,p1,Pathologic,0,0,0,Alive,0
67,Female,8147,Adenocarcinoma,p2,Pathologic,1,0,1,Alive,66
27,Female,8550,Acinar cell carcinoma,p1,Pathologic,0,0,0,Alive,41
87,Male,8071,Squamous cell carcinoma,p2,Pathologic,1,0,47,Esophagus,60
32,Male,8550,Acinar cell carcinoma,p2,Pathologic,0,0,0,Alive,64
67,Male,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,0,Alive,64
57,Female,8430,Mucoepidermoid carcinoma,p2,Pathologic,0,0,0,Alive,63
67,Male,8430,Mucoepidermoid carcinoma,c3,Clinical,0,1,1,Myeloma,49
47,Male,8941,Carcinoma ex pleomorphic adenoma,p2,Pathologic,0,0,0,Alive,62
47,Female,8502,Adenocarcinoma,p1,Pathologic,0,0,0,Alive,64
72,Female,8550,Acinar cell carcinoma,p1,Pathologic,0,0,0,Alive,63
72,Male,8070,Squamous cell carcinoma,T2,N0,1,0,0,Alive,24
72,Male,8430,Mucoepidermoid carcinoma,p4A,Pathologic,0,0,64,Gum and Other Mouth,47
82,Male,8000,unspecified neoplasms,cX,Clinical,0,0,Unable to calculate,Gum and Other Mouth,1
67,Male,8070,Squamous cell carcinoma,c3,Clinical,1,1,31,Alive,62
77,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,62,Alzheimers (ICD-9 and 10 only),15
67,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,0,Alive,61
77,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,3
72,Male,8550,Acinar cell carcinoma,p3,Clinical,1,0,0,Alive,61
62,Male,8500,Adenocarcinoma,p3,Pathologic,1,0,0,Alive,61
57,Female,8200,Adenoid cystic carcinoma,c4B,Clinical,1,0,49,Alive,62
62,Male,8500,Adenocarcinoma,p3,Pathologic,1,0,24,Salivary Gland,18
42,Female,8200,Adenoid cystic carcinoma,c4B,Clinical,1,0,64,Alive,61
52,Female,8550,Acinar cell carcinoma,p1,Pathologic,0,0,0,Alive,60
77,Female,8430,Mucoepidermoid carcinoma,T4a,N0,0,0,Unable to calculate,Salivary Gland,47
72,Male,8500,Adenocarcinoma,p2,Pathologic,1,1,0,Salivary Gland,31
42,Female,8430,Mucoepidermoid carcinoma,p3,Pathologic,1,1,65,Salivary Gland,10
72,Male,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,0,Alive,60
62,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,36,Alive,59
62,Female,8430,Mucoepidermoid carcinoma,T3,N1,1,0,35,Alive,59
82,Male,8070,Squamous cell carcinoma,TX,N3b,0,0,Unable to calculate,Urinary Bladder,0
32,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,42,Alive,60
72,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,0,0,Alive,59
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,59
72,Male,8550,Acinar cell carcinoma,T3,N0,1,0,0,Alive,57
62,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,57,Alive,59
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,28,Alive,50
72,Male,8070,Squamous cell carcinoma,T4a,N1,0,0,51,Miscellaneous Malignant Cancer,17
27,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,58
57,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,24
57,Female,8041,Small cell carcinoma,T3,N3b,1,0,0,Non-Melanoma Skin,11
67,Male,8140,Adenocarcinoma,TX,NX,0,1,49,Miscellaneous Malignant Cancer,7
47,Male,8550,Acinar cell carcinoma,T3,N0,0,0,0,Alive,57
67,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,32,Alive,58
47,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,57
62,Female,8500,Adenocarcinoma,T1,N0,1,0,0,Alive,57
57,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,56
67,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Cerebrovascular Diseases,13
67,Male,8550,Acinar cell carcinoma,T3,N0,1,0,24,Miscellaneous Malignant Cancer,21
42,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,55
77,Female,8430,Mucoepidermoid carcinoma,T1,NX,1,0,0,Alive,4
52,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,55
67,Male,8140,Adenocarcinoma,T1,N2b,1,0,41,Salivary Gland,35
72,Male,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,9
67,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,1,0,63,Alive,55
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,8
67,Female,8450,"cystic, mucinous and serous neoplasms",88,88,1,0,0,Alive,53
67,Male,8502,Adenocarcinoma,T1,N0,0,0,0,Alive,54
90,Female,8070,Squamous cell carcinoma,T2,N0,0,0,Unable to calculate,Miscellaneous Malignant Cancer,15
87,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N1,0,0,0,Non-Melanoma Skin,2
87,Female,8070,Squamous cell carcinoma,T1,N0,0,0,21,Alive,53
82,Male,8070,Squamous cell carcinoma,T2,N1,1,0,7,Diseases of Heart,34
77,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,53
62,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,53
67,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,43,Alive,2
32,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,52
22,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,53
72,Male,8550,Acinar cell carcinoma,T2,N1,0,0,0,Diseases of Heart,18
62,Female,8550,Acinar cell carcinoma,T3,N0,1,0,0,Alive,51
72,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,1,0,0,Alive,18
90,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,11,Other Cause of Death,11
52,Female,8070,Squamous cell carcinoma,T1,N0,1,1,0,Alive,51
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,54
82,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,50
77,Female,8070,Squamous cell carcinoma,TX,N3a,1,1,0,Accidents and Adverse Effects,6
52,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,51
57,Female,8500,Adenocarcinoma,T4b,N1,1,1,0,Alive,29
32,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,58
57,Male,8046,"epithelial neoplasms, NOS",TX,N1,0,0,0,Alive,50
47,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,50
77,Female,8550,Acinar cell carcinoma,T2,N0,1,0,33,Salivary Gland,19
82,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,36,Alive,1
32,Female,8550,Acinar cell carcinoma,T2,N0,0,0,44,Alive,49
77,Male,8070,Squamous cell carcinoma,T4a,NX,0,0,Unable to calculate,Alive,27
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,49
72,Male,8140,Adenocarcinoma,TX,N2b,0,1,36,Salivary Gland,10
57,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,49
37,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,21,Alive,49
37,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,56
90,Male,8430,Mucoepidermoid carcinoma,T4a,N0,0,0,5,Pneumonia and Influenza,28
72,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,0,19,Alive,49
87,Male,8430,Mucoepidermoid carcinoma,T1,N2b,0,0,29,Salivary Gland,26
52,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,35
72,Male,8070,Squamous cell carcinoma,T4b,N0,0,0,Unable to calculate,Salivary Gland,2
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,48
42,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,48
27,Male,8502,Adenocarcinoma,T1,N0,0,0,0,Alive,48
87,Male,8010,Carcinoma NOS,T2,N0,1,0,0,Other Cause of Death,19
27,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,45
62,Male,8941,Carcinoma ex pleomorphic adenoma,T1,N0,0,0,32,Alive,46
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,29,Alive,48
62,Male,8140,Adenocarcinoma,T2,N2b,1,0,Unable to calculate,Salivary Gland,32
62,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,0,55,Salivary Gland,26
72,Female,8010,Carcinoma NOS,TX,NX,1,0,63,Salivary Gland,5
37,Female,8430,Mucoepidermoid carcinoma,T2,N1,1,0,0,Salivary Gland,42
77,Female,8070,Squamous cell carcinoma,T4b,N2b,0,0,120,Salivary Gland,5
37,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,54,Alive,45
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,45
72,Male,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,45
77,Female,8147,Adenocarcinoma,T1,N0,1,0,0,Alive,45
90,Male,8070,Squamous cell carcinoma,T3,N0,0,0,0,Salivary Gland,5
90,Male,8000,unspecified neoplasms,T2,N0,1,0,38,"In situ, benign or unknown behavior neoplasm",2
12,Male,8070,Squamous cell carcinoma,T3,N0,1,1,0,Alive,46
90,Male,8074,Squamous cell carcinoma,T4a,N0,0,0,Unable to calculate,Salivary Gland,4
32,Female,8502,Adenocarcinoma,T1,N0,1,0,0,Alive,46
77,Male,8070,Squamous cell carcinoma,T3,N0,1,0,42,Alive,44
77,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Accidents and Adverse Effects,8
67,Female,8982,Myoepithelial carcinoma,T1,N0,0,0,0,Alive,40
72,Male,8070,Squamous cell carcinoma,T1,N2a,0,0,46,Alive,17
87,Male,8500,Adenocarcinoma,T1,N3b,1,0,0,Salivary Gland,8
57,Male,8430,Mucoepidermoid carcinoma,T4a,N3b,1,1,37,Alive,1
62,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,41
47,Male,8430,Mucoepidermoid carcinoma,T1,N2a,0,0,0,Alive,44
57,Male,8140,Adenocarcinoma,T1,N2b,1,0,4,Miscellaneous Malignant Cancer,28
32,Female,8551,Acinar cell carcinoma,88,88,0,0,0,Alive,43
52,Male,8502,Adenocarcinoma,T1,N0,0,0,0,Alive,43
27,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,42
90,Male,8247,Neuroendocrine carcinoma,88,88,1,0,0,Other Cause of Death,33
72,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,0,0,0,Alive,45
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,37
72,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,41
82,Female,8500,Adenocarcinoma,T4a,N2a,0,0,0,Alive,41
52,Female,8550,Acinar cell carcinoma,T2,N0,0,0,84,Alive,1
72,Male,8430,Mucoepidermoid carcinoma,T3,N3b,1,0,0,Salivary Gland,14
27,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,58
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,39
57,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,39
57,Female,8140,Adenocarcinoma,T4b,N2a,0,1,56,Alive,40
67,Male,8430,Mucoepidermoid carcinoma,T2,N3b,1,0,12,Salivary Gland,31
57,Female,8550,Acinar cell carcinoma,T3,N0,0,0,Unable to calculate,Alive,38
87,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N3b,1,0,0,Salivary Gland,14
77,Female,8941,Carcinoma ex pleomorphic adenoma,T4a,N2b,1,0,34,Salivary Gland,7
77,Female,8562,Epithelial-myoepithelial carcinoma,T2,NX,0,0,0,Alive,38
37,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,38
57,Female,8500,Adenocarcinoma,T2,N0,0,0,0,Alive,36
62,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,38
82,Female,8500,Adenocarcinoma,T4a,N3b,1,0,14,Alive,37
72,Female,8980,complex mixed and stromal neoplasms,T3,N0,1,0,0,Salivary Gland,17
52,Male,8500,Adenocarcinoma,T3,N2b,1,0,0,Alive,37
77,Male,8070,Squamous cell carcinoma,T3,N2a,0,0,2,Miscellaneous Malignant Cancer,2
52,Female,8550,Acinar cell carcinoma,T2,N0,0,0,48,Alive,8
62,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,36
62,Female,8440,Adenocarcinoma,88,88,0,0,0,Alive,39
37,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,0,0,Alive,36
27,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,34
32,Male,8550,Acinar cell carcinoma,T4a,N0,0,0,30,Salivary Gland,34
72,Male,8801,Sarcoma,T2,N0,1,0,0,Diseases of Heart,18
72,Female,8140,Adenocarcinoma,T2,N3b,1,0,28,Alive,35
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,53,Alive,36
32,Male,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,0,Alive,35
72,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,1,0,37,Alive,36
57,Female,8200,Adenoid cystic carcinoma,T4b,NX,0,0,104,Salivary Gland,10
82,Male,8941,Carcinoma ex pleomorphic adenoma,T1,N0,1,0,0,Alive,34
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,37
62,Male,8550,Acinar cell carcinoma,T2,N0,1,0,0,Prostate,19
32,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,35
62,Female,8502,Adenocarcinoma,T1,N0,1,0,0,Alive,34
62,Female,8200,Adenoid cystic carcinoma,T4b,N0,1,0,50,Alive,33
82,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,33
47,Male,8500,Adenocarcinoma,T2,N0,1,0,0,Alive,34
62,Male,8500,Adenocarcinoma,T2,N2a,0,0,28,Alive,33
52,Male,8500,Adenocarcinoma,T2,N2b,1,1,0,Alive,33
32,Male,8550,Acinar cell carcinoma,TX,N0,0,0,Unable to calculate,Alive,33
12,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,32
52,Female,8500,Adenocarcinoma,T1,N2b,1,1,0,Alive,32
62,Female,8430,Mucoepidermoid carcinoma,T3,NX,1,0,63,Alive,30
42,Male,8500,Adenocarcinoma,T4a,N0,0,0,0,Alive,21
67,Male,8851,lipomatous neoplasms,88,88,0,0,0,Alive,30
90,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Miscellaneous Malignant Cancer,8
77,Male,8500,Adenocarcinoma,T4a,N2b,1,1,0,Alive,30
72,Female,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,14,Salivary Gland,14
77,Female,8070,Squamous cell carcinoma,T3,N3b,0,0,21,Salivary Gland,3
72,Male,8500,Adenocarcinoma,T4a,N2b,1,0,71,Alive,30
72,Male,8562,Epithelial-myoepithelial carcinoma,T4a,N2b,1,0,0,Alive,30
72,Male,8500,Adenocarcinoma,T4a,N3b,1,1,21,Alive,30
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,29
67,Male,8010,Carcinoma NOS,T4a,N3b,0,0,29,Accidents and Adverse Effects,1
77,Male,8140,Adenocarcinoma,T3,N1,0,1,44,Salivary Gland,7
72,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N3b,1,0,0,Alive,29
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,29
67,Male,8500,Adenocarcinoma,T1,N0,1,0,0,Alive,29
77,Female,8500,Adenocarcinoma,T2,N3b,0,0,26,Salivary Gland,17
52,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,0,Alive,28
82,Female,8500,Adenocarcinoma,T2,N0,1,0,61,Alive,28
62,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,1,0,0,Alive,28
27,Female,8550,Acinar cell carcinoma,T1,N0,0,0,232,Alive,31
82,Male,8070,Squamous cell carcinoma,T1,N0,0,1,51,Alive,28
52,Male,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,27
52,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,26
42,Male,8502,Adenocarcinoma,T2,N0,0,0,30,Alive,27
52,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,29
67,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Other Cause of Death,12
67,Male,8290,Oncocytic carcinoma,T2,N0,1,0,47,Alive,36
72,Male,8500,Adenocarcinoma,T2,N3b,1,0,18,Salivary Gland,10
57,Male,8982,Myoepithelial carcinoma,T2,N0,1,0,0,Alive,26
62,Male,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,14
67,Male,8550,Acinar cell carcinoma,T4a,N0,1,0,26,Alive,26
57,Male,8200,Adenoid cystic carcinoma,T4a,N3b,1,1,0,Alive,25
57,Female,8430,Mucoepidermoid carcinoma,TX,N0,0,0,Unable to calculate,Alive,40
67,Female,8200,Adenoid cystic carcinoma,T1,NX,1,0,0,Alive,24
27,Female,8550,Acinar cell carcinoma,T2,N0,0,0,26,Alive,24
77,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,28,Alive,24
47,Male,8500,Adenocarcinoma,T2,N2b,1,0,26,Alive,25
52,Female,8500,Adenocarcinoma,T2,N0,1,0,40,Alive,24
27,Male,8010,Carcinoma NOS,T3,N2b,1,1,38,Alive,24
77,Female,8147,Adenocarcinoma,T2,N0,1,0,0,Alive,23
72,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,0,47,Alive,23
72,Male,8500,Adenocarcinoma,T4a,N3b,1,1,31,Alive,23
42,Male,8502,Adenocarcinoma,T3,N0,0,0,0,Alive,23
37,Female,8550,Acinar cell carcinoma,T2,N0,1,0,34,Alive,22
82,Male,8982,Myoepithelial carcinoma,T2,N0,1,0,0,Alive,23
22,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,22
77,Female,8500,Adenocarcinoma,T3,N0,1,0,0,Alive,22
57,Female,8200,Adenoid cystic carcinoma,TX,N2b,0,0,Unable to calculate,Salivary Gland,4
57,Male,8147,Adenocarcinoma,T1,N2b,1,0,15,Alive,21
52,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,30,Alive,22
52,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,21
57,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,22
77,Female,8500,Adenocarcinoma,T3,N0,1,1,0,Alive,21
82,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,21
67,Female,8147,Adenocarcinoma,T2,N0,1,0,0,Alive,21
72,Male,8070,Squamous cell carcinoma,T3,N0,1,1,0,Alive,21
52,Male,8140,Adenocarcinoma,T4a,N2c,0,1,25,Salivary Gland,14
72,Female,8147,Adenocarcinoma,T1,N0,1,0,0,Alive,20
67,Male,8071,Squamous cell carcinoma,T4b,N0,1,1,0,Alive,21
77,Female,8147,Adenocarcinoma,T2,N0,1,0,0,Alive,20
72,Male,8500,Adenocarcinoma,T2,N2a,1,0,25,Diseases of Heart,16
52,Male,8082,squamous cell neoplasms,T2,N0,1,0,57,Alive,20
57,Male,8010,Carcinoma NOS,TX,N2c,0,1,105,Salivary Gland,7
87,Male,8500,Adenocarcinoma,T3,N3b,1,0,60,Alive,20
62,Female,8200,Adenoid cystic carcinoma,T2,NX,1,0,0,Alive,20
32,Male,8200,Adenoid cystic carcinoma,T2,N0,0,0,0,Alive,19
72,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,19
62,Male,8070,Squamous cell carcinoma,T3,N2a,1,0,22,Alive,19
72,Female,8550,Acinar cell carcinoma,T2,N2b,1,1,36,Miscellaneous Malignant Cancer,16
22,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,19
62,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,19
62,Male,8500,Adenocarcinoma,T4b,N2b,1,0,0,Alive,19
47,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,19
42,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,0,0,Alive,18
72,Male,8140,Adenocarcinoma,T3,N0,1,0,0,Alive,18
87,Male,8071,Squamous cell carcinoma,T3,N0,1,0,64,Salivary Gland,7
62,Female,8200,Adenoid cystic carcinoma,T4b,N0,1,0,0,Alive,18
62,Male,8070,Squamous cell carcinoma,T3,N3b,1,1,0,Alive,18
22,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,18
47,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,46,Alive,17
42,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,0
90,Female,8070,Squamous cell carcinoma,T4a,N0,1,0,30,Other Cause of Death,7
57,Male,8070,Squamous cell carcinoma,T4a,N3b,1,1,40,Alive,17
87,Female,8070,Squamous cell carcinoma,T3,N0,1,0,0,Alive,16
57,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,16
52,Male,8070,Squamous cell carcinoma,T4a,N3b,1,1,Unable to calculate,Non-Melanoma Skin,15
67,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N3b,1,1,0,Alive,16
22,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,13
62,Female,8941,Carcinoma ex pleomorphic adenoma,T3,N0,0,0,0,Alive,16
42,Female,8941,Carcinoma ex pleomorphic adenoma,T1,N0,0,0,0,Alive,15
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,15
67,Male,8500,Adenocarcinoma,T2,N3b,0,1,0,Salivary Gland,22
72,Male,8500,Adenocarcinoma,T4a,N3b,0,0,87,Alive,15
42,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,0
72,Male,8001,unspecified neoplasms,88,88,1,1,46,Alive,14
57,Female,8200,Adenoid cystic carcinoma,T3,N2a,0,0,0,Alive,1
57,Male,8550,Acinar cell carcinoma,T3,N0,1,0,27,Alive,15
72,Male,8070,Squamous cell carcinoma,T4a,N0,1,0,32,Alive,15
67,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N2a,1,0,32,Alive,14
57,Female,8147,Adenocarcinoma,T2,N0,0,0,0,Alive,14
47,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,0,Alive,14
77,Male,8070,Squamous cell carcinoma,T2,N2b,0,1,76,Alive,14
72,Female,8941,Carcinoma ex pleomorphic adenoma,T3,N2b,1,0,0,Alive,13
77,Male,8070,Squamous cell carcinoma,T0,N3b,1,1,14,Miscellaneous Malignant Cancer,5
72,Female,8550,Acinar cell carcinoma,T3,N0,1,0,0,Alive,13
77,Female,8401,Adenocarcinoma,88,88,1,0,28,Alive,12
47,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,5
90,Male,8070,Squamous cell carcinoma,T2,N2b,0,0,28,Miscellaneous Malignant Cancer,4
12,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,13
67,Female,8550,Acinar cell carcinoma,T3,N2a,1,1,0,Miscellaneous Malignant Cancer,2
67,Female,8200,Adenoid cystic carcinoma,T2,N0,1,1,0,Alive,11
57,Male,8290,Oncocytic carcinoma,T1,N0,0,0,0,Alive,13
62,Male,8200,Adenoid cystic carcinoma,T3,NX,0,0,15,Alive,15
47,Male,8982,Myoepithelial carcinoma,T4a,N0,1,0,0,Alive,13
22,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,55,Alive,11
47,Male,8200,Adenoid cystic carcinoma,T3,N0,0,0,37,Alive,10
67,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,10
72,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,10
52,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,10
72,Female,8020,Undifferentiated carcinoma,88,88,1,1,15,Alive,9
62,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,10
57,Male,8500,Adenocarcinoma,TX,N3b,1,1,125,Alive,14
27,Female,8430,Mucoepidermoid carcinoma,T3,N0,0,1,64,Alive,10
67,Female,8550,Acinar cell carcinoma,T2,N1,1,0,0,Alive,9
72,Male,8200,Adenoid cystic carcinoma,T3,N3b,1,0,103,Alive,7
67,Male,8020,Undifferentiated carcinoma,88,88,1,1,32,Alive,9
77,Male,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,8
27,Female,8430,Mucoepidermoid carcinoma,T3,N0,1,0,0,Alive,8
62,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,8
57,Female,8070,Squamous cell carcinoma,T2,N2b,1,0,30,Alive,7
90,Female,8070,Squamous cell carcinoma,T2,N2b,1,0,156,Alive,9
62,Female,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,7
52,Male,8200,Adenoid cystic carcinoma,T2,N0,0,0,42,Alive,8
47,Male,8500,Adenocarcinoma,T2,N0,0,0,0,Alive,0
57,Male,8070,Squamous cell carcinoma,T3,N2a,1,1,29,Alive,8
77,Male,8500,Adenocarcinoma,T2,N2b,0,0,67,Salivary Gland,4
52,Male,8500,Adenocarcinoma,T4b,N3b,1,0,32,Alive,7
82,Male,8500,Adenocarcinoma,T2,N3b,1,0,22,Alive,5
67,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,5
32,Male,8550,Acinar cell carcinoma,TX,NX,0,0,0,Alive,5
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,5
62,Female,8147,Adenocarcinoma,T1,N0,1,0,0,Alive,5
82,Male,8500,Adenocarcinoma,T2,N3b,1,0,77,Alive,6
67,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,4
32,Male,8890,Leiomyosarcoma,T2,N0,1,0,0,Alive,4
42,Male,8502,Adenocarcinoma,T1,N0,0,0,0,Alive,4
62,Female,8430,Mucoepidermoid carcinoma,T3,N0,0,0,20,Alive,4
67,Female,8070,Squamous cell carcinoma,T3,N1,1,0,69,Alive,3
87,Male,8070,Squamous cell carcinoma,T1,N1,0,0,17,Alive,8
32,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,2
52,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,3
67,Female,8500,Adenocarcinoma,T4a,N0,1,0,0,Alive,2
62,Male,8070,Squamous cell carcinoma,T4a,N1,1,0,51,Alive,2
82,Male,8070,Squamous cell carcinoma,T3,N0,0,0,25,Salivary Gland,1
72,Male,8430,Mucoepidermoid carcinoma,T0,N2a,0,0,0,Alive,3
62,Female,8430,Mucoepidermoid carcinoma,T2,N1,1,0,69,Alive,1
62,Male,8200,Adenoid cystic carcinoma,T4b,N3b,1,0,0,Alive,1
52,Female,8941,Carcinoma ex pleomorphic adenoma,T1,NX,0,0,0,Alive,1
62,Male,8500,Adenocarcinoma,T3,N3b,1,0,65,Alive,0
87,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,0
52,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,0
72,Male,8430,Mucoepidermoid carcinoma,T3,N2b,1,0,29,Alive,0
77,Male,8502,Adenocarcinoma,T2,N1,1,1,38,Alive,2
42,Female,8502,Adenocarcinoma,T3,N1,1,0,19,Alive,0
77,Male,8500,Adenocarcinoma,T4a,N0,0,0,Unable to calculate,Alive,0
47,Male,8502,Adenocarcinoma,T2,N0,1,0,0,Alive,1
57,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,10
47,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,7
82,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,0
72,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,58,Alive,6
82,Male,8010,Carcinoma NOS,T4a,N2b,1,0,Unable to calculate,Hypertension without Heart Disease,25
67,Male,8401,Adenocarcinoma,88,88,0,0,38,State DC not available or state DC available but no COD,28
82,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,37
90,Male,8070,Squamous cell carcinoma,T2,N2c,1,0,23,Non-Melanoma Skin,4
67,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,139
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Hodgkin Lymphoma,36
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,55,Myeloma,104
62,Male,8502,Adenocarcinoma,p1,Clinical,0,0,0,Alive,83
72,Male,8500,Adenocarcinoma,T3,N0,0,0,76,Alive,11
72,Female,8140,Adenocarcinoma,T1,N0,1,0,40,Alive,89
72,Male,8070,Squamous cell carcinoma,T1,N1,0,0,23,Alive,87
90,Male,8070,Squamous cell carcinoma,T3,N1,0,0,17,Other Cause of Death,14
67,Female,8070,Squamous cell carcinoma,T2,N0,1,0,25,Alive,108
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,126
72,Male,8072,Squamous cell carcinoma,T3,N2b,0,0,Unable to calculate,Alive,2
82,Female,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,0
77,Female,8200,Adenoid cystic carcinoma,TX,N0,0,0,0,Alive,105
87,Male,8070,Squamous cell carcinoma,T3,N1,1,0,38,Alive,16
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,19
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,52,Alive,12
82,Male,8941,Carcinoma ex pleomorphic adenoma,T1,N2b,1,0,9,Alive,22
72,Male,8070,Squamous cell carcinoma,T1,N0,1,1,0,Diseases of Heart,7
87,Male,8500,Adenocarcinoma,T3,N0,0,0,0,Miscellaneous Malignant Cancer,43
72,Male,8430,Mucoepidermoid carcinoma,T2,N2b,1,0,0,Salivary Gland,17
77,Male,8941,Carcinoma ex pleomorphic adenoma,T4b,N0,0,0,0,"Aleukemic, Subleukemic and NOS",80
72,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Breast,20
87,Male,8430,Mucoepidermoid carcinoma,T4a,N0,0,0,0,Alive,39
77,Male,8500,Adenocarcinoma,TX,N0,0,0,0,Alive,26
77,Male,8070,Squamous cell carcinoma,T1,N0,1,0,0,Alive,110
87,Male,8070,Squamous cell carcinoma,T2,N0,1,0,0,Miscellaneous Malignant Cancer,15
82,Male,8010,Carcinoma NOS,T3,N1,0,0,0,Other Cause of Death,88
77,Female,8502,Adenocarcinoma,p2,Pathologic,0,0,0,Other Cause of Death,12
62,Male,8082,squamous cell neoplasms,T4b,N3b,1,1,6,Alive,56
82,Male,8070,Squamous cell carcinoma,T1,N1,1,0,24,Accidents and Adverse Effects,62
32,Female,8200,Adenoid cystic carcinoma,p1,Pathologic,0,0,0,Alive,62
82,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Other Lymphocytic Leukemia,79
67,Male,8200,Adenoid cystic carcinoma,p3,Pathologic,0,0,117,Miscellaneous Malignant Cancer,30
62,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,152
57,Female,8430,Mucoepidermoid carcinoma,TX,N0,0,0,0,Alive,2
57,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,0,Alive,78
82,Male,8500,Adenocarcinoma,T4a,N1,1,0,53,Alive,29
82,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Other Cause of Death,99
67,Male,8502,Adenocarcinoma,p1,Pathologic,0,0,0,Other Cause of Death,57
57,Female,8980,complex mixed and stromal neoplasms,T3,N2b,0,0,0,Breast,0
62,Male,8070,Squamous cell carcinoma,T3,N2b,1,1,27,Alive,125
72,Male,9120,blood vessel tumors,88,88,1,0,9,Soft Tissue including Heart,6
82,Male,8070,Squamous cell carcinoma,p1,Pathologic,1,0,0,Diseases of Heart,44
82,Female,8410,Adenocarcinoma,T1,N0,0,0,0,Non-Hodgkin Lymphoma,13
72,Male,8070,Squamous cell carcinoma,T3,N0,1,1,0,Alive,139
77,Female,8502,Adenocarcinoma,p1,Clinical,0,0,0,Other Cause of Death,71
67,Male,8430,Mucoepidermoid carcinoma,TX,N1,1,1,79,Alive,53
87,Male,8070,Squamous cell carcinoma,T1,N2b,1,0,25,Salivary Gland,23
47,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,136
90,Male,8074,Squamous cell carcinoma,T3,N2b,0,0,20,Soft Tissue including Heart,3
67,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,0,Alive,63
87,Male,8071,Squamous cell carcinoma,T1,N1,0,0,0,Other Cause of Death,28
82,Male,8070,Squamous cell carcinoma,T4b,N0,1,0,15,Alive,12
87,Female,8200,Adenoid cystic carcinoma,p1,Clinical,0,0,32,Other Cause of Death,51
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,55
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,140
77,Male,8941,Carcinoma ex pleomorphic adenoma,T1,N0,1,0,0,Gum and Other Mouth,31
77,Female,8440,Adenocarcinoma,T1,N0,0,0,0,Alive,114
67,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,152
57,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,155
72,Male,8140,Adenocarcinoma,T2,N2b,0,0,0,Salivary Gland,90
62,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Non-Hodgkin Lymphoma,16
57,Female,8550,Acinar cell carcinoma,TX,N0,0,0,0,Alive,150
42,Male,8430,Mucoepidermoid carcinoma,TX,N0,0,0,Unable to calculate,Alive,2
67,Female,8070,Squamous cell carcinoma,T2,N2b,1,0,0,Salivary Gland,26
37,Male,8550,Acinar cell carcinoma,TX,N0,1,0,0,Alive,151
62,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,155
72,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,27
32,Female,8070,Squamous cell carcinoma,TX,N0,0,1,41,Alive,154
47,Female,8290,Oncocytic carcinoma,T2,N1,1,0,0,Alive,155
47,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,49
57,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,153
67,Male,8430,Mucoepidermoid carcinoma,T1,NX,0,0,0,Alive,47
62,Male,8140,Adenocarcinoma,T2,N2b,1,1,0,Alive,151
17,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,142
52,Female,8200,Adenoid cystic carcinoma,T2,N0,0,0,0,Alive,83
90,Female,8010,Carcinoma NOS,T3,N0,0,0,7,"Symptoms, Signs and Ill-Defined Conditions",0
57,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,16,Alive,148
90,Female,8010,Carcinoma NOS,TX,N2b,0,0,0,Miscellaneous Malignant Cancer,5
72,Male,8041,Small cell carcinoma,T3,N2b,0,0,11,Diseases of Heart,16
82,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,0,14,Salivary Gland,14
72,Male,8070,Squamous cell carcinoma,T1,N1,0,0,35,Alive,146
72,Female,8440,Adenocarcinoma,T1,N0,0,0,0,Alive,146
52,Male,8550,Acinar cell carcinoma,TX,N1,0,0,Unable to calculate,Diseases of Heart,0
77,Female,8562,Epithelial-myoepithelial carcinoma,T4a,N0,1,0,20,Accidents and Adverse Effects,130
72,Female,8941,Carcinoma ex pleomorphic adenoma,T3,N0,1,1,15,Salivary Gland,6
27,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,142
32,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,142
77,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,143
77,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,142
87,Female,8550,Acinar cell carcinoma,T2,N0,0,0,189,Alive,11
37,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,1,8,Salivary Gland,25
77,Male,8246,Neuroendocrine carcinoma,TX,NX,0,0,0,Non-Melanoma Skin,5
52,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,141
27,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,141
62,Male,8140,Adenocarcinoma,T4a,N1,0,0,0,Salivary Gland,22
32,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,115
67,Female,8082,squamous cell neoplasms,T2,N0,0,0,0,Alive,141
37,Female,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,43,Diseases of Heart,8
62,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,5,Alive,121
62,Male,8550,Acinar cell carcinoma,TX,N2b,1,1,40,Salivary Gland,37
72,Male,8140,Adenocarcinoma,T2,N0,0,0,0,Salivary Gland,31
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,92
87,Female,8140,Adenocarcinoma,T2,N0,0,0,35,Alive,0
72,Female,8550,Acinar cell carcinoma,TX,N0,0,0,0,Alive,153
47,Male,8070,Squamous cell carcinoma,T3,N0,1,0,8,Lung and Bronchus,96
47,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,0
52,Female,8140,Adenocarcinoma,T1,N2c,1,1,0,Salivary Gland,52
47,Male,8140,Adenocarcinoma,T3,N0,0,0,0,Alive,148
67,Male,8290,Oncocytic carcinoma,T2,N1,1,0,0,Salivary Gland,34
62,Female,8941,Carcinoma ex pleomorphic adenoma,TX,N0,0,0,0,Alive,145
77,Female,8041,Small cell carcinoma,T2,N2a,0,0,45,Salivary Gland,4
67,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,1,0,0,Alive,139
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,98,Alive,57
77,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,42
77,Male,8070,Squamous cell carcinoma,T4b,N2b,0,0,0,Salivary Gland,29
57,Female,8147,Adenocarcinoma,T1,N1,1,0,0,Alive,138
72,Male,8430,Mucoepidermoid carcinoma,T4a,N1,1,1,18,Chronic Lymphocytic Leukemia,27
57,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,27,Alive,137
42,Female,8550,Acinar cell carcinoma,T1,N2b,1,0,0,Alive,135
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,135
67,Male,8550,Acinar cell carcinoma,T1,N1,0,0,0,Diabetes Mellitus,69
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Diseases of Heart,54
77,Male,8071,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Salivary Gland,3
47,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,132
77,Male,8041,Small cell carcinoma,T1,N0,0,0,0,Miscellaneous Malignant Cancer,7
72,Male,8200,Adenoid cystic carcinoma,T2,N0,0,0,41,Alive,93
42,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,0,0,0,Alive,136
72,Male,8550,Acinar cell carcinoma,p3,Pathologic,0,0,90,Alive,61
57,Female,8982,Myoepithelial carcinoma,T1,N0,0,0,0,Alive,130
67,Female,8480,Mucinous adenocarcinoma,T4b,N0,1,1,65,Salivary Gland,6
47,Female,8550,Acinar cell carcinoma,T3,N0,1,0,0,Alive,47
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,3
67,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,128
67,Male,8070,Squamous cell carcinoma,T2,N0,1,0,24,Alive,124
42,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,126
77,Male,8070,Squamous cell carcinoma,T2,N0,1,0,0,Cerebrovascular Diseases,61
90,Female,8200,Adenoid cystic carcinoma,T2,N0,0,0,Unable to calculate,Alive,30
42,Male,8070,Squamous cell carcinoma,T2,N0,0,0,Unable to calculate,Alive,127
27,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,60
47,Male,8574,Adenocarcinoma with neuroendocrine differentiation,T1,N0,1,1,0,Alive,127
72,Male,8140,Adenocarcinoma,T1,N2b,1,1,0,Accidents and Adverse Effects,58
87,Male,8550,Acinar cell carcinoma,T3,N0,0,0,0,"Nephritis, Nephrotic Syndrome and Nephrosis",20
62,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,122
82,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,131
67,Female,8070,Squamous cell carcinoma,T2,N0,0,0,15,Alive,121
67,Female,8941,Carcinoma ex pleomorphic adenoma,T1,N0,1,0,0,Other Cause of Death,73
22,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,8,Miscellaneous Malignant Cancer,25
52,Female,8550,Acinar cell carcinoma,T3,N0,1,0,0,Alive,118
87,Male,8200,Adenoid cystic carcinoma,T4a,N0,0,0,16,Hypertension without Heart Disease,77
17,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,128
72,Male,8010,Carcinoma NOS,T3,N2b,1,1,0,Salivary Gland,23
72,Male,8500,Adenocarcinoma,T3,N2b,0,0,28,Alive,88
77,Male,8500,Adenocarcinoma,T4a,N2b,1,0,35,Alive,11
57,Male,8500,Adenocarcinoma,T4a,N2b,1,0,0,Urinary Bladder,89
52,Male,8070,Squamous cell carcinoma,T3,N0,1,1,0,Alive,125
67,Male,8140,Adenocarcinoma,T4a,N2b,1,1,13,Bones and Joints,29
47,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,129
72,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,127
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,126
82,Female,8070,Squamous cell carcinoma,T2,N1,1,0,0,Salivary Gland,9
47,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,122
27,Female,8430,Mucoepidermoid carcinoma,TX,N0,0,0,0,Alive,115
27,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,131
72,Male,8010,Carcinoma NOS,T2,N2b,0,1,20,Miscellaneous Malignant Cancer,14
72,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,119
47,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,128
82,Female,8147,Adenocarcinoma,T2,N0,0,0,0,Alive,51
82,Male,8070,Squamous cell carcinoma,T1,N2b,0,0,0,Alive,127
67,Female,8010,Carcinoma NOS,TX,NX,0,1,Unable to calculate,Salivary Gland,1
52,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,108
22,Female,8140,Adenocarcinoma,T2,N0,0,0,0,Alive,110
82,Male,8070,Squamous cell carcinoma,T3,N2b,1,0,0,Salivary Gland,3
72,Female,8010,Carcinoma NOS,T3,N0,1,0,0,Alive,117
77,Male,8070,Squamous cell carcinoma,T4a,N1,1,1,Unable to calculate,Miscellaneous Malignant Cancer,56
57,Male,8200,Adenoid cystic carcinoma,T2,N2b,1,0,0,Salivary Gland,19
62,Male,8070,Squamous cell carcinoma,T2,N2b,1,1,34,Salivary Gland,22
62,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,19,Alive,114
82,Male,8500,Adenocarcinoma,T4a,N2b,1,1,0,Salivary Gland,10
87,Male,8070,Squamous cell carcinoma,T3,N1,0,0,15,Salivary Gland,10
62,Male,8430,Mucoepidermoid carcinoma,T1,N2b,0,0,0,Alive,10
77,Male,8070,Squamous cell carcinoma,TX,N0,1,0,0,Diseases of Heart,47
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,108
67,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,25,Lung and Bronchus,37
72,Male,8070,Squamous cell carcinoma,T2,N1,1,0,15,Salivary Gland,11
77,Male,8240,Neuroendocrine tumor,88,88,0,0,0,Alive,2
87,Male,8070,Squamous cell carcinoma,TX,N1,0,0,0,Lung and Bronchus,17
52,Female,8200,Adenoid cystic carcinoma,T1,N1,1,0,0,Alive,108
32,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,9,Alive,36
32,Female,8430,Mucoepidermoid carcinoma,T2,N1,1,0,0,Alive,49
82,Male,8070,Squamous cell carcinoma,TX,N0,1,0,0,Alive,105
67,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,110
67,Female,8550,Acinar cell carcinoma,T1,NX,0,0,0,Alive,12
67,Male,8200,Adenoid cystic carcinoma,T3,N0,1,0,36,Alive,117
72,Male,8430,Mucoepidermoid carcinoma,T1,NX,0,0,0,Alive,111
47,Female,8550,Acinar cell carcinoma,T3,N1,1,0,0,Alive,105
72,Female,8070,Squamous cell carcinoma,T2,N2b,1,0,21,Diseases of Heart,83
77,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,104
57,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,104
32,Male,8070,Squamous cell carcinoma,T3,N0,1,0,0,Diabetes Mellitus,100
62,Male,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,98
82,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Miscellaneous Malignant Cancer,36
62,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,1,1,0,Alive,106
62,Male,8083,Squamous cell carcinoma,T3,N2b,0,0,0,Alive,101
32,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,100
90,Male,8000,unspecified neoplasms,T1,N0,0,0,Unable to calculate,Diseases of Heart,43
17,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,107
77,Female,8550,Acinar cell carcinoma,T2,N2b,1,0,0,Chronic Obstructive Pulmonary Disease and Allied Cond,39
52,Female,8940,Mixed tumor,T4a,N1,1,0,0,Diseases of Heart,2
72,Male,8070,Squamous cell carcinoma,T4b,N2b,1,1,38,Prostate,59
82,Female,8140,Adenocarcinoma,T3,N2b,1,0,14,Miscellaneous Malignant Cancer,51
82,Female,8070,Squamous cell carcinoma,T1,N0,0,0,0,Diseases of Heart,46
32,Male,8140,Adenocarcinoma,T3,N1,1,1,0,Salivary Gland,86
90,Female,8070,Squamous cell carcinoma,T2,N0,1,0,38,Alzheimers (ICD-9 and 10 only),44
37,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,98
42,Male,8010,Carcinoma NOS,T3,N0,1,0,0,Alive,97
42,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,106
72,Male,8070,Squamous cell carcinoma,T4a,N0,1,1,34,Miscellaneous Malignant Cancer,21
22,Male,8290,Oncocytic carcinoma,TX,NX,1,0,0,Salivary Gland,93
17,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,93
62,Female,8502,Adenocarcinoma,T1,N0,0,0,0,Alive,99
52,Female,8200,Adenoid cystic carcinoma,T3,N2b,1,1,0,Miscellaneous Malignant Cancer,31
17,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,88
87,Male,8070,Squamous cell carcinoma,T1,N0,0,0,0,Alive,87
47,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,89
57,Male,8070,Squamous cell carcinoma,T3,N2b,1,1,0,Alive,84
32,Male,8562,Epithelial-myoepithelial carcinoma,T3,N0,1,1,0,Alive,86
67,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,0,0,0,Alive,85
72,Female,8982,Myoepithelial carcinoma,T3,N0,0,0,133,Alive,86
27,Male,8070,Squamous cell carcinoma,T2,N2b,1,1,51,Alive,91
27,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,7
52,Female,8140,Adenocarcinoma,T2,N2b,1,1,0,Alive,86
32,Male,8071,Squamous cell carcinoma,p1,Clinical,1,1,0,Miscellaneous Malignant Cancer,24
27,Male,8500,Adenocarcinoma,T3,N2b,1,1,18,Salivary Gland,34
62,Female,8140,Adenocarcinoma,p3,Pathologic,1,1,0,Salivary Gland,8
67,Male,8550,Acinar cell carcinoma,p3,Pathologic,1,0,48,Alive,82
42,Male,8147,Adenocarcinoma,T2,N0,0,0,0,Alive,87
62,Female,8140,Adenocarcinoma,T1,N1,1,0,8,Salivary Gland,38
82,Male,8246,Neuroendocrine carcinoma,T4a,N1,0,0,0,Other Cause of Death,19
77,Male,8070,Squamous cell carcinoma,T3,N2b,1,0,14,Alive,92
67,Female,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,87
22,Male,8430,Mucoepidermoid carcinoma,T1,N2b,1,0,0,Alive,89
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,87
87,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,State DC not available or state DC available but no COD,83
87,Female,8070,Squamous cell carcinoma,T1,N0,0,0,0,Hypertension without Heart Disease,56
57,Male,8430,Mucoepidermoid carcinoma,T3,N2c,1,1,0,Miscellaneous Malignant Cancer,29
27,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,0,0,Alive,87
67,Male,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,0,Alive,71
67,Male,8140,Adenocarcinoma,p3,Pathologic,1,1,0,Salivary Gland,53
72,Male,8500,Adenocarcinoma,T3,N0,1,0,0,Alive,84
72,Female,8525,ductal and lobular neoplasms,TX,NX,0,0,Unable to calculate,Breast,3
47,Male,8562,Epithelial-myoepithelial carcinoma,T1,N0,0,0,23,Alive,91
57,Female,8941,Carcinoma ex pleomorphic adenoma,p1,Pathologic,0,0,0,Alive,76
67,Female,8140,Adenocarcinoma,c4B,Clinical,1,0,45,"In situ, benign or unknown behavior neoplasm",5
57,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,0,0,0,Alive,93
32,Male,8502,Adenocarcinoma,T1,N0,0,0,0,Alive,91
37,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,0,Alive,73
52,Male,8550,Acinar cell carcinoma,p3,Pathologic,0,0,0,Alive,77
57,Female,8550,Acinar cell carcinoma,p1,Pathologic,0,0,0,Alive,71
72,Female,8562,Epithelial-myoepithelial carcinoma,p1,Pathologic,0,0,0,Other Cause of Death,64
57,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,85
47,Female,8980,complex mixed and stromal neoplasms,p3,Clinical,1,0,0,Alive,70
67,Female,8500,Adenocarcinoma,T1,N0,1,1,0,Alive,18
57,Female,8550,Acinar cell carcinoma,p2,Pathologic,0,0,0,Alive,69
90,Female,8070,Squamous cell carcinoma,p3,Clinical,1,0,0,Salivary Gland,6
87,Female,8550,Acinar cell carcinoma,c4B,Clinical,1,0,28,Miscellaneous Malignant Cancer,7
57,Male,8010,Carcinoma NOS,c3,Clinical,0,1,0,Salivary Gland,16
67,Male,8430,Mucoepidermoid carcinoma,p2,Pathologic,0,0,0,Alive,76
77,Male,8083,Squamous cell carcinoma,p4A,Pathologic,1,1,79,"Symptoms, Signs and Ill-Defined Conditions",25
87,Male,8200,Adenoid cystic carcinoma,p1,Pathologic,1,0,0,Other Cause of Death,32
72,Female,8941,Carcinoma ex pleomorphic adenoma,p2,Clinical,1,0,0,Alive,73
72,Female,8550,Acinar cell carcinoma,p3,Pathologic,1,0,12,Alive,68
67,Male,8070,Squamous cell carcinoma,p3,Pathologic,1,1,0,Alive,66
72,Female,8550,Acinar cell carcinoma,p2,Clinical,0,0,0,Septicemia,49
57,Male,8140,Adenocarcinoma,p3,Pathologic,1,0,63,Alive,81
72,Female,8980,complex mixed and stromal neoplasms,c4A,Clinical,1,1,24,Salivary Gland,27
82,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,39,Alive,68
67,Female,8402,adnexal and skin appendage neoplasms,p1,Pathologic,1,0,0,Alive,78
67,Male,8033,Undifferentiated carcinoma,p1,Pathologic,1,0,28,Alive,70
77,Male,8070,Squamous cell carcinoma,p3,Pathologic,1,0,0,Salivary Gland,8
82,Male,8940,Mixed tumor,p1,Pathologic,1,0,1,Salivary Gland,52
42,Female,8430,Mucoepidermoid carcinoma,p2,Clinical,1,0,0,Alive,66
67,Male,8200,Adenoid cystic carcinoma,p3,Pathologic,1,0,0,Alive,64
67,Female,8550,Acinar cell carcinoma,p2,Clinical,1,0,0,Miscellaneous Malignant Cancer,14
72,Female,8200,Adenoid cystic carcinoma,p1,Pathologic,1,0,8,Alive,64
82,Male,8097,Basal cell carcinoma,cX,Pathologic,1,0,0,Miscellaneous Malignant Cancer,55
42,Male,8071,Squamous cell carcinoma,c4A,Clinical,1,1,75,Alive,61
67,Female,8500,Adenocarcinoma,p1,Pathologic,1,0,0,Alive,80
32,Female,8430,Mucoepidermoid carcinoma,p2,Pathologic,0,0,41,Alive,83
42,Male,8070,Squamous cell carcinoma,c0,Clinical,1,0,0,Alive,61
62,Female,8500,Adenocarcinoma,p4A,Clinical,1,0,0,Alive,70
77,Male,8000,unspecified neoplasms,c1,Clinical,0,0,Unable to calculate,Alive,69
52,Male,8550,Acinar cell carcinoma,p2,Pathologic,1,0,0,Alive,68
72,Male,8070,Squamous cell carcinoma,p2,Pathologic,1,0,0,Diseases of Heart,7
37,Female,8550,Acinar cell carcinoma,p1,Pathologic,0,0,0,Alive,63
22,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,61
32,Male,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,0,Alive,64
12,Female,8430,Mucoepidermoid carcinoma,p4A,Pathologic,0,0,34,Alive,26
67,Male,8000,unspecified neoplasms,TX,NX,1,0,14,Miscellaneous Malignant Cancer,16
37,Female,8502,Adenocarcinoma,p1,Clinical,0,0,0,Alive,41
77,Male,8071,Squamous cell carcinoma,T2,N2b,0,0,4,Alive,53
22,Female,8550,Acinar cell carcinoma,p1,Pathologic,0,0,0,Alive,71
77,Male,8200,Adenoid cystic carcinoma,T1,N0,0,0,0,Alive,50
87,Male,8010,Carcinoma NOS,T3,N2c,0,0,Unable to calculate,Miscellaneous Malignant Cancer,0
77,Female,8010,Carcinoma NOS,T2,N2b,0,0,Unable to calculate,Salivary Gland,1
47,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,55
72,Male,8550,Acinar cell carcinoma,T3,NX,1,0,0,Alive,47
52,Male,8550,Acinar cell carcinoma,T2,N0,1,0,27,Alive,44
62,Male,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,56
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,56
82,Male,8070,Squamous cell carcinoma,T4a,N0,1,0,5,Alive,55
72,Female,8290,Oncocytic carcinoma,p1,Pathologic,0,0,0,Alive,68
27,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,51
57,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,59
72,Female,8010,Carcinoma NOS,T3,N0,1,0,0,Alive,57
32,Female,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,55
87,Male,8140,Adenocarcinoma,T1,N0,0,0,0,Alive,47
57,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,58
22,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,57
77,Female,8500,Adenocarcinoma,T1,N2b,1,0,27,Alive,50
67,Male,8500,Adenocarcinoma,T2,N1,1,0,50,Diabetes Mellitus,6
82,Male,8200,Adenoid cystic carcinoma,T3,N3b,1,0,0,Miscellaneous Malignant Cancer,24
57,Male,8033,Undifferentiated carcinoma,88,88,1,1,21,Salivary Gland,44
57,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,55
82,Male,8430,Mucoepidermoid carcinoma,T4a,N3b,1,1,64,Alive,51
37,Male,8550,Acinar cell carcinoma,T1,N0,0,0,26,Alive,15
77,Male,8010,Carcinoma NOS,TX,N0,0,0,0,Alive,47
47,Male,8550,Acinar cell carcinoma,T3,N0,0,0,0,Alive,55
57,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,28
72,Female,8010,Carcinoma NOS,T4a,N0,0,0,49,Accidents and Adverse Effects,16
52,Male,8140,Adenocarcinoma,T0,N0,1,0,0,Alive,46
62,Male,8200,Adenoid cystic carcinoma,T3,N0,0,0,0,Alive,32
72,Female,8200,Adenoid cystic carcinoma,T1,N0,0,0,49,Alive,39
62,Male,8070,Squamous cell carcinoma,T3,N2b,1,1,0,Alive,46
67,Male,8200,Adenoid cystic carcinoma,T2,N1,1,0,0,Alive,46
42,Male,8200,Adenoid cystic carcinoma,T3,N3b,1,1,50,Miscellaneous Malignant Cancer,8
27,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,35
77,Male,8500,Adenocarcinoma,T2,N1,1,0,41,Alive,36
62,Male,8070,Squamous cell carcinoma,T4a,N0,1,1,50,Alive,47
77,Male,8500,Adenocarcinoma,T3,N3b,0,0,0,Salivary Gland,0
62,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Alive,57
57,Male,8200,Adenoid cystic carcinoma,T4b,N3b,1,0,83,Salivary Gland,30
72,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,27,Alive,34
62,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,42
62,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,37
82,Male,8070,Squamous cell carcinoma,T2,N0,1,0,0,Other Cause of Death,27
87,Female,8200,Adenoid cystic carcinoma,T4b,N2b,1,0,30,Alive,37
57,Male,8010,Carcinoma NOS,TX,NX,0,1,22,Salivary Gland,8
22,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,22
27,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,52,Alive,33
32,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,48
87,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,1
82,Male,8246,Neuroendocrine carcinoma,T1,N1,1,1,0,Diseases of Heart,4
52,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,30
57,Male,8041,Small cell carcinoma,T3,N1,1,1,34,Miscellaneous Malignant Cancer,27
82,Male,8070,Squamous cell carcinoma,c2,Clinical,0,0,0,Other Cause of Death,12
42,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,32
57,Male,8070,Squamous cell carcinoma,T2,N0,1,1,14,Alive,33
42,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,7
72,Male,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,41
82,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,0,0,0,Alive,40
57,Male,8147,Adenocarcinoma,T1,N0,1,0,0,Alive,37
72,Male,8070,Squamous cell carcinoma,T3,N0,0,0,0,Alive,37
67,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,36
72,Female,8070,Squamous cell carcinoma,T0,N2a,1,0,0,Alive,45
82,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,43
32,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,29
62,Female,8140,Adenocarcinoma,T2,N0,1,1,0,Alive,32
87,Female,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,1
27,Female,8430,Mucoepidermoid carcinoma,T4a,N1,1,0,0,Alive,27
42,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,29
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,61,Alive,25
82,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,25
77,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,61,Alive,31
57,Male,8022,Undifferentiated carcinoma,88,88,1,0,56,Alive,25
42,Female,8140,Adenocarcinoma,T3,N0,0,0,54,Alive,23
42,Male,8430,Mucoepidermoid carcinoma,T2,N1,0,0,0,Alive,19
77,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,25
52,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,27
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Other Cause of Death,15
82,Male,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,0,Salivary Gland,22
72,Male,8500,Adenocarcinoma,T2,N2b,1,0,41,Alive,21
62,Male,8072,Squamous cell carcinoma,T2,N0,1,0,12,Alive,21
77,Female,8070,Squamous cell carcinoma,T3,N0,0,0,28,Miscellaneous Malignant Cancer,9
82,Male,8070,Squamous cell carcinoma,T1,N0,0,0,13,Alive,18
72,Male,8071,Squamous cell carcinoma,T2,NX,1,0,0,Chronic Obstructive Pulmonary Disease and Allied Cond,21
57,Male,8500,Adenocarcinoma,T4a,N0,1,1,26,Alive,22
52,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,24
57,Male,8430,Mucoepidermoid carcinoma,T4a,N2b,1,0,35,Salivary Gland,10
57,Male,8070,Squamous cell carcinoma,T3,N1,0,0,33,Alive,20
62,Male,8502,Adenocarcinoma,T1,N0,1,0,0,Alive,22
72,Male,8500,Adenocarcinoma,T4a,N1,1,0,62,Alive,15
72,Female,8430,Mucoepidermoid carcinoma,T2,N1,1,0,0,Miscellaneous Malignant Cancer,17
72,Female,8430,Mucoepidermoid carcinoma,T3,N2b,1,0,41,Alive,13
77,Male,8070,Squamous cell carcinoma,T2,N1,1,1,0,Alive,16
67,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,66,Alive,10
82,Male,8500,Adenocarcinoma,T3,N3b,0,0,22,Miscellaneous Malignant Cancer,1
77,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N2b,1,0,19,Alive,9
67,Male,8550,Acinar cell carcinoma,T3,N0,1,0,0,Alive,14
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,14
62,Male,8140,Adenocarcinoma,TX,N0,1,0,55,Lung and Bronchus,4
90,Female,8140,Adenocarcinoma,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
77,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,9
67,Male,8500,Adenocarcinoma,T4a,N3b,0,0,24,Alive,12
27,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,12
52,Female,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,13
22,Female,8550,Acinar cell carcinoma,T1,N1,0,0,51,Alive,13
67,Female,8500,Adenocarcinoma,T4a,N2b,1,0,40,Alive,11
32,Female,8430,Mucoepidermoid carcinoma,T2,NX,0,0,0,Alive,9
67,Male,8147,Adenocarcinoma,T1,N0,1,0,19,Alive,10
52,Male,8500,Adenocarcinoma,T2,N2b,1,1,34,Alive,7
27,Male,8260,Adenocarcinoma,88,88,1,0,0,Alive,9
57,Male,8502,Adenocarcinoma,T1,N0,0,0,107,Alive,14
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,8
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,6
67,Male,8500,Adenocarcinoma,T3,N2b,1,1,28,Alive,15
67,Female,8550,Acinar cell carcinoma,T2,N0,1,0,29,Alive,5
47,Female,8140,Adenocarcinoma,TX,NX,0,0,0,Alive,19
47,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,5
57,Male,8982,Myoepithelial carcinoma,T3,N1,0,0,34,Alive,6
47,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,5
82,Male,8500,Adenocarcinoma,T1,N0,1,0,67,Alive,5
22,Male,8430,Mucoepidermoid carcinoma,T2,N2a,1,0,0,Alive,4
22,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,134,Alive,4
37,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,1,0,Alive,4
57,Male,8070,Squamous cell carcinoma,T4a,N0,0,0,78,Alive,4
72,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,2
32,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,3
90,Male,8070,Squamous cell carcinoma,T3,N0,0,0,22,Alive,2
47,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,0
72,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N2b,1,0,34,Alive,3
62,Male,8147,Adenocarcinoma,T2,N0,0,0,22,Alive,1
67,Male,8500,Adenocarcinoma,TX,N0,0,0,0,Salivary Gland,7
90,Female,8980,complex mixed and stromal neoplasms,T3,NX,1,0,31,Diseases of Heart,5
52,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,0,38,Alive,5
67,Female,8550,Acinar cell carcinoma,T1,N0,0,0,Unable to calculate,Alive,58
87,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Other Cause of Death,1
62,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,0
72,Male,8500,Adenocarcinoma,T4a,N0,1,0,0,Alive,0
77,Male,8550,Acinar cell carcinoma,T1,N0,0,0,42,Alive,8
90,Male,8070,Squamous cell carcinoma,T1,N0,0,0,22,Alive,6
42,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,0
27,Male,8550,Acinar cell carcinoma,T1,N0,0,0,60,Alive,1
82,Female,8070,Squamous cell carcinoma,T1,N0,1,0,126,Non-Hodgkin Lymphoma,45
62,Female,8010,Carcinoma NOS,T2,N0,0,0,38,Breast,8
77,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,1,1,38,Alive,122
27,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,"In situ, benign or unknown behavior neoplasm",57
82,Male,8525,ductal and lobular neoplasms,TX,NX,0,0,167,Alive,26
87,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Other Cause of Death,71
77,Female,8801,Sarcoma,T4a,N0,1,0,56,Alive,36
82,Male,8070,Squamous cell carcinoma,T3,N2b,1,0,93,"Symptoms, Signs and Ill-Defined Conditions",75
62,Female,8430,Mucoepidermoid carcinoma,T3,N1,1,0,0,Alive,97
87,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
62,Female,8940,Mixed tumor,T3,N0,1,0,0,Alive,132
72,Female,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,13,Hypertension without Heart Disease,24
17,Male,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,17,Alive,125
82,Female,8010,Carcinoma NOS,T3,N0,0,0,Unable to calculate,"Nephritis, Nephrotic Syndrome and Nephrosis",3
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,113
82,Male,8246,Neuroendocrine carcinoma,T2,N2b,1,1,0,Non-Hodgkin Lymphoma,24
57,Female,8502,Adenocarcinoma,p1,Clinical,1,0,0,Alive,70
77,Male,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Diseases of Heart,79
77,Female,8070,Squamous cell carcinoma,T2,N1,1,0,0,Lung and Bronchus,51
67,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,38
72,Male,8010,Carcinoma NOS,T2,N0,1,0,0,Alive,16
82,Male,8070,Squamous cell carcinoma,T2,N1,0,0,28,Lung and Bronchus,24
67,Male,8071,Squamous cell carcinoma,TX,N1,0,0,0,Chronic Liver Disease and Cirrhosis,16
87,Male,8071,Squamous cell carcinoma,c3,Clinical,1,0,36,Prostate,2
87,Male,8070,Squamous cell carcinoma,c1,Clinical,1,0,20,Prostate,1
77,Male,8070,Squamous cell carcinoma,TX,N0,0,0,Unable to calculate,Salivary Gland,8
67,Male,8070,Squamous cell carcinoma,T2,N0,0,0,0,Alive,100
32,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,138
77,Male,8200,Adenoid cystic carcinoma,T4a,N2a,1,0,67,Alive,7
67,Male,8525,ductal and lobular neoplasms,p4B,Clinical,1,0,0,Alive,64
72,Male,8140,Adenocarcinoma,T2,N0,0,0,56,Alive,23
72,Male,8500,Adenocarcinoma,T3,N3b,1,0,0,Alive,18
77,Female,8140,Adenocarcinoma,T4b,N2b,0,0,Unable to calculate,Alive,4
62,Female,8525,ductal and lobular neoplasms,TX,NX,1,1,461,Alive,52
77,Male,8070,Squamous cell carcinoma,c2,Clinical,0,1,0,Alive,79
52,Female,8430,Mucoepidermoid carcinoma,TX,N1,0,0,0,Alive,123
67,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,54,Intrahepatic Bile Duct,99
87,Female,8070,Squamous cell carcinoma,T3,N2b,1,1,34,Non-Melanoma Skin,11
67,Male,8010,Carcinoma NOS,p2,Pathologic,1,0,0,Alive,63
52,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,68,Alive,65
72,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,0,Alive,28
72,Male,8200,Adenoid cystic carcinoma,T3,N2b,1,1,21,Salivary Gland,12
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,113
67,Male,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,111,Alive,60
77,Female,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Alive,53
77,Male,8246,Neuroendocrine carcinoma,T3,N2b,1,0,49,Alive,131
52,Male,8070,Squamous cell carcinoma,T3,N2c,1,1,171,Salivary Gland,60
42,Female,8071,Squamous cell carcinoma,T2,N1,0,0,0,Alive,112
57,Male,8070,Squamous cell carcinoma,T1,N0,1,0,8,Alive,145
77,Male,8070,Squamous cell carcinoma,T4b,N0,0,0,0,Cerebrovascular Diseases,4
72,Male,8071,Squamous cell carcinoma,TX,N0,0,0,Unable to calculate,Other Cause of Death,23
72,Female,8525,ductal and lobular neoplasms,c3,Clinical,0,0,0,Alive,77
37,Male,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,0,Alive,60
57,Male,8070,Squamous cell carcinoma,T4a,N1,1,0,0,Non-Hodgkin Lymphoma,35
67,Female,8500,Adenocarcinoma,T3,N1,1,0,0,Alive,50
87,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
67,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,58
77,Male,8070,Squamous cell carcinoma,TX,N0,0,0,103,Non-Melanoma Skin,10
82,Male,8070,Squamous cell carcinoma,T2,N0,1,0,57,Diseases of Heart,12
52,Female,8430,Mucoepidermoid carcinoma,T3,N1,1,0,0,Alive,13
37,Male,8430,Mucoepidermoid carcinoma,TX,N0,0,1,0,Alive,15
82,Male,8070,Squamous cell carcinoma,T3,N2b,0,0,0,Non-Melanoma Skin,13
77,Male,8500,Adenocarcinoma,T1,N0,1,0,0,Melanoma of the Skin,103
77,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,120
52,Female,8430,Mucoepidermoid carcinoma,p1,Clinical,0,0,0,Alive,81
62,Male,8010,Carcinoma NOS,T3,N0,0,1,15,Esophagus,28
47,Male,8070,Squamous cell carcinoma,T4b,N0,1,1,81,Other Infectious and Parasitic Diseases including HIV,11
62,Male,8140,Adenocarcinoma,T4a,N2b,0,0,Unable to calculate,Salivary Gland,56
90,Female,8070,Squamous cell carcinoma,T3,N0,0,0,Unable to calculate,Salivary Gland,17
47,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,0,0,0,Alive,153
57,Female,8480,Mucinous adenocarcinoma,T1,N0,0,0,0,Other Cause of Death,54
77,Male,8070,Squamous cell carcinoma,T3,N2b,1,1,91,Miscellaneous Malignant Cancer,12
82,Male,8140,Adenocarcinoma,T4a,N2b,0,0,62,Salivary Gland,22
57,Male,8010,Carcinoma NOS,T2,N2b,1,0,0,Alive,151
67,Female,8010,Carcinoma NOS,T3,N1,1,1,0,Other Cause of Death,120
52,Male,8070,Squamous cell carcinoma,T3,N2c,0,1,27,Salivary Gland,22
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,150
42,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,151
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,148
62,Male,8070,Squamous cell carcinoma,T3,N3,1,0,12,Miscellaneous Malignant Cancer,4
37,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,150
57,Male,8070,Squamous cell carcinoma,T3,N2b,1,1,0,Intrahepatic Bile Duct,90
62,Female,8147,Adenocarcinoma,T2,N0,1,0,0,Alive,149
82,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Gum and Other Mouth,82
52,Female,8070,Squamous cell carcinoma,T1,N0,1,0,0,Miscellaneous Malignant Cancer,71
27,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,150
67,Male,8070,Squamous cell carcinoma,T4a,N0,0,0,43,Alive,1
77,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,148
42,Male,8010,Carcinoma NOS,T1,N0,0,0,105,Alive,147
77,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,150
67,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Other Cause of Death,114
62,Male,8550,Acinar cell carcinoma,T2,N0,1,0,19,Alive,145
47,Male,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,141
62,Male,8070,Squamous cell carcinoma,T2,N0,0,0,54,Alive,47
52,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,46,Alive,149
87,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Cerebrovascular Diseases,89
82,Male,8500,Adenocarcinoma,T3,N1,1,0,46,Alive,30
72,Male,8070,Squamous cell carcinoma,T4NOS,N0,1,0,103,Other Cause of Death,3
62,Female,8562,Epithelial-myoepithelial carcinoma,TX,N0,0,0,0,Alive,151
67,Male,8070,Squamous cell carcinoma,T2,N0,1,1,35,Diseases of Heart,110
52,Male,8012,"epithelial neoplasms, NOS",T4a,N2b,1,1,71,Alive,141
82,Male,8140,Adenocarcinoma,T3,N0,0,0,0,Salivary Gland,23
37,Female,8200,Adenoid cystic carcinoma,TX,N0,1,0,0,Alive,143
57,Female,8430,Mucoepidermoid carcinoma,T3,N0,1,0,0,Alive,89
52,Female,8550,Acinar cell carcinoma,T1,N0,0,0,17,Alive,145
67,Male,8246,Neuroendocrine carcinoma,T3,N0,1,1,7,Chronic Obstructive Pulmonary Disease and Allied Cond,13
87,Female,8200,Adenoid cystic carcinoma,T2,N0,0,0,0,Chronic Obstructive Pulmonary Disease and Allied Cond,135
77,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,0,0,107,Other Cause of Death,105
47,Male,8550,Acinar cell carcinoma,T2,N0,0,0,18,Alive,141
57,Male,8123,Transitional cell carcinoma,TX,N0,1,0,128,Non-Melanoma Skin,16
67,Female,8500,Adenocarcinoma,T4a,N2b,1,1,Unable to calculate,Salivary Gland,6
52,Female,8070,Squamous cell carcinoma,T3,N2NOS,0,1,19,Miscellaneous Malignant Cancer,18
57,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N2a,1,1,0,Salivary Gland,25
47,Female,8550,Acinar cell carcinoma,T3,N2a,1,0,0,Alive,137
57,Female,8550,Acinar cell carcinoma,T1,N1,0,0,0,Alive,47
87,Male,8010,Carcinoma NOS,T1,N2b,1,0,0,Diseases of Heart,10
62,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,53,Alive,3
32,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,139
57,Male,8200,Adenoid cystic carcinoma,T3,N2b,1,0,0,Miscellaneous Malignant Cancer,26
67,Male,8941,Carcinoma ex pleomorphic adenoma,T4a,N1,1,0,82,Alive,28
52,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,134
77,Male,8075,Squamous cell carcinoma,T4a,N0,1,0,0,Diseases of Heart,54
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,152
27,Female,8200,Adenoid cystic carcinoma,TX,N0,1,0,37,Alive,136
47,Male,8290,Oncocytic carcinoma,T3,N1,1,0,55,Salivary Gland,92
77,Male,8982,Myoepithelial carcinoma,T3,N0,1,0,0,Diseases of Heart,53
52,Female,8940,Mixed tumor,T2,N0,0,0,0,Alive,132
57,Female,8471,"cystic, mucinous and serous neoplasms",T3,N2b,1,0,59,Alive,133
82,Male,8450,"cystic, mucinous and serous neoplasms",T3,N0,1,0,58,Alive,132
77,Male,8147,Adenocarcinoma,T4a,N0,1,0,6,Diseases of Heart,29
72,Male,8550,Acinar cell carcinoma,T4a,N0,1,0,0,Alive,9
62,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,129
67,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,52,Salivary Gland,54
47,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N2b,1,1,35,Salivary Gland,6
77,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
87,Male,8070,Squamous cell carcinoma,T1,N1,1,0,0,Other Cause of Death,127
67,Female,8200,Adenoid cystic carcinoma,T2,N0,0,0,0,Alive,97
47,Female,8200,Adenoid cystic carcinoma,T2,N2b,1,1,5,Salivary Gland,2
82,Male,8070,Squamous cell carcinoma,T3,N0,1,0,0,Non-Melanoma Skin,60
67,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,129
90,Male,8070,Squamous cell carcinoma,T3,N0,0,0,41,Diseases of Heart,10
62,Male,8500,Adenocarcinoma,T4a,N0,1,0,34,Salivary Gland,41
62,Female,8941,Carcinoma ex pleomorphic adenoma,TX,N0,0,0,53,Cerebrovascular Diseases,39
72,Male,8200,Adenoid cystic carcinoma,T4a,N0,1,0,0,Salivary Gland,75
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,129
87,Female,8255,adenomas and adenocarcinomas,T2,N0,0,0,0,Other Cause of Death,115
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,34,Alive,127
57,Female,8070,Squamous cell carcinoma,T2,N0,1,0,0,Alive,128
87,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Other Cause of Death,39
87,Male,8001,unspecified neoplasms,T2,N0,1,0,20,Alzheimers (ICD-9 and 10 only),41
52,Male,8502,Adenocarcinoma,T1,N0,0,0,0,Alive,126
62,Male,8070,Squamous cell carcinoma,T4a,N2a,0,0,42,"Nephritis, Nephrotic Syndrome and Nephrosis",117
62,Male,8140,Adenocarcinoma,T3,N0,0,0,36,Alive,125
67,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,12,Alive,126
67,Male,8000,unspecified neoplasms,T1,N0,0,0,Unable to calculate,Alive,124
67,Male,8550,Acinar cell carcinoma,T3,N0,1,0,0,Suicide and Self-Inflicted Injury,48
47,Male,8982,Myoepithelial carcinoma,T4b,N0,0,1,44,"Nose, Nasal Cavity and Middle Ear",28
47,Male,8140,Adenocarcinoma,T4b,N2b,0,1,177,Salivary Gland,10
37,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,124
82,Female,8140,Adenocarcinoma,T4a,N1,1,0,0,Diseases of Heart,111
90,Female,8070,Squamous cell carcinoma,T3,N2b,0,0,0,Miscellaneous Malignant Cancer,26
22,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,19
47,Female,8550,Acinar cell carcinoma,T3,N0,1,0,0,Alive,122
22,Male,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,121
72,Male,8500,Adenocarcinoma,T3,N2b,1,1,26,Salivary Gland,78
57,Female,8562,Epithelial-myoepithelial carcinoma,T4b,N0,1,1,0,Alive,52
82,Male,8070,Squamous cell carcinoma,T2,N0,1,0,23,Chronic Lymphocytic Leukemia,6
47,Female,8140,Adenocarcinoma,T1,N0,0,0,0,Alive,122
87,Male,8070,Squamous cell carcinoma,T3,N0,0,0,Unable to calculate,Non-Melanoma Skin,1
47,Male,8481,Mucinous adenocarcinoma,T3,N0,1,0,44,Alive,126
57,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,0,0,0,Pancreas,58
67,Male,8430,Mucoepidermoid carcinoma,T4a,N2b,0,1,74,Salivary Gland,38
67,Male,8562,Epithelial-myoepithelial carcinoma,T1,N0,1,0,0,Alive,122
22,Male,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,120
82,Male,8070,Squamous cell carcinoma,T1,N1,0,0,0,Diseases of Heart,40
62,Male,8010,Carcinoma NOS,cX,Pathologic,0,0,50,Non-Melanoma Skin,27
42,Female,8140,Adenocarcinoma,T1,N0,0,0,283,Alive,124
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,56
27,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,117
27,Male,8430,Mucoepidermoid carcinoma,T2,N2b,1,1,0,Alive,119
67,Female,8562,Epithelial-myoepithelial carcinoma,p2,Clinical,1,0,0,Myeloma,72
57,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,43,Alive,120
27,Female,8010,Carcinoma NOS,T2,N0,1,0,0,Alive,115
72,Male,8140,Adenocarcinoma,T3,N0,0,0,250,Esophagus,87
72,Male,8083,Squamous cell carcinoma,TX,NX,0,1,62,Salivary Gland,83
62,Male,8500,Adenocarcinoma,p4B,Pathologic,0,0,96,Salivary Gland,68
72,Male,8071,Squamous cell carcinoma,TX,N2a,0,0,77,Other Cause of Death,29
37,Female,8430,Mucoepidermoid carcinoma,T2,N1,1,0,19,Alive,111
87,Male,8430,Mucoepidermoid carcinoma,T3,N1,1,0,0,Salivary Gland,6
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,117
57,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,112
72,Male,8000,unspecified neoplasms,T2,N0,0,0,0,Alive,112
87,Male,8070,Squamous cell carcinoma,T2,N0,1,0,76,Diseases of Heart,68
77,Female,8200,Adenoid cystic carcinoma,T2,N0,0,0,77,Alive,118
37,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,114
57,Female,8430,Mucoepidermoid carcinoma,T4b,N3,1,1,30,Salivary Gland,24
67,Male,8010,Carcinoma NOS,T3,N1,1,1,75,Other Digestive Organs,9
62,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Other Cause of Death,91
62,Male,8010,Carcinoma NOS,T3,N2c,0,0,Unable to calculate,Colon excluding Rectum,2
42,Female,8140,Adenocarcinoma,T2,N0,0,0,0,Breast,83
90,Male,8070,Squamous cell carcinoma,TX,N1,1,0,0,Diseases of Heart,13
82,Male,8010,Carcinoma NOS,T4a,N2b,1,0,0,Salivary Gland,34
72,Female,8550,Acinar cell carcinoma,T3,N0,0,0,0,Alive,112
67,Male,8140,Adenocarcinoma,T3,N2b,1,1,29,Salivary Gland,6
82,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,5,Alzheimers (ICD-9 and 10 only),70
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,111
7,Female,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,110
57,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,109
42,Female,8502,Adenocarcinoma,T1,N0,0,0,22,Alive,113
57,Female,8941,Carcinoma ex pleomorphic adenoma,T1,N0,0,0,0,Alive,110
82,Female,8562,Epithelial-myoepithelial carcinoma,T4b,N0,1,0,0,Salivary Gland,51
52,Male,8070,Squamous cell carcinoma,T3,N0,1,0,0,Miscellaneous Malignant Cancer,0
37,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,111
82,Male,8070,Squamous cell carcinoma,T3,N0,1,0,62,Other Cause of Death,3
67,Male,8070,Squamous cell carcinoma,TX,NX,0,0,0,Alive,151
72,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,106
52,Female,8500,Adenocarcinoma,T3,N1,1,0,13,Alive,109
57,Female,8430,Mucoepidermoid carcinoma,T3,N0,1,0,51,Other Cause of Death,51
57,Female,8140,Adenocarcinoma,T2,N2b,1,1,27,Salivary Gland,4
57,Female,8200,Adenoid cystic carcinoma,T4b,N1,1,1,32,Gum and Other Mouth,42
67,Female,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,0,Alive,39
77,Female,8010,Carcinoma NOS,T3,N3b,1,0,0,Salivary Gland,10
87,Male,8070,Squamous cell carcinoma,T2,N0,0,0,29,Diseases of Heart,58
37,Male,8200,Adenoid cystic carcinoma,T3,N0,0,0,0,Alive,103
42,Male,8200,Adenoid cystic carcinoma,T3,N0,1,1,26,Pneumonia and Influenza,62
67,Male,8550,Acinar cell carcinoma,T3,N0,0,0,Unable to calculate,Salivary Gland,8
2.5,Male,8071,Squamous cell carcinoma,T4a,N0,1,1,0,Alive,106
42,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,0
67,Male,8070,Squamous cell carcinoma,T3,N2b,1,1,0,Esophagus,45
62,Female,8010,Carcinoma NOS,T1,N0,1,0,57,Alive,106
57,Male,8500,Adenocarcinoma,T1,N0,1,0,0,Liver,51
62,Male,8147,Adenocarcinoma,T3,N0,1,0,0,Alive,107
62,Male,8940,Mixed tumor,T2,N0,0,0,0,Alive,105
90,Male,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,68,Suicide and Self-Inflicted Injury,5
42,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,52
87,Female,8562,Epithelial-myoepithelial carcinoma,T3,N0,1,1,43,Salivary Gland,14
57,Male,8070,Squamous cell carcinoma,TX,N2a,1,0,0,Alive,101
62,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,98
82,Female,8070,Squamous cell carcinoma,T4a,N2b,1,0,89,Salivary Gland,22
77,Male,8046,"epithelial neoplasms, NOS",T3,N1,1,0,21,Salivary Gland,4
57,Male,8070,Squamous cell carcinoma,T4a,N0,0,0,0,Non-Melanoma Skin,11
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,10,Alive,110
27,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,94
77,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,1,0,Alive,100
42,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,39,Alive,97
77,Female,8140,Adenocarcinoma,T3,N1,0,0,Unable to calculate,Salivary Gland,0
32,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,30,Alive,105
27,Female,8430,Mucoepidermoid carcinoma,T3,N0,0,0,45,Alive,98
27,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,102
90,Female,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,Unknown
52,Male,8430,Mucoepidermoid carcinoma,T2,N0,1,0,71,Alive,38
87,Female,8070,Squamous cell carcinoma,T2,N2b,1,0,25,Salivary Gland,4
77,Male,8500,Adenocarcinoma,T3,N0,1,0,115,Alive,99
42,Female,8070,Squamous cell carcinoma,T4a,N2a,1,0,0,Salivary Gland,23
72,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,88
47,Male,8140,Adenocarcinoma,T3,N0,1,0,0,Alive,100
67,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,0,35,Diseases of Heart,51
32,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,1,0,Alive,92
57,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,93
72,Male,8071,Squamous cell carcinoma,T3,N0,1,1,28,Alive,100
47,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Accidents and Adverse Effects,73
27,Female,8403,adnexal and skin appendage neoplasms,T3,N2b,1,0,105,Alive,94
27,Female,8082,squamous cell neoplasms,T4a,N0,1,1,35,Alive,25
67,Female,8562,Epithelial-myoepithelial carcinoma,T4a,N0,0,0,0,Other Cause of Death,50
82,Female,8500,Adenocarcinoma,T3,N2b,1,1,55,Alive,95
32,Female,8430,Mucoepidermoid carcinoma,T1,N1,1,0,0,Alive,92
37,Female,8430,Mucoepidermoid carcinoma,T3,N0,0,1,0,Alive,16
62,Female,8430,Mucoepidermoid carcinoma,T4b,N0,0,0,95,Alive,89
67,Male,8070,Squamous cell carcinoma,T2,N2b,1,0,11,Alive,89
67,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,88
62,Male,8500,Adenocarcinoma,T3,N2b,1,1,37,Alive,93
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,111
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alzheimers (ICD-9 and 10 only),8
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,90
62,Male,8070,Squamous cell carcinoma,TX,N0,1,0,34,Diseases of Heart,37
37,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,14,Alive,93
27,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,95
77,Female,8941,Carcinoma ex pleomorphic adenoma,T3,N2b,0,0,107,Alive,86
27,Male,8200,Adenoid cystic carcinoma,T4a,N0,1,1,27,Alive,86
62,Male,8140,Adenocarcinoma,T4a,N0,1,0,8,Salivary Gland,2
42,Female,8430,Mucoepidermoid carcinoma,T4a,N1,0,0,0,Alive,90
52,Male,8550,Acinar cell carcinoma,p1,Pathologic,1,0,43,Alive,82
42,Male,8140,Adenocarcinoma,p2,Pathologic,1,1,26,Alive,80
52,Male,8070,Squamous cell carcinoma,c4B,Clinical,1,1,220,Non-Melanoma Skin,15
32,Female,8940,Mixed tumor,p1,Clinical,0,0,106,Alive,81
42,Male,8010,Carcinoma NOS,p4A,Pathologic,1,0,0,Alive,77
47,Female,8562,Epithelial-myoepithelial carcinoma,T3,N0,1,0,0,Alive,85
67,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,0,Alive,79
57,Male,8982,Myoepithelial carcinoma,p3,Pathologic,0,0,0,Alive,78
67,Female,8430,Mucoepidermoid carcinoma,p3,Pathologic,1,0,0,Alive,77
52,Female,8560,Adenosquamous carcinoma,T2,N0,1,0,0,Alive,92
37,Female,8430,Mucoepidermoid carcinoma,p2,Pathologic,1,0,0,Alive,82
87,Male,8010,Carcinoma NOS,p1,Clinical,1,0,0,Alive,76
47,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,58,Alive,83
42,Male,8480,Mucinous adenocarcinoma,p1,Clinical,0,0,24,Alive,82
82,Male,8500,Adenocarcinoma,T2,N2b,1,0,0,Alive,9
77,Male,8525,ductal and lobular neoplasms,p2,Pathologic,1,0,0,Alive,72
72,Male,8430,Mucoepidermoid carcinoma,c1,Clinical,0,0,Unable to calculate,Alive,81
72,Male,8140,Adenocarcinoma,c3,Clinical,1,1,27,Salivary Gland,48
47,Female,8140,Adenocarcinoma,c4B,Clinical,0,0,Unable to calculate,Salivary Gland,2
72,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,9
77,Male,8070,Squamous cell carcinoma,T1,N1,0,0,46,Alive,2
52,Male,8430,Mucoepidermoid carcinoma,c2,Clinical,0,0,Unable to calculate,Alive,0
57,Male,8982,Myoepithelial carcinoma,p2,Pathologic,0,0,0,Alive,76
90,Male,8071,Squamous cell carcinoma,p3,Pathologic,1,0,102,Other Cause of Death,50
67,Female,8550,Acinar cell carcinoma,p4A,Pathologic,0,0,26,Salivary Gland,67
82,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,0,Chronic Obstructive Pulmonary Disease and Allied Cond,70
67,Female,8982,Myoepithelial carcinoma,p2,Pathologic,1,0,0,Alive,76
47,Male,8982,Myoepithelial carcinoma,p1,Clinical,0,0,0,Alive,70
42,Female,8550,Acinar cell carcinoma,p4B,Pathologic,1,0,20,Salivary Gland,53
47,Female,8430,Mucoepidermoid carcinoma,T4a,N0,0,0,0,Alive,26
77,Male,8562,Epithelial-myoepithelial carcinoma,p2,Clinical,0,0,0,Alive,76
82,Male,8500,Adenocarcinoma,p2,Pathologic,1,0,64,Alive,71
57,Female,8430,Mucoepidermoid carcinoma,p2,Pathologic,0,0,0,Alive,69
72,Male,8500,Adenocarcinoma,T2,N2b,0,0,Unable to calculate,Salivary Gland,14
22,Male,8123,Transitional cell carcinoma,p4A,Pathologic,0,0,48,Salivary Gland,51
72,Male,8070,Squamous cell carcinoma,TX,N3b,0,0,14,Alive,52
62,Female,8140,Adenocarcinoma,c3,Clinical,0,0,73,Alive,72
77,Male,8070,Squamous cell carcinoma,c3,Clinical,1,0,23,Salivary Gland,4
72,Female,8070,Squamous cell carcinoma,c2,Clinical,0,0,Unable to calculate,Other Cause of Death,6
57,Male,8071,Squamous cell carcinoma,T1,N1,0,0,0,Alive,88
67,Male,8070,Squamous cell carcinoma,TX,N1,0,0,0,Alive,85
82,Male,8140,Adenocarcinoma,T3,N0,0,0,0,Other Infectious and Parasitic Diseases including HIV,1
72,Male,8140,Adenocarcinoma,T1,N0,0,0,0,Alive,54
62,Female,8982,Myoepithelial carcinoma,p1,Pathologic,1,0,0,Alive,71
87,Male,8070,Squamous cell carcinoma,p2,Pathologic,1,0,0,Pneumonia and Influenza,53
47,Male,8500,Adenocarcinoma,p2,Pathologic,1,0,0,Alive,64
67,Male,8561,Adenosquamous carcinoma,88,88,0,0,0,Alive,14
72,Male,8507,Adenocarcinoma,p4A,Pathologic,1,1,143,Diseases of Heart,36
82,Male,8070,Squamous cell carcinoma,T4a,N2b,1,0,36,Other Cause of Death,31
77,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,26,Alive,24
27,Male,8000,unspecified neoplasms,cX,Clinical,0,0,Unable to calculate,Alive,73
72,Female,8200,Adenoid cystic carcinoma,p1,Clinical,1,0,0,Alive,76
47,Male,8010,Carcinoma NOS,cX,Pathologic,0,0,0,Alive,72
52,Female,8982,Myoepithelial carcinoma,p2,Clinical,0,0,0,Alive,29
42,Male,8982,Myoepithelial carcinoma,p3,Clinical,1,0,0,Alive,58
87,Female,8140,Adenocarcinoma,p4A,Pathologic,0,0,0,Salivary Gland,0
47,Male,8390,Adenocarcinoma,p2,Pathologic,1,1,0,Salivary Gland,16
62,Male,8430,Mucoepidermoid carcinoma,p1,Pathologic,1,0,0,Alive,65
57,Male,8070,Squamous cell carcinoma,c4B,Clinical,1,1,69,Oropharynx,43
47,Female,8430,Mucoepidermoid carcinoma,T3,N0,1,0,0,Alive,0
52,Female,8525,ductal and lobular neoplasms,T3,N0,0,0,57,Alive,49
87,Female,8430,Mucoepidermoid carcinoma,p4A,Pathologic,0,0,67,Diseases of Heart,30
62,Male,8941,Carcinoma ex pleomorphic adenoma,p2,Pathologic,1,0,0,Alive,67
27,Female,8430,Mucoepidermoid carcinoma,p1,Pathologic,0,0,141,Alive,67
27,Female,8200,Adenoid cystic carcinoma,p2,Pathologic,1,0,0,Alive,62
47,Female,8500,Adenocarcinoma,c4A,Clinical,0,1,27,Salivary Gland,29
82,Male,8070,Squamous cell carcinoma,c1,Clinical,0,0,14,Alive,62
72,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,41
62,Female,8401,Adenocarcinoma,c0,Pathologic,0,0,20,Salivary Gland,28
27,Male,8200,Adenoid cystic carcinoma,cX,Clinical,1,0,0,Alive,61
57,Male,8200,Adenoid cystic carcinoma,p2,Clinical,1,0,0,Other Cause of Death,60
27,Male,8502,Adenocarcinoma,p1,Clinical,1,0,0,Alive,68
52,Female,8147,Adenocarcinoma,p2,Pathologic,1,0,0,Alive,61
67,Male,8430,Mucoepidermoid carcinoma,T2,NX,0,0,0,Alive,32
57,Male,8200,Adenoid cystic carcinoma,T3,N0,0,0,0,Miscellaneous Malignant Cancer,55
87,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Diseases of Heart,11
12,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,57
62,Male,8070,Squamous cell carcinoma,p2,Pathologic,1,1,0,Alive,70
87,Male,8070,Squamous cell carcinoma,c2,Clinical,1,0,167,Salivary Gland,13
67,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N1,1,1,161,Alive,54
72,Male,8500,Adenocarcinoma,T1,N0,0,0,16,Alive,56
87,Female,8070,Squamous cell carcinoma,T3,N1,1,0,32,Alive,31
42,Male,8941,Carcinoma ex pleomorphic adenoma,p2,Pathologic,0,0,2,Alive,63
87,Male,8574,Adenocarcinoma with neuroendocrine differentiation,88,88,1,1,0,Septicemia,11
82,Male,8290,Oncocytic carcinoma,T1,N0,0,0,70,Alive,40
27,Female,8200,Adenoid cystic carcinoma,T1,N0,1,0,0,Alive,54
90,Male,8246,Neuroendocrine carcinoma,T3,N2c,1,0,31,Other Cause of Death,15
82,Male,8200,Adenoid cystic carcinoma,T4b,N0,1,0,0,Other Cause of Death,1
72,Female,8010,Carcinoma NOS,T4b,N1,1,0,97,Salivary Gland,4
47,Female,8430,Mucoepidermoid carcinoma,T3,N0,0,0,55,Alive,54
90,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,0,0,Unable to calculate,Cerebrovascular Diseases,0
52,Female,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,45
47,Female,8200,Adenoid cystic carcinoma,T1,N0,0,0,60,Alive,51
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,53
67,Male,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,63,Alive,52
52,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N0,0,0,0,Soft Tissue including Heart,49
47,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,54
22,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,51
47,Female,8502,Adenocarcinoma,T1,N0,1,0,0,Alive,50
67,Female,8941,Carcinoma ex pleomorphic adenoma,T4a,N3b,1,1,16,Alive,41
62,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,50
67,Male,8562,Epithelial-myoepithelial carcinoma,T4a,N0,1,1,90,Alive,50
72,Male,8071,Squamous cell carcinoma,T3,N0,1,0,6,Alive,51
77,Female,8290,Oncocytic carcinoma,T1,N0,0,0,0,Alive,14
62,Female,8502,Adenocarcinoma,T1,N0,0,0,0,Alive,45
77,Male,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,51
67,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,59
77,Female,8200,Adenoid cystic carcinoma,T2,N0,0,0,Unable to calculate,Salivary Gland,8
67,Male,8140,Adenocarcinoma,T1,N0,1,0,0,Alive,54
72,Male,8070,Squamous cell carcinoma,T3,N1,0,0,65,Alive,48
52,Female,8550,Acinar cell carcinoma,T1,N0,1,0,0,Alive,48
52,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,1,0,0,Alive,40
87,Male,8941,Carcinoma ex pleomorphic adenoma,T4b,N2a,1,0,68,Alive,49
72,Male,8070,Squamous cell carcinoma,T2,N0,1,0,0,Alive,40
72,Male,8070,Squamous cell carcinoma,T4a,N0,1,0,0,Alive,19
72,Male,8070,Squamous cell carcinoma,TX,NX,0,0,0,Diseases of Heart,7
77,Male,8070,Squamous cell carcinoma,cX,Pathologic,1,1,0,Other Cause of Death,51
72,Male,8010,Carcinoma NOS,T1,N0,0,0,0,Alive,58
82,Female,8090,Basal cell carcinoma,88,88,0,0,Unable to calculate,Alive,59
57,Male,8071,Squamous cell carcinoma,TX,N0,0,0,Unable to calculate,Alive,49
42,Male,8097,Basal cell carcinoma,88,88,0,0,Unable to calculate,Alive,50
90,Female,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,48
57,Male,8147,Adenocarcinoma,T1,N0,0,0,0,Alive,38
52,Male,8123,Transitional cell carcinoma,cX,Clinical,0,0,Unable to calculate,Non-Melanoma Skin,33
57,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,51
27,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,49
77,Male,8140,Adenocarcinoma,T3,N3a,1,1,50,Salivary Gland,8
42,Female,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,11
57,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,0
57,Male,8550,Acinar cell carcinoma,T1,N0,0,0,17,Alive,45
90,Male,8070,Squamous cell carcinoma,T1,N2b,0,0,0,Other Cause of Death,10
57,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,30
77,Male,8010,Carcinoma NOS,T2,N0,0,0,Unable to calculate,Salivary Gland,5
72,Male,8140,Adenocarcinoma,T2,N0,1,0,0,Alive,45
32,Male,8550,Acinar cell carcinoma,T1,N0,0,0,0,Alive,40
87,Male,8010,Carcinoma NOS,T3,N0,0,0,Unable to calculate,Salivary Gland,2
32,Female,8070,Squamous cell carcinoma,T4b,N0,1,0,7,"In situ, benign or unknown behavior neoplasm",31
32,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,39
57,Male,8010,Carcinoma NOS,T3,N1,1,0,0,Salivary Gland,8
87,Female,8000,unspecified neoplasms,TX,N0,1,0,30,Miscellaneous Malignant Cancer,1
47,Male,8550,Acinar cell carcinoma,T3,N0,1,0,31,Alive,35
72,Female,8200,Adenoid cystic carcinoma,TX,N2b,1,1,91,Alive,36
27,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,12
37,Male,8550,Acinar cell carcinoma,T3,N0,1,0,0,Alive,7
72,Male,8071,Squamous cell carcinoma,T2,N1,0,0,0,Alive,44
52,Female,8140,Adenocarcinoma,TX,N0,0,0,Unable to calculate,Alive,57
72,Female,8070,Squamous cell carcinoma,T2,N2a,1,1,7,Lung and Bronchus,8
52,Male,8022,Undifferentiated carcinoma,88,88,1,0,49,Alive,15
67,Male,8000,unspecified neoplasms,TX,NX,0,0,Unable to calculate,Salivary Gland,0
82,Female,8500,Adenocarcinoma,T1,N0,0,0,0,Alive,41
32,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,39
72,Female,8200,Adenoid cystic carcinoma,T2,NX,0,0,0,Alive,43
27,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,28,Alive,2
72,Male,8070,Squamous cell carcinoma,T1,N2a,1,0,23,Alive,41
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,19
42,Male,8982,Myoepithelial carcinoma,T3,N0,1,0,0,Alive,38
22,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,9
87,Male,8070,Squamous cell carcinoma,TX,NX,1,0,64,Alive,34
27,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,37
62,Male,8010,Carcinoma NOS,T4a,N0,1,1,27,Alive,5
62,Female,8430,Mucoepidermoid carcinoma,T1,N1,1,0,0,Alive,38
47,Male,8500,Adenocarcinoma,T3,N2a,1,1,0,Alive,36
72,Male,8430,Mucoepidermoid carcinoma,T4a,NX,1,0,0,Alive,33
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,38
37,Male,8010,Carcinoma NOS,T1,N0,0,0,7,"Nose, Nasal Cavity and Middle Ear",7
67,Female,8941,Carcinoma ex pleomorphic adenoma,T3,N0,0,0,0,Alive,41
47,Male,8550,Acinar cell carcinoma,T3,N0,1,1,0,Miscellaneous Malignant Cancer,14
27,Male,8430,Mucoepidermoid carcinoma,T3,N2b,0,0,Unable to calculate,Alive,6
62,Male,8500,Adenocarcinoma,T3,N3b,1,1,105,Alive,37
72,Male,8070,Squamous cell carcinoma,T4a,N0,1,0,22,Alive,35
32,Female,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Alive,31
72,Male,8550,Acinar cell carcinoma,T1,NX,0,0,0,Alive,0
77,Male,8070,Squamous cell carcinoma,T2,N3b,0,0,0,Alive,37
42,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,30
17,Female,8550,Acinar cell carcinoma,T1,N0,0,0,34,Alive,44
52,Female,8200,Adenoid cystic carcinoma,T2,N0,1,1,0,Lung and Bronchus,22
42,Male,8000,unspecified neoplasms,T2,N0,0,0,Unable to calculate,Alive,0
52,Male,8070,Squamous cell carcinoma,TX,N0,0,0,0,Alive,28
32,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,28
87,Female,8046,"epithelial neoplasms, NOS",T2,N0,0,0,23,Alive,10
57,Male,8140,Adenocarcinoma,T4a,NX,0,0,77,Accidents and Adverse Effects,12
27,Female,8147,Adenocarcinoma,T3,N0,0,0,0,Alive,38
57,Female,8200,Adenoid cystic carcinoma,T4b,N3b,1,1,53,Salivary Gland,9
57,Female,8500,Adenocarcinoma,T3,N3b,1,1,62,Salivary Gland,25
62,Male,8550,Acinar cell carcinoma,T4a,N3b,1,1,27,Salivary Gland,21
62,Male,8200,Adenoid cystic carcinoma,T2,N0,0,0,43,Alive,19
62,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,29,Alive,18
72,Male,8070,Squamous cell carcinoma,T4b,N3b,0,0,0,Miscellaneous Malignant Cancer,4
47,Male,8200,Adenoid cystic carcinoma,T4a,N0,1,1,0,Miscellaneous Malignant Cancer,9
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,13,Alive,10
47,Female,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,21
72,Male,8800,Sarcoma,T2,N0,1,0,0,Alive,30
52,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,34,Alive,23
32,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,25
47,Male,8525,ductal and lobular neoplasms,TX,N0,0,0,Unable to calculate,Alive,0
22,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,21
67,Female,8550,Acinar cell carcinoma,T2,N0,1,0,35,Alive,21
77,Female,8082,squamous cell neoplasms,T3,N1,1,0,65,Alive,28
52,Female,8200,Adenoid cystic carcinoma,T4a,N0,1,1,0,Alive,21
57,Male,8070,Squamous cell carcinoma,T3,N2b,0,0,Unable to calculate,Miscellaneous Malignant Cancer,2
62,Male,8070,Squamous cell carcinoma,TX,N2a,0,0,Unable to calculate,Alive,20
72,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,19
82,Male,8200,Adenoid cystic carcinoma,T3,N0,0,0,731+ days,Alive,19
67,Male,8140,Adenocarcinoma,T2,N0,1,0,0,Alive,23
17,Female,8430,Mucoepidermoid carcinoma,T2,N0,0,0,0,Alive,27
32,Male,8070,Squamous cell carcinoma,T2,N0,0,0,0,Alive,0
42,Female,8070,Squamous cell carcinoma,T1,N1,1,0,0,Alive,27
67,Male,8070,Squamous cell carcinoma,T3,N0,0,0,731+ days,Non-Melanoma Skin,30
82,Female,8070,Squamous cell carcinoma,T3,N2a,0,0,22,Non-Melanoma Skin,10
67,Male,8140,Adenocarcinoma,T1,N0,0,0,0,Alive,14
62,Male,8430,Mucoepidermoid carcinoma,T1,NX,0,0,0,Alive,18
67,Male,8070,Squamous cell carcinoma,T4a,N2b,0,0,52,Non-Melanoma Skin,14
72,Male,8071,Squamous cell carcinoma,T2,N0,1,0,0,Alive,16
32,Male,8010,Carcinoma NOS,T3,N0,1,0,0,Alive,13
72,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,34,Alive,20
72,Female,8430,Mucoepidermoid carcinoma,T1,N1,1,0,0,Alive,16
62,Female,8070,Squamous cell carcinoma,T3,N1,1,0,0,Alive,15
90,Female,8010,Carcinoma NOS,T3,N2c,0,0,Unable to calculate,Miscellaneous Malignant Cancer,1
82,Female,8550,Acinar cell carcinoma,TX,N0,0,0,Unable to calculate,Salivary Gland,9
67,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,Unable to calculate,Alive,14
82,Female,8010,Carcinoma NOS,T1,N1,0,0,324,Alive,15
47,Female,8430,Mucoepidermoid carcinoma,T1,N1,0,0,0,Alive,18
87,Male,8071,Squamous cell carcinoma,T4a,N0,0,0,79,Salivary Gland,4
67,Male,8500,Adenocarcinoma,T2,N0,0,0,64,Alive,13
77,Female,8200,Adenoid cystic carcinoma,T3,N0,1,0,0,Alive,11
52,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,16
47,Male,8010,Carcinoma NOS,T2,N0,1,0,48,Alive,10
27,Female,8550,Acinar cell carcinoma,T2,N0,1,0,0,Alive,15
57,Male,8550,Acinar cell carcinoma,T2,N0,0,0,27,Alive,11
90,Female,8430,Mucoepidermoid carcinoma,T3,N2a,0,0,Unable to calculate,Bones and Joints,1
47,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,0,59,Alive,11
57,Male,8000,unspecified neoplasms,T2,N0,0,0,Unable to calculate,Alive,9
62,Male,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,12
77,Female,8550,Acinar cell carcinoma,T1,N0,0,0,Unable to calculate,Alive,22
7,Male,8430,Mucoepidermoid carcinoma,T4a,N1,1,0,29,Alive,21
7,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,31,Alive,24
82,Male,8001,unspecified neoplasms,88,88,1,0,57,Alive,7
57,Male,8070,Squamous cell carcinoma,T1,N0,0,0,Unable to calculate,Alive,9
67,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,55,Alive,8
90,Male,8070,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Salivary Gland,1
27,Female,8200,Adenoid cystic carcinoma,T2,N0,1,0,0,Alive,11
67,Male,8430,Mucoepidermoid carcinoma,T3,N0,1,0,29,Alive,6
27,Female,8140,Adenocarcinoma,T1,N0,1,0,40,Alive,20
87,Male,8500,Adenocarcinoma,T1,N0,0,0,84,Alive,12
72,Female,8140,Adenocarcinoma,T1,N0,0,0,0,Alive,21
57,Female,8502,Adenocarcinoma,T2,N0,0,0,29,Alive,4
67,Male,8147,Adenocarcinoma,T3,N0,0,0,0,Alive,10
52,Female,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,6
72,Male,8070,Squamous cell carcinoma,T1,N0,1,1,0,Alive,6
82,Male,8000,unspecified neoplasms,TX,N0,0,0,49,Alive,1
57,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,47,Alive,5
67,Female,8982,Myoepithelial carcinoma,T1,N0,0,0,0,Alive,12
47,Female,8200,Adenoid cystic carcinoma,T2,N0,1,1,56,Alive,15
72,Female,8000,unspecified neoplasms,TX,N0,0,0,Unable to calculate,Lung and Bronchus,0
67,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,12
72,Male,8071,Squamous cell carcinoma,TX,NX,0,0,Unable to calculate,Other Cause of Death,8
57,Female,8502,Adenocarcinoma,T2,N0,0,0,0,Alive,17
67,Male,8010,Carcinoma NOS,T2,N3b,0,0,21,Other Cause of Death,6
57,Male,8070,Squamous cell carcinoma,T1,N2a,1,0,56,Alive,22
67,Male,8550,Acinar cell carcinoma,T3,N0,1,0,36,Alive,17
52,Male,8550,Acinar cell carcinoma,T2,N0,1,0,63,Alive,15
62,Female,8140,Adenocarcinoma,T2,N0,1,0,30,Alive,21
27,Female,8010,Carcinoma NOS,T1,N0,0,0,0,Alive,13
52,Male,8200,Adenoid cystic carcinoma,T4b,N1,1,0,0,Alive,19
77,Male,8071,Squamous cell carcinoma,TX,N1,0,0,26,Alive,14
82,Female,8430,Mucoepidermoid carcinoma,T3,N0,0,0,0,Alive,0
77,Female,8082,squamous cell neoplasms,TX,NX,0,0,0,Alive,4
37,Male,8502,Adenocarcinoma,T2,N0,0,0,0,Alive,4
72,Female,8430,Mucoepidermoid carcinoma,T2,N0,1,0,0,Alive,7
57,Male,8200,Adenoid cystic carcinoma,TX,N1,0,0,0,Alive,1
17,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,6
57,Male,8000,unspecified neoplasms,T4b,N3b,0,0,Unable to calculate,Other Cause of Death,0
82,Female,8010,Carcinoma NOS,T4b,N1,0,0,Unable to calculate,Alive,1
67,Male,8070,Squamous cell carcinoma,T1,N0,0,0,31,Alive,1
37,Female,8430,Mucoepidermoid carcinoma,T1,N0,1,0,0,Alive,0
57,Male,8430,Mucoepidermoid carcinoma,T3,N0,0,0,Unable to calculate,Alive,4
52,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,Unable to calculate,Alive,1
77,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,3
72,Male,8430,Mucoepidermoid carcinoma,T1,N0,1,0,14,Alive,3
52,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,2
57,Male,8083,Squamous cell carcinoma,T1,N0,1,0,80,Alive,9
90,Male,8070,Squamous cell carcinoma,T1,N0,0,0,42,Alive,0
52,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,8
77,Female,8941,Carcinoma ex pleomorphic adenoma,T2,N0,0,0,Unable to calculate,Alive,9
72,Male,8070,Squamous cell carcinoma,T1,N0,0,0,Unable to calculate,Alive,2
67,Male,8071,Squamous cell carcinoma,T1,N0,0,0,Unable to calculate,Alive,11
67,Female,8550,Acinar cell carcinoma,T2,N0,0,0,0,Alive,4
67,Male,8140,Adenocarcinoma,T3,N0,0,0,Unable to calculate,Other Cause of Death,1
77,Female,8562,Epithelial-myoepithelial carcinoma,T1,N0,1,0,0,Alive,0
82,Male,8071,Squamous cell carcinoma,T2,N0,0,0,23,Alive,4
42,Female,8000,unspecified neoplasms,TX,N0,0,0,Unable to calculate,Alive,0
12,Male,8550,Acinar cell carcinoma,T2,N0,0,0,44,Alive,6
87,Male,8010,Carcinoma NOS,T2,N0,0,0,73,Alive,2
37,Male,8140,Adenocarcinoma,T3,N0,1,0,27,Salivary Gland,8
67,Male,8500,Adenocarcinoma,T3,N0,1,0,0,Alive,6
57,Male,8941,Carcinoma ex pleomorphic adenoma,T3,N3b,0,0,102,Salivary Gland,3
57,Male,8430,Mucoepidermoid carcinoma,T4a,N0,1,0,0,Alive,10
52,Female,8200,Adenoid cystic carcinoma,T3,N0,1,1,0,Alive,10
72,Male,8562,Epithelial-myoepithelial carcinoma,T2,N0,1,0,0,Alive,10
82,Female,8070,Squamous cell carcinoma,T4a,N0,1,0,20,Diseases of Heart,10
57,Female,8310,Adenocarcinoma,T4b,N3a,1,0,57,Alive,10
47,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,Unable to calculate,Alive,0
67,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,4
57,Female,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,4
22,Male,8430,Mucoepidermoid carcinoma,T1,N0,0,0,0,Alive,6
77,Male,8430,Mucoepidermoid carcinoma,T2,N0,0,0,Unable to calculate,Alive,4
